Sentence,class,file
J Clin Endocrinol Metab  1992; 74:645-53; PMID:1740500; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
J Clin Endocrinol Metab 2003; 88:2965-71; PMID:12843128; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
Clin Immunol  2002; 103:303-8; PMID:12173305; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
Arthritis Rheum  2003; 48:1109-16; PMID:12687555; http://dx.doi.org/10.1002/art.10888.,Non-OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
Ann Rheum  Dis 2005; 64:845-8; PMID:15550532; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
Arthritis Rheum 2002; 46:1039- 43; PMID:11953982; http://dx.doi.org/10.1002/ art.10137.,Non-OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
N Engl J Med 1998; 338:1186- 91; PMID:9554859; http://dx.doi.org/10.1056/NEJM199804233381704.,OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
Circ  Res 2012; 110:82-93; PMID:22082491; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
Mol Hum Reprod  2010; 16:869-78; PMID:20663958; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
Cancer Res 2008; 68:8482-8;  PMID:18922922; http://dx.doi.org/10.1158/0008- 5472.CAN-08-0672.,Non-OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
Arthritis Rheum 2001; 44:2107-11;  PMID:11592373; http://dx.doi.org/10.1002/1529-0131(200109)44:9<2107::AID-ART361>3.0.CO;2-9.,Non-OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
Horm Metab Res 2009; 41:436-42; PMID:19343619; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
J Clin Endocrinol Metab 2005; 90:5309-12;  PMID:15956077; http://dx.doi.org/10.1210/jc.2005- 0771.,Non-OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
Eur J Endocrinol 2006; 154:39- 45; PMID:16381989; http://dx.doi.org/10.1530/ eje.1.02070.,Non-OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
Thyroid 2010; 20:1151-6; PMID:20883173; http://dx.doi.org/10.1089/thy.2009.0424.,Non-OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
Autoimmunity 2008; 41:174-80; PMID:18324487;  http://dx.doi.org/10.1080/08916930701777629.,Non-OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
Cancer Res 2007; 67:9035-8;  PMID:17909006; http://dx.doi.org/10.1158/0008- 5472.CAN-06-4209.,Non-OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
Breast Cancer Res 2008; 10:R14; PMID:18271969;  http://dx.doi.org/10.1186/bcr1860.,Non-OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
Reprod Biomed Online 2008; 16:382-90;  PMID:18339261; http://dx.doi.org/10.1016/S1472- 6483(10)60600-1.,OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
Am J Pathol 2009; 174:630- 7; PMID:19147820; http://dx.doi.org/10.2353/ajpath.2009.080566.,Non-OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
Hepatology 2002; 36:1295-7; PMID:12395344;  http://dx.doi.org/10.1053/jhep.2002.35622.,Non-OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
Hepatology 2005; 42:35- 43; PMID:15962317; http://dx.doi.org/10.1002/ hep.20761.,Non-OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
Biochem Biophys Res Commun 2004; 325:961-7; PMID:15541383; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
Stem Cells  2005; 23:1443-52; PMID:16091558; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
Arthritis Rheum  2000; 43:2598-605; PMID:11083286; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
Curr Opin Rheumatol 2005; 17:86- 90; PMID:15604910; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
Thyroid  2010; 20:715-25; PMID:20604685; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
J Clin Endocrinol Metab 2009; 94:4439-43;  PMID:19808849; http://dx.doi.org/10.1210/jc.2009-0813.,Non-OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
Best Pract Res Clin Obstet Gynaecol 2004; 18:959-75; PMID:15582549; http://dx.doi.org/10.1016/j.bpob- gyn.2004.06.007.,Non-OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
Rheumatology (Oxford)  2007; 46:200-8; PMID:17135226; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
J Reprod Immunol 2008; 78:68- 75; PMID:18329105; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
Cancer Lett  2010; 287:136-41; PMID:19541407; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/e3/chim-4-111.PMC3921191.pdf
"Hum Reprod 2012; 27:2607-12; PMID:22752611; http://dx.doi.org/10.1093/humrep/des244.Keywords:  microchimerism, miscarriage,  pregnancy termination, fetal, aneuploidy Abbreviations:  PBMC, peripheral blood  mononuclear cellsSubmitted: 05/01/13Accepted: 05/02/13http://dx.doi.org/10.4161/chim.24915 *Correspondence to: Hilary S Gammill;   Email: hgammill@u.washington.eduFetal cells transfer to the mother dur - ing pregnancy and can persist long- term as microchimerism.",Non-OADS,/arxiv_data1/oa_pdf/c9/11/chim-4-136.PMC3921195.pdf
Lancet 1998; 351:559-62; PMID:9492775; http://dx.doi.org/10.1016/S0140-6736(97)08357-8.,Non-OADS,/arxiv_data1/oa_pdf/c9/11/chim-4-136.PMC3921195.pdf
Cancer Res 2007; 67:9035-8;  PMID:17909006; http://dx.doi.org/10.1158/0008- 5472.CAN-06-4209.,Non-OADS,/arxiv_data1/oa_pdf/c9/11/chim-4-136.PMC3921195.pdf
Am J Obstet Gynecol 2001; 184:703-6; PMID:11262475; http://dx.doi.org/10.1067/ mob.2001.111072.,Non-OADS,/arxiv_data1/oa_pdf/c9/11/chim-4-136.PMC3921195.pdf
Perspect Sex  Reprod Health 2011; 43:41-50; PMID:21388504;  http://dx.doi.org/10.1363/4304111.,Non-OADS,/arxiv_data1/oa_pdf/c9/11/chim-4-136.PMC3921195.pdf
N Engl J Med 1988; 319:189- 94; PMID:3393170; http://dx.doi.org/10.1056/ NEJM198807283190401.,OADS,/arxiv_data1/oa_pdf/c9/11/chim-4-136.PMC3921195.pdf
Am J  Med 2005; 118:899-906; PMID:16084184; http://dx.doi.org/10.1016/j.amjmed.2005.03.037.,OADS,/arxiv_data1/oa_pdf/c9/11/chim-4-136.PMC3921195.pdf
Arthritis Rheum 2003; 48:3237- 41; PMID:14613289; http://dx.doi.org/10.1002/ art.11324.,Non-OADS,/arxiv_data1/oa_pdf/c9/11/chim-4-136.PMC3921195.pdf
Hum Reprod 2012; 27:2607- 12; PMID:22752611; http://dx.doi.org/10.1093/ humrep/des244.,OADS,/arxiv_data1/oa_pdf/c9/11/chim-4-136.PMC3921195.pdf
"Arthritis Rheum 2004;  50:3058-9, author reply 3059; PMID:15457487;  http://dx.doi.org/10.1002/art.20650.12.",Non-OADS,/arxiv_data1/oa_pdf/c9/11/chim-4-136.PMC3921195.pdf
Fertil Steril 2004; 81:638-44; PMID:15037414; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c9/11/chim-4-136.PMC3921195.pdf
Am J Hum Genet  1998; 62:768-75; PMID:9529358; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c9/11/chim-4-136.PMC3921195.pdf
Placenta 2010; 31:589- 94; PMID:20569981; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c9/11/chim-4-136.PMC3921195.pdf
Ann Intern Med  1985; 103:566-78; PMID:2864010; http://dx.doi.org/10.7326/0003-4819-103-4-566.,Non-OADS,/arxiv_data1/oa_pdf/c9/11/chim-4-136.PMC3921195.pdf
Lancet  1994; 344:353-6; PMID:7914304; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c9/11/chim-4-136.PMC3921195.pdf
Neurology 2001; 57:979-84;  PMID:11571320; http://dx.doi.org/10.1212/ W NL .57.6.979.,Non-OADS,/arxiv_data1/oa_pdf/c9/11/chim-4-136.PMC3921195.pdf
PLoS One 2012; 7:e45592;  PMID:23049819; http://dx.doi.org/10.1371/jour - nal.pone.0045592.,Non-OADS,/arxiv_data1/oa_pdf/c9/11/chim-4-136.PMC3921195.pdf
Stem Cells Dev 2010; 19:1819- 30; PMID:20707697; http://dx.doi.org/10.1089/ scd.2010.0046.,Non-OADS,/arxiv_data1/oa_pdf/c9/11/chim-4-136.PMC3921195.pdf
Am J Hum Genet 1997; 61:822-9; PMID:9382092; http://dx.doi.org/10.1086/514885.,OADS,/arxiv_data1/oa_pdf/c9/11/chim-4-136.PMC3921195.pdf
"OncoImmunology 2013; 2:e26689; http://dx.doi.org/10.4161/onci.26689Impact of STAT1 and CD8+ T cells   on the antineoplastic activity of lapatinib   and doxorubicin against spontaneous   mammary tumors Piotr Tymoszuk and w olfgang Doppler* Division of Medical Biochemistry; Biocenter; Innsbruck Medical u niversity; Innsbruck, austria Keywords:  antitumor immunity, CD8+ T cells, CXCR3 ligands, doxorubicin, mammary cancer, lapatinib, STAT1 Abbreviations: CXCL, chemokine (C-X-C motif) ligand; CXCR3, chemokine (C-X-C motif) receptor 3; IFN γ, interferon γ ;  IFNGR, IFN γ receptor; MMTV, mouse mammary tumor virus; STAT1, signal transducer and activator of transcription 1;   TAM, tumor-associated macrophage we have recently demonstrated that CD8+ T cells provide a critical contribution to the antineoplastic activity of 2  chemotherapeutic agents, i.e., doxorubicin and lapatinib, in a model of spontaneous mammary carcinogenesis.",Non-OADS,/arxiv_data1/oa_pdf/3c/88/onci-2-e26689.PMC3921202.pdf
Nat  Rev Immunol 2008; 8:59-73;  PMID:18097448 ;  http://dx.doi.org/10.1038/nri2216 .,Non-OADS,/arxiv_data1/oa_pdf/3c/88/onci-2-e26689.PMC3921202.pdf
J Immunol  2011 ; 186:3847 - 57;  PMID:21346233 ; http://dx.doi.org/10.4049/ jimmunol.1000361 .5.,Non-OADS,/arxiv_data1/oa_pdf/3c/88/onci-2-e26689.PMC3921202.pdf
J Exp Med 2005 ; 201:1591- 602;  PMID:15883172 ;  http://dx.doi.org/10.1084/ jem.20042167 .,Non-OADS,/arxiv_data1/oa_pdf/3c/88/onci-2-e26689.PMC3921202.pdf
Eur J Immunol 2013 ;  PMID:23843024 ;  http://dx.doi.org/10.1002/eji.2012425058.,Non-OADS,/arxiv_data1/oa_pdf/3c/88/onci-2-e26689.PMC3921202.pdf
Cancer Res 2011 ; 71:4809 -20;   PMID:21646474 ; http://dx.doi.org/10.1158/0008- 5472.CAN-11-0753 .,Non-OADS,/arxiv_data1/oa_pdf/3c/88/onci-2-e26689.PMC3921202.pdf
"Nat Med  2012 ; 18:344-6,  author reply 346 ;  PMID:22395693 ; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/3c/88/onci-2-e26689.PMC3921202.pdf
Communicative & Integrative Biology 2013; 6:e27122; http://dx.doi.org/10.4161/cib.27122,Non-OADS,/arxiv_data1/oa_pdf/9a/1b/cib-6-e27122.PMC3921203.pdf
Naturwissenschaften 1941; 29:201-18;  http://dx.doi.org/10.1007/BF01481755 8.,Non-OADS,/arxiv_data1/oa_pdf/9a/1b/cib-6-e27122.PMC3921203.pdf
Nature  1951 ;  168:373-5; http://dx.doi.org/10.1038/168373a0 10.,Non-OADS,/arxiv_data1/oa_pdf/9a/1b/cib-6-e27122.PMC3921203.pdf
Anim Cogn  2009 ; 12:193- 9; http://dx.doi.org/10.1007/s10071-008-0185-9 ;  PMID:18712531 11.,OADS,/arxiv_data1/oa_pdf/9a/1b/cib-6-e27122.PMC3921203.pdf
Behav Sci 2012 ; 2012 :50-6;  http://dx.doi.org/10.3390/bs202005012.,Non-OADS,/arxiv_data1/oa_pdf/9a/1b/cib-6-e27122.PMC3921203.pdf
Anim Cogn  2012 ; 15:955-61; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/1b/cib-6-e27122.PMC3921203.pdf
Front Psychol  2012 ;  3:181; http://dx.doi.org/10.3389/fpsyg.2012.00181 ;  PMID:22675317Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/9a/1b/cib-6-e27122.PMC3921203.pdf
"The TransEuro Project ( http://www.transeuro.org.uk ) is currently evaluating grafts of human fetal ventral mesencephalon (hfVM, rich in precursor dopaminergic cells) in treatment of PD.",Non-OADS,/arxiv_data1/oa_pdf/f7/00/wnr-25-139.PMC3921258.pdf
"Available at: http://eu-cancer.iarc.fr.Accessed March 25, 2013.",Non-OADS,/arxiv_data1/oa_pdf/ca/83/igj-24-260.PMC3921259.pdf
"MATERIALS AND METHODS Please refer to the Supplemental data for detailed methods, available at http://links.lww.com/IGC/A194.",Non-OADS,/arxiv_data1/oa_pdf/c1/ee/igj-24-329.PMC3921261.pdf
"S1,available at http://links.lww.com/IGC/A194).",Non-OADS,/arxiv_data1/oa_pdf/c1/ee/igj-24-329.PMC3921261.pdf
"We additionally performed allele frequency analysis of all identified mutations to evaluate the extent to which exome reads support a mutation (SupplementalDigital Content Table S1, available at http://links.lww.com/IGC/A194).",Non-OADS,/arxiv_data1/oa_pdf/c1/ee/igj-24-329.PMC3921261.pdf
http://links.lww.com/IGC/A19 4.,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/igj-24-329.PMC3921261.pdf
Supplemental data are availableat http://links.lww.com/IGC/A194.,OADS,/arxiv_data1/oa_pdf/c1/ee/igj-24-329.PMC3921261.pdf
"For COSMIC genes that fell in CNVs, we evaluated if these genes also demonstrated expression changes in the tumor (Supplemental Digital Content Table S3, available at http://links.lww.com/IGC/A194).",Non-OADS,/arxiv_data1/oa_pdf/c1/ee/igj-24-329.PMC3921261.pdf
"Quantitative PCR validation confirmed PIK3CA overexpression in the tum or as compared against A- actin ( CCt = 8.7; Supplemental Digital Content Table S4, available at http://links.lww.com/IGC/A194).",Non-OADS,/arxiv_data1/oa_pdf/c1/ee/igj-24-329.PMC3921261.pdf
"The top 10 affected pathways for each analysis are listed in Supple- mentary Table S5, available at http://links.lww.com/IGC/A194.Overall, pathways that are likely to be the most affected by identified expression changes include cell cycle processes, DNA methylation, stromal-epithelial i nteractions, cell adhesion, and DNA damage processes.",OADS,/arxiv_data1/oa_pdf/c1/ee/igj-24-329.PMC3921261.pdf
"of reads that were acquired for each gene to determine the level of expression (Supplemental Digital Content Table S7, avail- able at http://links.lww.com/IGC/A194).",OADS,/arxiv_data1/oa_pdf/c1/ee/igj-24-329.PMC3921261.pdf
"Thesegenes include TP53 (tumor protein p53), WAF1/CDKN1A (p21; cycle-dependent kinase inhibitor 1A), RB1 (retino- blastoma 1), CCNE2 (cyclin E2), E2F1 (E2F transcription factor 1), CDKN2A (cyclin-dependent kinase inhibitor 2A), BRD4 (bromodomain containing 4), and CDC25A (cell di- vision cycle 25A; Supplemental Digital Content Table S8,available at http://links.lww.com/IGC/A194).",Non-OADS,/arxiv_data1/oa_pdf/c1/ee/igj-24-329.PMC3921261.pdf
"PCR products were Sanger sequenced,and resulting chromatograms confirmed the presence of the 4 junctions (Supplemental Digital Content Figure S2, available at http://links.lww.com/IGC/A194).",OADS,/arxiv_data1/oa_pdf/c1/ee/igj-24-329.PMC3921261.pdf
More detail on the design of the underlyingeffectiveness trial and its clinical outcomes can be found in acompanion publication 11and at http://clinicaltrials.gov/ct2/show/ NCT00718796 .,Non-OADS,/arxiv_data1/oa_pdf/2f/0b/joem-56-171.PMC3921268.pdf
"Unit Costs and Sources ResourceUnit Cost (2008 Canadian Dollars) Naturopathic doctor visit (per hour)* $152.50 Biometric screening for the control group (per screening) †$21.00 Conventional doctor visit ‡ $42.35 Chiropractic visit§ $43.31Physiotherapist visit§ $65.67 Massage visit§ $59.82 Acupuncture visit§ $57.03Employer cost (per hour)|| $27.40 *Average of range of $125 to $180 per hour from the Canadian Association of Naturopathic Doctors Web site ( http://www.cand.ca/index.php?39 ), accessed on-line September 10, 2010.",Non-OADS,/arxiv_data1/oa_pdf/2f/0b/joem-56-171.PMC3921268.pdf
"‡Cost of a repeat consultation (A006) from the Schedule of Beneﬁts for Physician Services, Ontario Health Insurance Program (http://health.gov.on.ca/ english/providers/program/ohip/sob/physserv/a_consul.pdf), accessed on-lineSeptember 10, 2010.",Non-OADS,/arxiv_data1/oa_pdf/2f/0b/joem-56-171.PMC3921268.pdf
"Key Words :  Default mode · Functional MRI · Motor task · Deactivation · Intracranial lesion.Laboratory Investigation • Received : February 19, 2013  • Revised : August 22, 2013  • Accepted : December 12, 2013 • Address for reprints : Jun Seok Koh, M.D., Ph.D.  Department of Neurosurgery, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, 892 Dongnam-ro, Gangdong-gu, Seoul 134-727, Korea  Tel : +82-2-440-6145,  Fax : +82-2-440-7171,  E-mail : neurokoh@hanmail.net • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 453-460, 2013http://dx.doi.org/10.3340/jkns.2013.54.6.453 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/7f/7c/jkns-54-453.PMC3921271.pdf
"• Received : February 5, 2013  • Revised : June 17, 2013  • Accepted : December 12, 2013  • Address for reprints : Jeong-Hyun Hwang, M.D., Ph.D.   Department of Neurosurgery, School of Medicine, Kyungpook National University, 130 Dongdeok-ro, Jung-gu, Daegu 700-721, Korea   Tel : +82-53-420-5651,  Fax : +82-53-423-0504,  E-mail : jhwang@knu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 461-466, 2013http://dx.doi.org/10.3340/jkns.2013.54.6.461 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr Therapeutic Advantages of Treatment of High-Dose  Curcumin in the Ovariectomized Rat  Dae-Chul Cho, M.D., Ph.D.,1* Hyun-Sik Jung, M.D.,1* Kyoung-Tae Kim, M.D., Ph.D.,1 Younghoon Jeon, M.D., Ph.D.,2  Joo-Kyung Sung, M.D., Ph.D.,1 Jeong-Hyun Hwang, M.D., Ph.D.1 Department of Neurosurgery,1 School of Medicine, Department of Anesthesiology and Pain Medicine,2  School of Dentistry, Kyungpook National University, Daegu, Korea  Objective :  Although curcumin has a protective effect on bone remodeling, appropriate therapeutic concentrations of curcumin are not well known  as therapeutic drugs for osteoporosis.",Non-OADS,/arxiv_data1/oa_pdf/7f/ba/jkns-54-461.PMC3921272.pdf
"By  promoting angiogenesis15), the hBM-MSCs may help to restore  •	Received 	:	February 	22,	2013 		•	Revised 	:	July	17,	2013 		•	Accepted 	:	December 	12,	2013 •	Address 	for	reprints 	:	Byung 	Kook 	Kwak, 	M.D., 	Ph.D. 	 	Department 	of	Radiology, 	Chung-Ang 	University 	Hospital, 	102	Heukseok-ro, 	Dongjak-gu, 	Seoul 	156-755, 	Korea 	Tel	:	+82-2-6299-2661, 		Fax	:	+82-2-6263-1557, 		E-mail 	:	kwakbk@cau.ac.kr •	This	is	an	Open 	Access 	article 	distributed 	under 	the	terms 	of	the	Creative 	Commons 	Attribution 	Non-Commercial 	License 	(http://creativecommons.org/licenses/by-nc/3.0) 			 	 which 	permits 	unrestricted 	non-commercial 	use,	distribution, 	and	reproduction 	in	any	medium, 	provided 	the	original 	work 	is	properly 	cited.J Korean Neurosurg Soc 54  : 467-476, 	2013http://dx.doi.org/10.3340/jkns.2013.54.6.467 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr Engraftment of Human Mesenchymal Stem Cells   in a Rat Photothrombotic Cerebral Infarction Model :  Comparison of Intra-Arterial and Intravenous Infusion  Using MRI and Histological Analysis  Jun Soo Byun, M.D., Ph.D., Byung Kook Kwak, M.D., Ph.D., Jae Kyun Kim, M.D., Jisung Jung, M.S., Bon Chul Ha, M.S., Serah Park, B.S.",Non-OADS,/arxiv_data1/oa_pdf/b5/4d/jkns-54-467.PMC3921273.pdf
"However, be - •	Received 	:	May	29,	2013 		•	Revised 	:	August 	16,	2013 		•	Accepted 	:	December 	12,	2013 •	Address 	for	reprints 	:	Jae	Min	Kim,	M.D., 	Ph.D. 	Department 	of	Neurosurgery, 	Hanyang 	University 	Guri	Hospital, 	153	Gyeongchun-ro, 	Guri	471-701, 	Korea 	Tel	:	+82-31-560-2323, 		Fax	:	+82-31-560-2327, 		E-mail 	:	kjm2323@hanyang.ac.kr •	This	is	an	Open 	Access 	article 	distributed 	under 	the	terms 	of	the	Creative 	Commons 	Attribution 	Non-Commercial 	License 	(http://creativecommons.org/licenses/by-nc/3.0) 			 	 which 	permits 	unrestricted 	non-commercial 	use,	distribution, 	and	reproduction 	in	any	medium, 	provided 	the	original 	work 	is	properly 	cited.J Korean Neurosurg Soc 54  : 477-483, 	2013http://dx.doi.org/10.3340/jkns.2013.54.6.477 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr Internal Carotid Artery Reconstruction Using Multiple  Fenestrated Clips for Complete Occlusion of Large  Paraclinoid Aneurysms Sang Kook Lee, M.D., Ph.D., Jae Min Kim, M.D., Ph.D. Department of Neurosurgery, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea Objective : 	Although 	surgical 	techniques 	for	clipping 	paraclinoid 	aneurysms 	have 	evolved 	significantly 	in	recent 	times, 	direct 	microsurgical 	clipping 	 of	large 	and	giant 	paraclinoid 	aneurysms 	remains 	a	formidable 	surgical 	challenge.",Non-OADS,/arxiv_data1/oa_pdf/7b/b6/jkns-54-477.PMC3921274.pdf
"Department 	of	Physical 	Medicine 	&	Rehabilitation, 	Chonbuk 	National 	University 	Medical 	School, 	Research 	Institute 	of	Clinical 	Medicine 	of	Chonbuk 	National 	University- 		Biomedical 	Research 	Institute 	of	Chonbuk 	National 	University 	Hospital, 	567	Baekje-daero, 	Deokjin-gu, 	Jeonju 	561-756, 	Korea 	Tel	:	+82-63-250-1795, 		Fax	:	+82-63-254-4145, 		E-mail 	:	mhko@jbnu.ac.kr •	This	is	an	Open 	Access 	article 	distributed 	under 	the	terms 	of	the	Creative 	Commons 	Attribution 	Non-Commercial 	License 	(http://creativecommons.org/licenses/by-nc/3.0) 			 	 which 	permits 	unrestricted 	non-commercial 	use,	distribution, 	and	reproduction 	in	any	medium, 	provided 	the	original 	work 	is	properly 	cited.J Korean Neurosurg Soc 54  : 484-488, 	2013http://dx.doi.org/10.3340/jkns.2013.54.6.484 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr A Double-Blind, Sham-Controlled, Pilot Study to Assess  the Effects of the Concomitant Use of Transcranial  Direct Current Stimulation with the Computer Assisted  Cognitive Rehabilitation to the Prefrontal Cortex   on Cognitive Functions in Patients with Stroke See-Hyun Park, M.D.,1 Eun-Jeong Koh, M.D.,2 Ha-Young Choi, M.D.,2 Myoung-Hwan Ko, M.D.1 Department of Physical Medicine & Rehabilitation,1 Chonbuk National University Medical School, Research Institute of Clinical Medicine of  Chonbuk National University-Biomedical Research Institute of Chonbuk National University Hospital, Jeonju, Korea   Department of Neurosurgery,2 Chonbuk National University School of Medicine, Jeonju, Korea Objective : 	To	examine 	the	synergistic 	effects 	of	both	computer-assisted 	cognitive 	rehabilitation 	(CACR) 	and	transcranial 	direct 	current 	stimulation 	 	 (tDCS) 	on	cognitive 	function 	in	patients 	with	stroke.",Non-OADS,/arxiv_data1/oa_pdf/b0/f5/jkns-54-484.PMC3921275.pdf
"Key Words :  Anaplastic oligodendroglioma · Anaplastic oligoastrocytoma · Chemotherapy · Recurrence · Temozolomide.Clinical Article • Received : April 20, 2013  • Revised : August 22, 2013  • Accepted : September 30, 2013 • Address for reprints : Seung Hoon Lee, M.D., Ph.D.  Neuro-Oncology Clinic, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 410-769, Korea  Tel : +82-31-920-1503,  Fax : +82-31-920-2798,  E-mail : nslsh@ncc.re.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 489-495, 2013http://dx.doi.org/10.3340/jkns.2013.54.6.489 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/28/a4/jkns-54-489.PMC3921276.pdf
"Therefore, postmenopausal women over 50 years of age  •	Received 	:	July	10,	2013 		•	Revised 	:	October 	12,	2013 		•	Accepted 	:	December 	12,	2013 •	Address 	for	reprints 	:	Young 	Seob 	Chung, 	M.D., 	Ph.D. 	Department 	of	Neurosurgery, 	Seoul 	National 	University 	Boramae 	Hospital, 	20	Boramae-ro 	5-gil, 	Dongjak-gu, 	Seoul 	156-707, 	Korea 	Tel	:	+82-2-870-2301, 		Fax	:	+82-2-870-3863, 		E-mail 	:	yschung@snu.ac.kr •	This	is	an	Open 	Access 	article 	distributed 	under 	the	terms 	of	the	Creative 	Commons 	Attribution 	Non-Commercial 	License 	(http://creativecommons.org/licenses/by-nc/3.0) 			 	 which 	permits 	unrestricted 	non-commercial 	use,	distribution, 	and	reproduction 	in	any	medium, 	provided 	the	original 	work 	is	properly 	cited.J Korean Neurosurg Soc 54  : 496-500, 	2013http://dx.doi.org/10.3340/jkns.2013.54.6.496 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr The Impact of Menopause on Bone Fusion after the  Single-Level Anterior Cervical Discectomy and Fusion Sung Bae Park, M.D.,1 Chun Kee Chung, M.D., Ph.D.,2,3 Sang Hyung Lee, M.D., Ph.D.,1 Hee-Jin Yang, M.D., Ph.D.,1 Young-Je Son, M.D.,1  Young Seob Chung, M.D., Ph.D.1 Department of Neurosurgery,1 Seoul National University Boramae Medical Center, Seoul, Korea Department of Neurosurgery,2 Seoul National University College of Medicine, Seoul, Korea Clinical Research Institute,3 Seoul National University Hospital, Seoul, Korea Objective : 	To	evaluate 	the	successful 	fusion 	rate	in	postmenopausal 	women 	with	single-level 	anterior 	cervical 	discectomy 	and	successful 	fusion 	 (ACDF) 	and	identify 	the	significant 	factors 	related 	to	bone 	successful 	fusion 	in	pre-	and	postmenopausal 	women.",Non-OADS,/arxiv_data1/oa_pdf/77/de/jkns-54-496.PMC3921277.pdf
"With the increasing rate of spinal surgery, the number of pa - •	Received 	:	April	22,	2013 		•	Revised 	:	June 	17,	2013 		•	Accepted 	:	December 	12,	2013 •	Address 	for	reprints 	:	Chung-kee 	Chough, 	M.D., 	Ph.D. 	Department 	of	Neurosurgery, 	Yeouido 	St.	Mary’s 	Hospital, 	The	Catholic 	University 	of	Korea 	College 	of	Medicine, 	10	63-ro, 	Yeongdeungpo-gu, 	Seoul 	150-713, 	Korea 	Tel	:	+82-2-3779-1042, 		Fax	:	+82-2-786-5809, 		E-mail 	:	chough@catholic.ac.kr •	This	is	an	Open 	Access 	article 	distributed 	under 	the	terms 	of	the	Creative 	Commons 	Attribution 	Non-Commercial 	License 	(http://creativecommons.org/licenses/by-nc/3.0) 			 	 which 	permits 	unrestricted 	non-commercial 	use,	distribution, 	and	reproduction 	in	any	medium, 	provided 	the	original 	work 	is	properly 	cited.J Korean Neurosurg Soc 54  : 501-506, 	2013http://dx.doi.org/10.3340/jkns.2013.54.6.501 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr Factors Associated with the Success of Trial Spinal  Cord Stimulation in Patients with Chronic Pain   from Failed Back Surgery Syndrome Byung-chul Son, M.D., Ph.D.,1 Deok-ryeong Kim, M.D.,2 Sang-won Lee, M.D., Ph.D.,2 Chung-kee Chough, M.D., Ph.D.3 Department of Neurosurgery,1 Seoul St. Mary’ s Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea Department of Neurosurgery,2 St. Vincent’ s Hospital, The Catholic University of Korea College of Medicine, Suwon, Korea Department of Neurosurgery,3 Yeouido St. Mary’ s Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea Objective : 	Spinal 	cord	stimulation 	(SCS) 	is	an	effective 	means 	of	treatment 	of	chronic 	neuropathic 	pain	from 	failed 	back 	surgery 	syndrome 	(FBSS).",Non-OADS,/arxiv_data1/oa_pdf/26/ff/jkns-54-501.PMC3921278.pdf
"Department 	of	Neurosurgery, 	School 	of	Medicine, 	Hallym 	University, 	77	Sakju-ro, 	Chuncheon 	200-704, 	Korea 	 	Tel	:	+82-33-240-5171, 		Fax	:	+82-33-252-0941, 		E-mail 	:	neurosurgeon@hallym.or.kr •	This	is	an	Open 	Access 	article 	distributed 	under 	the	terms 	of	the	Creative 	Commons 	Attribution 	Non-Commercial 	License 	(http://creativecommons.org/licenses/by-nc/3.0) 			 	 which 	permits 	unrestricted 	non-commercial 	use,	distribution, 	and	reproduction 	in	any	medium, 	provided 	the	original 	work 	is	properly 	cited.J Korean Neurosurg Soc 54  : 507-510, 	2013http://dx.doi.org/10.3340/jkns.2013.54.6.507 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr Effect of Pulsed Radiofrequency Neuromodulation   on Clinical Improvements in the Patients of Chronic  Intractable Shoulder Pain Ji Su Jang, M.D.,1 Hyuk Jai Choi, M.D.,2 Suk Hyung Kang, M.D.,2 Jin Seo Yang, M.D.,2 Jae Jun Lee, M.D.,1 Sung Mi Hwang, M.D.1  Departments of Anesthesiology and Pain Medicine,1 Neurosurgery,2 School of Medicine, Hallym University, Chuncheon, Korea  Objective : 	The	aim	of	this	study 	was	to	evaluate 	effect 	of	pulsed 	radiofrequency 	(PRF) 	neuromodulation 	of	suprascpaular 	nerve 	(SSN) 	in	patients 	 with	chronic 	shoulder 	pain	due	to	adhesive 	capsulitis 	and/or 	rotator 	cuff	tear.",Non-OADS,/arxiv_data1/oa_pdf/60/37/jkns-54-507.PMC3921279.pdf
"Department of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea  Tel : +82-2-2072-2358,  Fax : +82-744-8459,  E-mail : sparkahn@naver.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 511-514, 2013http://dx.doi.org/10.3340/jkns.2013.54.6.511 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/dc/b8/jkns-54-511.PMC3921280.pdf
"Key Words :  Concomitant disease · Cranial subdural hematoma · Spinal subdural hematoma · Migration · Subdural space.Case Report • Received : May 7, 2013  • Revised : September 25, 2013  • Accepted : December 12, 2013 • Address for reprints : Dong Ah Shin, M.D., Ph.D.  Department of Neurosurgery, College of Medicine, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea  Tel : +82-2-2228-2150,  Fax : +82-2-393-9979,  E-mail : shindongah@me.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 515-517, 2013http://dx.doi.org/10.3340/jkns.2013.54.6.515 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/95/28/jkns-54-515.PMC3921281.pdf
"Key Words :  Lipoma · Osteolipoma · Ossified lipoma · Ossifying lipoma · Lipomatous tumor.Case Report • Received : May 30, 2013  • Revised : September 29, 2013  • Accepted : December 12, 2013 • Address for reprints : Suk Hyung Kang, M.D., Ph.D.  Department of Neurosurgery, Chuncheon Sacred Heart Hospital, College of Medicine, Hallym University, 77 Sakju-ro, Chuncheon 200-704, Korea  Tel : +82-33-240-5173,  Fax : +82-33-242-9970,  E-mail : nscharisma@hanmail.net • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 518-520, 2013http://dx.doi.org/10.3340/jkns.2013.54.6.518 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/0e/cc/jkns-54-518.PMC3921282.pdf
"Department of Neurosurgery, Konkuk University School of Medicine, 120-1 Neungdong-ro, Gwangjin-gu, Seoul 143-729, Korea  Tel : +82-2-2030-7625,  Fax : +82-2-2030-7359,  E-mail : s1nsman@chol.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 521-524, 2013http://dx.doi.org/10.3340/jkns.2013.54.6.521 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/ef/28/jkns-54-521.PMC3921283.pdf
"Key Words :  Subgaleo-peritoneal shunt · Migration · Pseudomeningocele.Case Report • Received : April 18, 2013  • Revised : August 8, 2013  • Accepted : December 12, 2013 • Address for reprints : Gi-Taek Yee, M.D., Ph.D.  Department of Neurosurgery, Gil Medical Center, Gachon University, 21 Namdong-daero 774beon-gil, Namdong-gu, Incheon 405-760, Korea   Tel : +82-32-460-3304,  Fax : +82-32-460-3899,  E-mail : gtyee@gilhospital.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 525-527, 2013http://dx.doi.org/10.3340/jkns.2013.54.6.525 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr Fig.",Non-OADS,/arxiv_data1/oa_pdf/5e/f3/jkns-54-525.PMC3921284.pdf
"325, Sec 2, Cheng-Gong Rd, Neihu, Taipei 114, Taiwan, ROC  Tel : +886-2-87927122,  Fax : +886-2-66002357,  E-mail : yeeminjen@gmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 528-531, 2013http://dx.doi.org/10.3340/jkns.2013.54.6.528 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/d9/42/jkns-54-528.PMC3921285.pdf
"Department of Orthopedic Surgery, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, 77 Sakju-ro, Chuncheon 200-704, Korea   Tel : +82-33-240-5198,  Fax : +82-33-252-0177,  E-mail : seoem@hallym.or.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 532-536, 2013http://dx.doi.org/10.3340/jkns.2013.54.6.532 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/2c/17/jkns-54-532.PMC3921286.pdf
"Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea  Tel : +82-2-3410-2457,  Fax : +82-2-3410-0048,  E-mail : sobotta72@hotmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 537-539, 2013http://dx.doi.org/10.3340/jkns.2013.54.6.537 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/a2/b8/jkns-54-537.PMC3921287.pdf
"Department of Neurosurgery, Konkuk UniversityMedical Center, 120-1 Neungdong-ro, Gwangjin-gu, Seoul 143-729, Korea  Tel : +82-2-2030-2357,  Fax : +82-2-2030-7359,  E-mail : s1nsman@chol.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 540-543, 2013http://dx.doi.org/10.3340/jkns.2013.54.6.540 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/5e/eb/jkns-54-540.PMC3921288.pdf
"http://e-cnr.org1 Clin Nutr Res 2014;3:1-8 http://dx.doi.org/10.7762/cnr.2014.3.1.1pISSN 2287-3732 ∙ eISSN 2287-3740Review Article This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.© 2014 The Korean Society of Clinical Nutrition  *Corresponding author  Hyeran Jang Address  Division of Endocrinology, Diabetes and Hypertension Brigham and Women's Hospital/HMS 221 Longwood ave. EBRC-212  Boston, MA 02115, USA   Tel +1-617-525-9054   Fax +1-617-582-6193 E-mail  hjang1@partners.org Received November 28, 2013 Revised  December 21, 2013 Accepted  December 21, 2013Introduction Many human diseases that appear in adulthood are related  to growth patterns during early life.",Non-OADS,/arxiv_data1/oa_pdf/a9/5a/cnr-3-1.PMC3921290.pdf
http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.12 Dutch Famine Birth Cohort Insights in the importance of nutritional supply during a  critical period on long-term disease outcome were gained  from the Dutch Famine cohort.,Non-OADS,/arxiv_data1/oa_pdf/a9/5a/cnr-3-1.PMC3921290.pdf
Nutrition and Epigenetic Programming http://dx.doi.org/10.7762/cnr.2014.3.1.13 http://e-cnr.orgpression that are not caused by changes in the DNA sequence  [12].,Non-OADS,/arxiv_data1/oa_pdf/a9/5a/cnr-3-1.PMC3921290.pdf
http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.14 NAs with the genome [13].,OADS,/arxiv_data1/oa_pdf/a9/5a/cnr-3-1.PMC3921290.pdf
Nutrition and Epigenetic Programming http://dx.doi.org/10.7762/cnr.2014.3.1.15 http://e-cnr.orggenes throughout the embryonic development.,Non-OADS,/arxiv_data1/oa_pdf/a9/5a/cnr-3-1.PMC3921290.pdf
http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.16product of the agouti  gene interferes with the regulation of  body weight at the level of the hypothalamus.,Non-OADS,/arxiv_data1/oa_pdf/a9/5a/cnr-3-1.PMC3921290.pdf
Nutrition and Epigenetic Programming http://dx.doi.org/10.7762/cnr.2014.3.1.17 http://e-cnr.org3.,Non-OADS,/arxiv_data1/oa_pdf/a9/5a/cnr-3-1.PMC3921290.pdf
http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.18developmental overfeeding.,Non-OADS,/arxiv_data1/oa_pdf/a9/5a/cnr-3-1.PMC3921290.pdf
"http://e-cnr.org17 Clin Nutr Res 2014;3:17-23 http://dx.doi.org/10.7762/cnr.2014.3.1.17pISSN 2287-3732 ∙ eISSN 2287-3740Original Article This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.© 2014 The Korean Society of Clinical Nutrition  *Corresponding author  Jung Eun Lee Address  Department of Food and Nutrition, Sookmyung Women's  University, 100 Cheongpa-ro 47-gil, Yongsan-gu, Seoul 140-742,  South Korea  Tel +82-2-2077-7560  Fax +82-2-710-9479  E-mail  junglee@sookmyung.ac.kr Received December 23, 2013 Revised January 15, 2014 Accepted January 16, 2014Introduction Colorectal cancer is the third most common type of cancer  in Korea [1].",Non-OADS,/arxiv_data1/oa_pdf/c7/2d/cnr-3-17.PMC3921291.pdf
"http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.1718 C-peptide is secreted by beta cells on an equal molar basis  with insulin; therefore, it is regarded as a marker of insulin  secretion [8].",Non-OADS,/arxiv_data1/oa_pdf/c7/2d/cnr-3-17.PMC3921291.pdf
C-Peptide and Colorectal Adenoma http://dx.doi.org/10.7762/cnr.2014.3.1.1719 http://e-cnr.orgdid not include these factors in the analysis.,Non-OADS,/arxiv_data1/oa_pdf/c7/2d/cnr-3-17.PMC3921291.pdf
http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.1720 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/c7/2d/cnr-3-17.PMC3921291.pdf
"C-Peptide and Colorectal Adenoma http://dx.doi.org/10.7762/cnr.2014.3.1.1721 http://e-cnr.orgsmall sample size, which may have lowered the power of our  analysis.",Non-OADS,/arxiv_data1/oa_pdf/c7/2d/cnr-3-17.PMC3921291.pdf
"http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.1722Acknowledgments Funding: This research was supported by the National Re - search Foundation of Korea (NRF) grant, which was funded by  the Korean government (no.",Non-OADS,/arxiv_data1/oa_pdf/c7/2d/cnr-3-17.PMC3921291.pdf
C-Peptide and Colorectal Adenoma http://dx.doi.org/10.7762/cnr.2014.3.1.1723 http://e-cnr.orgvivo.,Non-OADS,/arxiv_data1/oa_pdf/c7/2d/cnr-3-17.PMC3921291.pdf
"http://e-cnr.org24 Clin Nutr Res 2014;3:24-32 http://dx.doi.org/10.7762/cnr.2014.3.1.24pISSN 2287-3732 ∙ eISSN 2287-3740Original Article © 2014 The Korean Society of Clinical Nutrition  This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/a1/cnr-3-24.PMC3921292.pdf
"Collegians' Energy Content Estimation on the Standard Portion Size of Foods  http://dx.doi.org/10.7762/cnr.2014.3.1.2425 http://e-cnr.orgfood energy content and energy allowances for an individual,  and appropriate energy consumption are essential.",Non-OADS,/arxiv_data1/oa_pdf/b6/a1/cnr-3-24.PMC3921292.pdf
http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.2426 0.001) and weight (p < 0.001) were significantly higher in the  male group than in the female group.,Non-OADS,/arxiv_data1/oa_pdf/b6/a1/cnr-3-24.PMC3921292.pdf
Collegians' Energy Content Estimation on the Standard Portion Size of Foods  http://dx.doi.org/10.7762/cnr.2014.3.1.2427 http://e-cnr.orgGrains and starchesProtein foods Vegetables Fruits Dairy Beverages020406080100Subjects (%)Under Accurate Over Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/b6/a1/cnr-3-24.PMC3921292.pdf
"http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.2428 Discussion In this study, we investigated the knowledge of the energy  content of the standard portion size of 30 typical Korean  foods among male and female collegians in Korea.",Non-OADS,/arxiv_data1/oa_pdf/b6/a1/cnr-3-24.PMC3921292.pdf
Collegians' Energy Content Estimation on the Standard Portion Size of Foods  http://dx.doi.org/10.7762/cnr.2014.3.1.2429 http://e-cnr.orgfoods.,Non-OADS,/arxiv_data1/oa_pdf/b6/a1/cnr-3-24.PMC3921292.pdf
"http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.2430 among collegians in Korea, both the proper portion size and  calorie content of beverages including alcoholic beverages  should be emphasized in nutrition education programs for col - legians.",Non-OADS,/arxiv_data1/oa_pdf/b6/a1/cnr-3-24.PMC3921292.pdf
"Collegians' Energy Content Estimation on the Standard Portion Size of Foods  http://dx.doi.org/10.7762/cnr.2014.3.1.2431 http://e-cnr.orglike the present study’s setting, calorie awareness of food can  potentially affect energy intake and food choice by informed  decision making.",Non-OADS,/arxiv_data1/oa_pdf/b6/a1/cnr-3-24.PMC3921292.pdf
http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.2432 3.,Non-OADS,/arxiv_data1/oa_pdf/b6/a1/cnr-3-24.PMC3921292.pdf
"http://e-cnr.org33 Clin Nutr Res 2014;3:33-38 http://dx.doi.org/10.7762/cnr.2014.3.1.33pISSN 2287-3732 ∙ eISSN 2287-3740Original Article © 2014 The Korean Society of Clinical Nutrition  Relationship of Delayed Parenteral Nutrition   Protocol with the Clinical Outcomes   in a Medical Intensive Care Unit Hosun Lee1, Kyung Soo Chung2, Moo Suk Park2, Sungwon Na3, Young Sam Kim2* 1Department of Nutrition and Dietetics, Severance Hospital, Yonsei University Health System, Seoul 120-752, Korea   2Department of Internal Medicine, Yonsei University College of Medicine, Seoul 120-752, Korea   3Department of Pain and Anesthesiology, Yonsei University College of Medicine, Seoul 120-752, Korea Although parenteral nutrition (PN) is an important treatment for patients who are unable to tolerate enteral nutrition (EN),  recent international guidelines recommended that PN should be reserved and initiated only after 7 days in well-nourished pa- tients.",Non-OADS,/arxiv_data1/oa_pdf/5d/8d/cnr-3-33.PMC3921293.pdf
"For patients  who are intolerant of or have other contraindications to EN,  European guidelines recommend starting PN within 24-48 h if This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/8d/cnr-3-33.PMC3921293.pdf
http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.3334 the patient is not expected to be on full oral nutrition within  3 days [3].,Non-OADS,/arxiv_data1/oa_pdf/5d/8d/cnr-3-33.PMC3921293.pdf
Implementation of Delayed PN Protocol in an Intensive Care Unit http://dx.doi.org/10.7762/cnr.2014.3.1.3335 http://e-cnr.orgtion episodes were provided by hospital-acquired infection  controllers who were unaware of our study.,Non-OADS,/arxiv_data1/oa_pdf/5d/8d/cnr-3-33.PMC3921293.pdf
"http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.3336 significantly later in the post-protocol group than in the pre- protocol group (2.7 ± 2.2 days vs. 1.9 ± 2.0 days, p = 0.046).",OADS,/arxiv_data1/oa_pdf/5d/8d/cnr-3-33.PMC3921293.pdf
"Implementation of Delayed PN Protocol in an Intensive Care Unit http://dx.doi.org/10.7762/cnr.2014.3.1.3337 http://e-cnr.orgOne of the most serious complications of PN is catheter- related sepsis, which has been reported to occur in 1.3%- 26.2% of the catheters used to administer PN [10-12].",Non-OADS,/arxiv_data1/oa_pdf/5d/8d/cnr-3-33.PMC3921293.pdf
http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.3338physicians’ compliance with the protocol.,Non-OADS,/arxiv_data1/oa_pdf/5d/8d/cnr-3-33.PMC3921293.pdf
"http://e-cnr.org39 Clin Nutr Res 2014;3:39-47 http://dx.doi.org/10.7762/cnr.2014.3.1.39pISSN 2287-3732 ∙ eISSN 2287-3740Original Article Effect of 8-Week Nutrition Counseling to Increase Phyto - chemical Rich Fruit and Vegetable Consumption in Korean  Breast Cancer Patients: A Randomized Controlled Trial Sang Woon Cho1, Jin Hee Kim1, Seung Min Lee2, Song Mi Lee3, Eun Jung Choi4, Joon Jeong5*, Yoo Kyoung Park1,6*  1Department of Medical Nutrition, Graduate School of East-West Medical Science, Kyung Hee University, Yongin 446-701, Korea   2Department of Food and Nutrition, Sungshin Women’s University, Seoul 136-742, Korea   3Nutrition Services Department, Gangnam Severance Hospital, Yonsei University, Seoul 135-720, Korea   4Department of Food Nutrition, Shinheung College, UijeongBu 480-701, Korea   5Department of Surgery, Gangnam Severance Hospital, Yonsei University Medical College, Seoul 135-720, Korea   6Research Institute of Medical Nutrition, Kyung Hee University, Seoul 130-701, Korea High fruit and vegetable consumption is associated with a lower risk of breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/21/14/cnr-3-39.PMC3921294.pdf
"Key Words:  Counseling, Breast neoplasms, Fruits, Vegetables, Antioxidants © 2014 The Korean Society of Clinical Nutrition  This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/14/cnr-3-39.PMC3921294.pdf
"http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.3940 Introduction Although breast cancer is still less prevalent in Korea than in  western countries, the incidence of breast cancer, especially in  the younger women, is increasing.",Non-OADS,/arxiv_data1/oa_pdf/21/14/cnr-3-39.PMC3921294.pdf
Phytochemical Rich Dietary Intervention in Breast Cancer Patients http://dx.doi.org/10.7762/cnr.2014.3.1.3941 http://e-cnr.orgTable 1.,Non-OADS,/arxiv_data1/oa_pdf/21/14/cnr-3-39.PMC3921294.pdf
http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.3942 Measurements Anthropometric measurements of subjects were conducted  by a trained staff.,OADS,/arxiv_data1/oa_pdf/21/14/cnr-3-39.PMC3921294.pdf
"Phytochemical Rich Dietary Intervention in Breast Cancer Patients http://dx.doi.org/10.7762/cnr.2014.3.1.3943 http://e-cnr.orgwas a significant increase in the daily intake of energy (p =   0.009), plant protein (p < 0.001), carbohydrate (p = 0.011),  fiber (p < 0.001), vitamin A (p < 0.001), vitamin C (p < 0.001),  vitamin E (p < 0.001), folate (p < 0.001), and β-carotene (p  < 0.001).",Non-OADS,/arxiv_data1/oa_pdf/21/14/cnr-3-39.PMC3921294.pdf
http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.3944Discussion The goal for this particular nutrition intervention was to  adopt and maintain an antioxidant rich dietary habit of breast  cancer patients.,Non-OADS,/arxiv_data1/oa_pdf/21/14/cnr-3-39.PMC3921294.pdf
"Phytochemical Rich Dietary Intervention in Breast Cancer Patients http://dx.doi.org/10.7762/cnr.2014.3.1.3945 http://e-cnr.organd monthly newsletters led to significant increase in fruit  (18%, 0.6 serving/d) and vegetable (82%, 3.2 serving/d) intake  in the intervention group of breast cancer survivors.",Non-OADS,/arxiv_data1/oa_pdf/21/14/cnr-3-39.PMC3921294.pdf
http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.3946influence this variable.,OADS,/arxiv_data1/oa_pdf/21/14/cnr-3-39.PMC3921294.pdf
"Phytochemical Rich Dietary Intervention in Breast Cancer Patients http://dx.doi.org/10.7762/cnr.2014.3.1.3947 http://e-cnr.orgKaranja N, Kealey S, Madlensky L, Marshall J, Ritenbaugh C, Rock CL,  Stefanick ML, Thomson C, Wasserman L, Parker BA.",Non-OADS,/arxiv_data1/oa_pdf/21/14/cnr-3-39.PMC3921294.pdf
Availble from: http://www.facit.org/FACITOrg/ Questionnaires.,Non-OADS,/arxiv_data1/oa_pdf/21/14/cnr-3-39.PMC3921294.pdf
"http://e-cnr.org48 Clin Nutr Res 2014;3:48-55 http://dx.doi.org/10.7762/cnr.2014.3.1.48pISSN 2287-3732 ∙ eISSN 2287-3740Original Article This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.© 2014 The Korean Society of Clinical Nutrition  *Corresponding author  Yun Jung Bae Address  Department of Food and Nutritional Sciences Hanbuk Uni - versity Gyeonggi-do, 483-120 Korea Tel +82-31-860-1445  Mobile  +82-10-8735-8603  E-mail  byj@hanbuk.ac.kr  Received January 2, 2014 Revised January 8, 2014 Accepted January 9, 2014Introduction The Korea Central Cancer Registry reported that the inci - dence of cancer in 2010 was 405.1 per 100,000 populations.",Non-OADS,/arxiv_data1/oa_pdf/b6/de/cnr-3-48.PMC3921295.pdf
Palatability of Cereal Based Nutritional Supplements  http://dx.doi.org/10.7762/cnr.2014.3.1.4849 http://e-cnr.orgoverall quality of life in cancer patients.,Non-OADS,/arxiv_data1/oa_pdf/b6/de/cnr-3-48.PMC3921295.pdf
"http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.4850 the insoluble rice bran components were then removed by  centrifugation, and the polysaccharides were collected from  the resulting supernatant by alkali extraction and ethanol  precipitation, affording the rice bran exo-biopolymer.",Non-OADS,/arxiv_data1/oa_pdf/b6/de/cnr-3-48.PMC3921295.pdf
Palatability of Cereal Based Nutritional Supplements  http://dx.doi.org/10.7762/cnr.2014.3.1.4851 http://e-cnr.orgin each rank (1 to 4) was analyzed (Table 5).,OADS,/arxiv_data1/oa_pdf/b6/de/cnr-3-48.PMC3921295.pdf
http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.4852 status of the patient  with higher possibility of malnutrition  than patients with other diseases [16-18].,Non-OADS,/arxiv_data1/oa_pdf/b6/de/cnr-3-48.PMC3921295.pdf
Palatability of Cereal Based Nutritional Supplements  http://dx.doi.org/10.7762/cnr.2014.3.1.4853 http://e-cnr.orgfor cancer patients were performed.,Non-OADS,/arxiv_data1/oa_pdf/b6/de/cnr-3-48.PMC3921295.pdf
http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.4854 kcal/200 mL.,OADS,/arxiv_data1/oa_pdf/b6/de/cnr-3-48.PMC3921295.pdf
Avail - able from: http://kosis.kr/common/meta_onedepth.jsp?vwcd=MT_ OTITLE&listid=MT_CTITLE_1.,OADS,/arxiv_data1/oa_pdf/b6/de/cnr-3-48.PMC3921295.pdf
Available from: https://www.nutritioncaremanual.org/ index.cfm.,Non-OADS,/arxiv_data1/oa_pdf/b6/de/cnr-3-48.PMC3921295.pdf
"Palatability of Cereal Based Nutritional Supplements  http://dx.doi.org/10.7762/cnr.2014.3.1.4855 http://e-cnr.orgBermejo LM, Zamora Auñón P. Efficacy evaluation of an oral powder  supplement enriched with eicosapentaenoic acid in cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b6/de/cnr-3-48.PMC3921295.pdf
"http://e-cnr.org56 Clin Nutr Res 2014;3:56-63 http://dx.doi.org/10.7762/cnr.2014.3.1.56pISSN 2287-3732 ∙ eISSN 2287-3740Original Article This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.© 2014 The Korean Society of Clinical Nutrition  *Corresponding author  Gyung Ah Wie Address  Department of Clinical Nutrition, National Cancer Center,  111 Jungbalsan-ro, Ilsandong-gu, Goyang 410-769, South Korea   Tel +82-31-920-0273  Fax +82-31-920-0269 E-mail  gawie@ncc.re.kr Received December 3, 2013 Revised January 7, 2014 Accepted January 9, 2014Introduction The global prevalence of hyperuricemia is increasing [1], and  this may be related to recent changes in diet, lifestyle and  increasing prevalence of obesity.",Non-OADS,/arxiv_data1/oa_pdf/09/01/cnr-3-56.PMC3921296.pdf
Nutrient Intake and Diet Quality in Hyperuricemia  http://dx.doi.org/10.7762/cnr.2014.3.1.5657 http://e-cnr.orgmay explain the association with metabolic syndrome [8].,Non-OADS,/arxiv_data1/oa_pdf/09/01/cnr-3-56.PMC3921296.pdf
http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.5658 appropriateness of nutrient intake.,Non-OADS,/arxiv_data1/oa_pdf/09/01/cnr-3-56.PMC3921296.pdf
Nutrient Intake and Diet Quality in Hyperuricemia  http://dx.doi.org/10.7762/cnr.2014.3.1.5659 http://e-cnr.orgwas significantly lower in the hyperuricemia subjects than  in the controls (p < 0.001).,Non-OADS,/arxiv_data1/oa_pdf/09/01/cnr-3-56.PMC3921296.pdf
http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.5660 Table 3.,Non-OADS,/arxiv_data1/oa_pdf/09/01/cnr-3-56.PMC3921296.pdf
Nutrient Intake and Diet Quality in Hyperuricemia  http://dx.doi.org/10.7762/cnr.2014.3.1.5661 http://e-cnr.orgweight loss reduced the risk [19].,Non-OADS,/arxiv_data1/oa_pdf/09/01/cnr-3-56.PMC3921296.pdf
http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.5662 cate that a decrease in uric acid levels can prevent or reverse  the features of metabolic syndrome [25-26].,Non-OADS,/arxiv_data1/oa_pdf/09/01/cnr-3-56.PMC3921296.pdf
Nutrient Intake and Diet Quality in Hyperuricemia  http://dx.doi.org/10.7762/cnr.2014.3.1.5663 http://e-cnr.orgMed 2004;350:1093-103.,Non-OADS,/arxiv_data1/oa_pdf/09/01/cnr-3-56.PMC3921296.pdf
"http://e-cnr.org64 Clin Nutr Res 2014;3:64-68 http://dx.doi.org/10.7762/cnr.2014.3.1.64pISSN 2287-3732 ∙ eISSN 2287-3740Case Report This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.© 2014 The Korean Society of Clinical Nutrition  Introduction According to a recently released ‘The Korean Diabetes Re - search Report 2012’ by Korean Diabetes Association, one out  of ten adults has diabetes disease, two out of ten have the  impaired fasting glucose which is stage of diabetes, and three  out of ten adults are threatened by high blood glucose [1].",Non-OADS,/arxiv_data1/oa_pdf/b3/3a/cnr-3-64.PMC3921297.pdf
"Nutritional Intervention of Patient with Diabetic Nephropathy http://dx.doi.org/10.7762/cnr.2014.3.1.6465 http://e-cnr.orgDiabetic nephropathy occurs in 20% to 40% of patients  with diabetes, and is a most likely causes of end-stage renal  disease reported worldwide [5].",Non-OADS,/arxiv_data1/oa_pdf/b3/3a/cnr-3-64.PMC3921297.pdf
Kim HY http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.6466ing for 2 hrs (3 times a week).,Non-OADS,/arxiv_data1/oa_pdf/b3/3a/cnr-3-64.PMC3921297.pdf
"Nutritional Intervention of Patient with Diabetic Nephropathy http://dx.doi.org/10.7762/cnr.2014.3.1.6467 http://e-cnr.orgtient’s blood profile data was collected from electronic medical  records (EMR), and the patient’s dietary intake data was col - lected through direct interviews.",Non-OADS,/arxiv_data1/oa_pdf/b3/3a/cnr-3-64.PMC3921297.pdf
"Kim HY http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.6468hours, and then blanched in boiling water before cooking [4,7].",Non-OADS,/arxiv_data1/oa_pdf/b3/3a/cnr-3-64.PMC3921297.pdf
http://e-cnr.org69 Clin Nutr Res 2014;3:69-73 http://dx.doi.org/10.7762/cnr.2014.3.1.69pISSN 2287-3732 ∙ eISSN 2287-3740Case Report © 2014 The Korean Society of Clinical Nutrition  Introduction  Postoperative malnutrition is relatively common in patients  who undergo esophagectomy.,Non-OADS,/arxiv_data1/oa_pdf/88/d6/cnr-3-69.PMC3921298.pdf
"Key Words:  Early feeding, Esophagectomy, Jejunostomy   This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/d6/cnr-3-69.PMC3921298.pdf
http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.6970Jejunostomy feeding for patients after esophagectomy is  not common in Korea.,Non-OADS,/arxiv_data1/oa_pdf/88/d6/cnr-3-69.PMC3921298.pdf
Early 24-Hour Continuous Jejunostomy Feeding After Esophagectomy http://dx.doi.org/10.7762/cnr.2014.3.1.6971 http://e-cnr.orgtients were men who were diagnosed with esophageal cancer.,Non-OADS,/arxiv_data1/oa_pdf/88/d6/cnr-3-69.PMC3921298.pdf
"http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.6972quality of life [1,5].",Non-OADS,/arxiv_data1/oa_pdf/88/d6/cnr-3-69.PMC3921298.pdf
"Early 24-Hour Continuous Jejunostomy Feeding After Esophagectomy http://dx.doi.org/10.7762/cnr.2014.3.1.6973 http://e-cnr.orgIn conclusion, we noted that the protocol of early and 24- hour continuous jejunostomy feeding could be safely applied  for enhancing nutritional support after esophagectomy.",Non-OADS,/arxiv_data1/oa_pdf/88/d6/cnr-3-69.PMC3921298.pdf
"http://e-cnr.org9 Clin Nutr Res 2014;3:9-16 http://dx.doi.org/10.7762/cnr.2014.3.1.9pISSN 2287-3732 ∙ eISSN 2287-3740Original Article This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.© 2014 The Korean Society of Clinical Nutrition  *Corresponding author  Yoon-Seok Chang Address  Division of Allergy and Clinical Immunology, Department of  Internal Medicine, Seoul National University Bundang Hospital, 82  Gumi-ro  173beon-gil, Bundang-gu, Seongnam 463-707, Korea  Tel +82-31-787-7023  Fax +82-31-787-4052 E-mail  addchang@snu.ac.kr Received December 17, 2013 Revised January 8, 2014 Accepted January 13, 2014Introduction Chronic urticaria (CU) is defined as the urticaria persisting  for more than 6 weeks.",Non-OADS,/arxiv_data1/oa_pdf/fc/6d/cnr-3-9.PMC3921299.pdf
"http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.910 ings, coloring agents, antioxidants or preservatives [5].",Non-OADS,/arxiv_data1/oa_pdf/fc/6d/cnr-3-9.PMC3921299.pdf
"Basophil Activation Test with Food Additives in Chronic Urticaria http://dx.doi.org/10.7762/cnr.2014.3.1.911 http://e-cnr.orgtivation was ≥5% and the SI was ≥2, in accordance with the  manufacturer’s instructions.",Non-OADS,/arxiv_data1/oa_pdf/fc/6d/cnr-3-9.PMC3921299.pdf
http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.912 (37.5% activation; Figure 2).,OADS,/arxiv_data1/oa_pdf/fc/6d/cnr-3-9.PMC3921299.pdf
Basophil Activation Test with Food Additives in Chronic Urticaria http://dx.doi.org/10.7762/cnr.2014.3.1.913 http://e-cnr.orgmercially prepared forms of foods that are tolerated when  prepared at home [33].,Non-OADS,/arxiv_data1/oa_pdf/fc/6d/cnr-3-9.PMC3921299.pdf
http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.914duct the test in a placebo-controlled manner due to the fact  that food additives have their own taste and smell.,Non-OADS,/arxiv_data1/oa_pdf/fc/6d/cnr-3-9.PMC3921299.pdf
Basophil Activation Test with Food Additives in Chronic Urticaria http://dx.doi.org/10.7762/cnr.2014.3.1.915 http://e-cnr.orgditives in patients with CU.,Non-OADS,/arxiv_data1/oa_pdf/fc/6d/cnr-3-9.PMC3921299.pdf
http://e-cnr.org http://dx.doi.org/10.7762/cnr.2014.3.1.91622.,Non-OADS,/arxiv_data1/oa_pdf/fc/6d/cnr-3-9.PMC3921299.pdf
Available from: http:// http://www.buhlmannlabs.ch/files/documents/ core/CellularAllergy/Corporate/allergenliste-ml15e.pdf 29.,OADS,/arxiv_data1/oa_pdf/fc/6d/cnr-3-9.PMC3921299.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/50/a4/ncomms4085.PMC3921466.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Li, Z. et al.",Non-OADS,/arxiv_data1/oa_pdf/50/a4/ncomms4085.PMC3921466.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4085 12 NATURE COMMUNICATIONS | 5:3085 | DOI: 10.1038/ncomms4085 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/50/a4/ncomms4085.PMC3921466.pdf
"http://www.mortality.org.hmd [Accessed November 11, 2011].",Non-OADS,/arxiv_data1/oa_pdf/8f/c3/IADT-13-2.PMC3921468.pdf
http://www.gro-scotland.gov.,Non-OADS,/arxiv_data1/oa_pdf/8f/c3/IADT-13-2.PMC3921468.pdf
"December 29, 2008. http://bloomberg.com/apps/ne ws?sid=az9ShNouwC8U&pid=newsarchive [Accessed October 10, 2011].",Non-OADS,/arxiv_data1/oa_pdf/8f/c3/IADT-13-2.PMC3921468.pdf
"Pharmaceutical-Manufacturing News., May 18, 2009. http://www.pharmaceutical-manufacturingnews.com/news-214-parac etamol-pharmaceuticals-chinesemanufacturers-pharmaceuticalschina.html [Accessed March 10, 2011].",Non-OADS,/arxiv_data1/oa_pdf/8f/c3/IADT-13-2.PMC3921468.pdf
"March 2006. http://www.reportlinker.com/p091142/The-Paracetamol-Industry-in-China.pdf [Accessed October 26, 2011].",Non-OADS,/arxiv_data1/oa_pdf/8f/c3/IADT-13-2.PMC3921468.pdf
"December 21, 2011. http://www.free-press-release.com/news/print-1324451715.html [Accessed January 12, 2012].",Non-OADS,/arxiv_data1/oa_pdf/8f/c3/IADT-13-2.PMC3921468.pdf
"January 6, 2009. http://www.in-pharmatechnologist.com/Industry-Drivers/Europe-s-last-paracetamol-plant-closes-its-doors [Accessed October 27, 2011].",Non-OADS,/arxiv_data1/oa_pdf/8f/c3/IADT-13-2.PMC3921468.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/nature communications.,Non-OADS,/arxiv_data1/oa_pdf/19/72/ncomms4176.PMC3921469.pdf
Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions.,Non-OADS,/arxiv_data1/oa_pdf/19/72/ncomms4176.PMC3921469.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4176 12 NATURE COMMUNICATIONS | 5:3176 | DOI: 10.1038/ncomms4176 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/19/72/ncomms4176.PMC3921469.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/MSC-mediated immunosuppression in mammals JS u et al 396 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/43/90/cdd2013149a.PMC3921585.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4080 | DOI: 10.1038/srep04080 6",Non-OADS,/arxiv_data1/oa_pdf/9c/f3/srep04080.PMC3921627.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4072 | DOI: 10.1038/srep04072 4",Non-OADS,/arxiv_data1/oa_pdf/bb/eb/srep04072.PMC3921630.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b5/28/srep04075.PMC3921631.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4075 | DOI: 10.1038/srep04075 7",Non-OADS,/arxiv_data1/oa_pdf/b5/28/srep04075.PMC3921631.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/db/45/srep04081.PMC3921632.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4081 | DOI: 10.1038/srep04081 6",Non-OADS,/arxiv_data1/oa_pdf/db/45/srep04081.PMC3921632.pdf
All other primers were designed by Primer-Blast19at http://www.ncbi.nlm.nih.gov/tools/primer-blast/.,OADS,/arxiv_data1/oa_pdf/ba/00/srep04070.PMC3921633.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4070 | DOI: 10.1038/srep04070 5",Non-OADS,/arxiv_data1/oa_pdf/ba/00/srep04070.PMC3921633.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/45/1e/srep04077.PMC3921634.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4077 | DOI: 10.1038/srep04077 6",Non-OADS,/arxiv_data1/oa_pdf/45/1e/srep04077.PMC3921634.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/38/3b/srep04079.PMC3921635.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4079 | DOI: 10.1038/srep04079 6",Non-OADS,/arxiv_data1/oa_pdf/38/3b/srep04079.PMC3921635.pdf
"JV i s 12, 333, doi:10.1167/ 12.9.333 http://www.journalofvision.org/content/12/9/333.",Non-OADS,/arxiv_data1/oa_pdf/9d/dd/srep04067.PMC3921636.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4067 | DOI: 10.1038/srep04067 6",Non-OADS,/arxiv_data1/oa_pdf/9d/dd/srep04067.PMC3921636.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/55/98/srep04071.PMC3921638.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4071 | DOI: 10.1038/srep04071 9",Non-OADS,/arxiv_data1/oa_pdf/55/98/srep04071.PMC3921638.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/bc/0f/srep04073.PMC3921639.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4073 | DOI: 10.1038/srep04073 7",Non-OADS,/arxiv_data1/oa_pdf/bc/0f/srep04073.PMC3921639.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3c/5f/srep04078.PMC3921640.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4078 | DOI: 10.1038/srep04078 5",Non-OADS,/arxiv_data1/oa_pdf/3c/5f/srep04078.PMC3921640.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.12.004,OADS,/arxiv_data1/oa_pdf/d1/ed/main.PMC3921641.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.11.006,OADS,/arxiv_data1/oa_pdf/8f/31/main.PMC3921642.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.11.002,OADS,/arxiv_data1/oa_pdf/8d/d7/main.PMC3921643.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.12.019,OADS,/arxiv_data1/oa_pdf/3b/59/main.PMC3921644.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.11.012,OADS,/arxiv_data1/oa_pdf/5c/c3/main.PMC3921645.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.12.018,OADS,/arxiv_data1/oa_pdf/e2/5d/main.PMC3921646.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.12.017,OADS,/arxiv_data1/oa_pdf/ff/13/main.PMC3921647.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.11.013,OADS,/arxiv_data1/oa_pdf/34/ac/main.PMC3921648.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.12.005,OADS,/arxiv_data1/oa_pdf/a8/0c/main.PMC3921649.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.11.003,OADS,/arxiv_data1/oa_pdf/d4/07/main.PMC3921650.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.12.020,OADS,/arxiv_data1/oa_pdf/7e/bc/main.PMC3921651.pdf
"Scand  J  Trauma  Resusc  Emerg  Med  2009; 17(April  (17)):19, http://dx.doi.org/10.1186/1757-7241-17-19 .",Non-OADS,/arxiv_data1/oa_pdf/7e/bc/main.PMC3921651.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.11.015,OADS,/arxiv_data1/oa_pdf/cc/7c/main.PMC3921653.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.12.010,OADS,/arxiv_data1/oa_pdf/ba/5f/main.PMC3921654.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.12.003,OADS,/arxiv_data1/oa_pdf/f5/8a/main.PMC3921655.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.12.015,OADS,/arxiv_data1/oa_pdf/5f/0e/main.PMC3921656.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.12.002,OADS,/arxiv_data1/oa_pdf/2e/02/main.PMC3921657.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.11.011,OADS,/arxiv_data1/oa_pdf/32/4e/main.PMC3921658.pdf
"Knee  Surg  Sports  Traumatol  Arthrosc  2013, http://dx.doi.org/10.1007/s00167-012-2062-y  [epub  ahead  of  print].",Non-OADS,/arxiv_data1/oa_pdf/32/4e/main.PMC3921658.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.12.016,OADS,/arxiv_data1/oa_pdf/4d/74/main.PMC3921659.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.12.023,OADS,/arxiv_data1/oa_pdf/82/f0/main.PMC3921660.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.12.021,OADS,/arxiv_data1/oa_pdf/9b/fe/main.PMC3921661.pdf
http://clinicaltrials.gov/show/NCT01212991.,Non-OADS,/arxiv_data1/oa_pdf/47/fa/pcan201341a.PMC3921671.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Abiraterone acetate in mCRPC with visceral disease OB Goodman et al 39 &2014 Macmillan Publishers Limited Prostate Cancer and Prostatic Disease (2014), 34 – 39",Non-OADS,/arxiv_data1/oa_pdf/47/fa/pcan201341a.PMC3921671.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Prostate Cancer and Prostatic Diseases website (http://www.nature.com/pcan)Biomarkers at diagnosis estimate prostate cancer overall survival Z Peng et al 90 Prostate Cancer and Prostatic Disease (2014), 81 – 90 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/6e/60/pcan201357a.PMC3921673.pdf
http://planning.cancer.gov/pdfprgreports/2002kidneyreport.,Non-OADS,/arxiv_data1/oa_pdf/f3/af/CEJU-64-00088.PMC3921734.pdf
Virchows Arch 2009; 455: 1-13.http://info.cancerresearchuk.org/cancerstats/types/prostate/incidence/39.,Non-OADS,/arxiv_data1/oa_pdf/67/e9/CEJU-64-00149.PMC3921735.pdf
"Radmayr C, Schwentner C, Lunacek A, et al: embryology and anatomy of  the vesicoureteric junction with special reference to the etiology of vesi- coureteral reflux, Therapeutic Advances in Urology , (2010) http://www.ncbi.",Non-OADS,/arxiv_data1/oa_pdf/01/4a/CEJU-65-00154.PMC3921757.pdf
"Disease: Evaluation, Classification, and Stratification, 2002 National Kidney Foundation http://www.kidney.org/professionals/KDOQI/index.cfmUzzo RG, Novick AC: 10.",Non-OADS,/arxiv_data1/oa_pdf/35/cd/CEJU-65-00133.PMC3921763.pdf
Linia  Otwocka  2008. http://www.linia.com.pl/public/article.php?1-16018-05.,Non-OADS,/arxiv_data1/oa_pdf/3c/6b/CEJU-65-00193.PMC3921793.pdf
"The developed nomogram is already available  on a website (http://deb.uthscsa.edu/URORiskCalc/Pages/calc- sPCA3.jsp) and comprises six variables besides PCA3: age, race,  family history, DRE, prior biopsy, and prostate volume.",Non-OADS,/arxiv_data1/oa_pdf/15/4c/CEJU-65-00190.PMC3921800.pdf
http://emedicine.medscape.com/article/447239-overview.,Non-OADS,/arxiv_data1/oa_pdf/99/19/CEJU-65-00222.PMC3921814.pdf
Available at: http://emedicine.medscape.com/article/450651-overview .,Non-OADS,/arxiv_data1/oa_pdf/a1/f0/CEJU-65-224a.PMC3921817.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6d/b8/pgpm-7-043.PMC3921827.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpPharmacogenomics and Personalized Medicine 2014:7 43–51Pharmacogenomics and Personalized Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  43Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PGPM.S3869 8Molecular variants and mutations   in medulloblastoma Kristin Schroeder Sri Gururangan Pediatric Clinical Services, Preston  Robert Tisch Brain Tumor Center  at Duke, Duke University Medical  Center, Durham, NC, USA Correspondence: Sri Gururangan   Pediatric Clinical Services,   Preston Robert Tisch Brain Tumor  Center at Duke, Duke University Medical  Center, Room 307, Hanes House,   Box 102382, 330 Trent Drive, Durham,   NC 27710, USA   Tel +1 919 668 6288   Fax +1 919 668 2485   email s ridharan.gururangan@duke.ed uAbstract:  Medulloblastoma is the commonest malignant brain tumor in children.",Non-OADS,/arxiv_data1/oa_pdf/6d/b8/pgpm-7-043.PMC3921827.pdf
"Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journa lPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype  on pharmacology leading to the development of personalized treatment  programs and individualized drug selection for improved safety, efficacy  and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/6d/b8/pgpm-7-043.PMC3921827.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/6d/b8/pgpm-7-043.PMC3921827.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/77/00/pgpm-7-053.PMC3921828.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPharmacogenomics and Personalized Medicine 2014:7 53–64Pharmacogenomics and Personalized Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  53Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PGPM.S3829 5Human ABC transporter ABCG2/BCRP  expression in chemoresistance: basic and clinical  perspectives for molecular cancer therapeutics Kohji Noguchi Kazuhiro Katayama Y oshikazu Sugimoto Division of Chemotherapy,    Faculty of Pharmacy, Keio   University, T okyo, Japan Correspondence: Yoshikazu Sugimoto   Keio University Faculty of Pharmacy,   1-5-30, Shibakoen, Minatoku,   Tokyo 105-8512, Japan   Tel +81 3 5400 2698   Fax +81 3 5400 2669   email sugimoto-ys@pha.keio.ac.j pAbstract:  Adenine triphosphate (ATP)-binding cassette (ABC) transporter proteins, such as  ABCB1/P-glycoprotein (P-gp) and ABCG2/breast cancer resistance protein (BCRP), transport  various structurally unrelated compounds out of cells.",Non-OADS,/arxiv_data1/oa_pdf/77/00/pgpm-7-053.PMC3921828.pdf
"Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journa lPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype  on pharmacology leading to the development of personalized treatment  programs and individualized drug selection for improved safety, efficacy  and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/77/00/pgpm-7-053.PMC3921828.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/77/00/pgpm-7-053.PMC3921828.pdf
"Original ArticleAsia Pacific allergypISSN 2233-8276 · eISSN 2233-8268  http://dx.doi.org/10.5415/apallergy.2014.4.1.25 Asia Pac Allergy 2014;4:25-31Prevalence of asthma and allergic rhinitis among  adult population in Ulaanbaatar, Mongolia Munkhbayarlakh Sonomjamts1,*, Sarangerel Dashdemberel2, Narantsetseg Logii3, Kimihiro Nakae4, Yuichi Chigusa4,  Shuji Ohhira4, Clyde Ito5, Hironori Sagara6, and Sohei Makino5 1School of Medicine, Health Sciences University of Mongolia, Ulaanbaatar 210648, Mongolia  Departments of 2Physiology and 3Biochemistry and Laboratory, School of Bio-Medicine, Health Sciences University of Mongolia, Ulaanbaatar  210648, Mongolia  4Dokkyo Medical University , T ochigi 321-0293, Japan 5WHO Collaborating Centre for Prevention and Control of Chronic Respiratory Disease, Dokkyo Medical University , T ochigi 321-0293, Japan 6Department of Respiratory Medicine, Dokkyo Medical University , Koshigaya Hospital, Saitama 343-8555, Japan Background: Mongolia is changing lifestyle, unhealthy habits, increase of air pollution, increasing life expectancy have led to an up  rise of chronic respiratory diseases.",Non-OADS,/arxiv_data1/oa_pdf/50/c7/apa-4-25.PMC3921862.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/50/c7/apa-4-25.PMC3921862.pdf
"Asia Pacific allergy26 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.25INTRODUCTION In the last couple of decades, the prevalence of atopic diseases  is increasing in the different parts of the world.",Non-OADS,/arxiv_data1/oa_pdf/50/c7/apa-4-25.PMC3921862.pdf
Prevalence of asthma and allergic rhinitis among adults27       apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.25to at least one of questions *2 to *5.,Non-OADS,/arxiv_data1/oa_pdf/50/c7/apa-4-25.PMC3921862.pdf
"Asia Pacific allergy28 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.25rhinitis: 28.4% out of subjects with allergic rhinitis has current wheezer,  while 1 1.6% of subjects without allergic rhinitis has asthma ( p <  0.01).",Non-OADS,/arxiv_data1/oa_pdf/50/c7/apa-4-25.PMC3921862.pdf
"Prevalence of asthma and allergic rhinitis among adults29 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.25prevalence of asthma was 2.1% in Ulaanbaatar, 2.4% in rural towns  and 1.1% in villages.",OADS,/arxiv_data1/oa_pdf/50/c7/apa-4-25.PMC3921862.pdf
Asia Pacific allergy30 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.25and Russia.,Non-OADS,/arxiv_data1/oa_pdf/50/c7/apa-4-25.PMC3921862.pdf
"Prevalence of asthma and allergic rhinitis among adults31 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.25C, Tanimoto Y, Takahashi K, Kimura T, Eboshida A, Hirota R, Ikei J,  Odajima H, Nakagawa T, Akasawa A, Akiyama K. Nationwide cross- sectional population-based study on the prevalences of asthma and  asthma symptoms among Japanese adults.",OADS,/arxiv_data1/oa_pdf/50/c7/apa-4-25.PMC3921862.pdf
"Current ReviewAsia Pacific allergypISSN 2233-8276 · eISSN 2233-8268  http://dx.doi.org/10.5415/apallergy.2014.4.1.19 Asia Pac Allergy 2014;4:19-24Airway remodelling in asthma: role for mechanical  forces Wiparat Manuyakorn* Division of Pediatric Allergy and Immunology, Department of Pediatrics , Faculty of Medicine Ramathibodi Hospital, Mahidol University,   Bangkok, Thailand Asthma is a chronic airway inflammatory disease with functional and structural changes, leading to bronchial hyperresponsiveness  and airflow obstruction.",Non-OADS,/arxiv_data1/oa_pdf/e3/95/apa-4-19.PMC3921863.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/e3/95/apa-4-19.PMC3921863.pdf
"Manuyakorn WAsia Pacific allergy20 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.19inflammation, inhaled corticosteroids treatment in atopic children  with recurrent wheezing has shown to have no effect on declining  in lung function and the natural history of asthma [3-5].",Non-OADS,/arxiv_data1/oa_pdf/e3/95/apa-4-19.PMC3921863.pdf
Mechanical forces and airway remodeling21 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.19to human and cat airway epithelium cells inhibited epithelial  layer repair after wounded by scraping.,Non-OADS,/arxiv_data1/oa_pdf/e3/95/apa-4-19.PMC3921863.pdf
Manuyakorn WAsia Pacific allergy22 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.19Mechanical forces to the airway and airway  remodelling: is there any evidence  in vivo?,Non-OADS,/arxiv_data1/oa_pdf/e3/95/apa-4-19.PMC3921863.pdf
Mechanical forces and airway remodeling23 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.19lergy Clin Immunol 2012;129:974-82.e13.,Non-OADS,/arxiv_data1/oa_pdf/e3/95/apa-4-19.PMC3921863.pdf
Manuyakorn WAsia Pacific allergy24 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.19growth factor activity.,OADS,/arxiv_data1/oa_pdf/e3/95/apa-4-19.PMC3921863.pdf
"EditorialAsia Pacific allergypISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2014.4.1.1 Asia Pac Allergy 2014;4:1-2Asia Pacific, and beyond Yoon-Seok Chang1,* and Sang-Il Lee2 1 Division of Allergy and Clinical Immunology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National  University College of Medicine, Seongnam 463-802, Korea 2Department of Pediatrics, Sungkyunkwan University School of Medicine, Seoul 135-710, Korea Wish you have a very Happy New Year!",Non-OADS,/arxiv_data1/oa_pdf/67/c7/apa-4-1.PMC3921864.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/67/c7/apa-4-1.PMC3921864.pdf
apallergy.org  Chang YS and Lee SIAsia Pacific allergy http://dx.doi.org/10.5415/apallergy.2014.4.1.12    renal involvement in Henoch-Schönlein purpura [8].,Non-OADS,/arxiv_data1/oa_pdf/67/c7/apa-4-1.PMC3921864.pdf
"Current ReviewAsia Pacific allergypISSN 2233-8276 · eISSN 2233-8268  http://dx.doi.org/10.5415/apallergy.2014.4.1.14 Asia Pac Allergy 2014;4:14-18Correspondence:  Chih-Hsing Hung Department of Pediatrics, Kaohsiung Medical University  Hospital, Kaohsiung Medical University, 100 Tz-You  1st Road, Kaohsiung, Taiwan Tel: +886-7-31 15140 Fax: +886-7-3213931 E-mail: pedhung@gmail.com † Kuo CH and Hsieh CC contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/a2/ce/apa-4-14.PMC3921865.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/a2/ce/apa-4-14.PMC3921865.pdf
Epigenetic regulation in allergic disease15 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.14 INTRODUCTION Asthma and allergic diseases are the most common chronic  inflammatory disease in child and cause a substantial morbidity and  mortality burden in severe cases [1].,Non-OADS,/arxiv_data1/oa_pdf/a2/ce/apa-4-14.PMC3921865.pdf
"Asia Pacific allergy16 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.14example, nonylphenol and 4 octylphenol may have functional  effects on the response of myeloid dendritic cells (DCs) via, in  part, the estrogen receptor, MKK3/6-p38 MAPK signaling pathway,  and histone modifications, with subsequent influence on the T  cell-associated cytokine responses in our study [17].",Non-OADS,/arxiv_data1/oa_pdf/a2/ce/apa-4-14.PMC3921865.pdf
Epigenetic regulation in allergic disease17 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.14allergies is just being realized.,Non-OADS,/arxiv_data1/oa_pdf/a2/ce/apa-4-14.PMC3921865.pdf
"Asia Pacific allergy18 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.14WJ, Jong YJ, Hung CH.",Non-OADS,/arxiv_data1/oa_pdf/a2/ce/apa-4-14.PMC3921865.pdf
"Educational & Teaching Material Review ArticleAsia Pacific allergypISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2014.4.1.54 Asia Pac Allergy 2014;4:54-67Drug hypersensitivity in human immunodeficien - cy virus-infected patient: challenging diagnosis  and management Evy Yunihastuti1,2,*, Alvina Widhani1, and Teguh Harjono Karjadi1,2 1Division of Allergy and Clinical Immunology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Jakarta 10430, In - donesia 2HIV Integrated Clinic Cipto Mangunkusumo Hospital, Jakarta 10430, Indonesia Human immunodeficiency virus (HIV)-infected patients present complex immunological alterations.",Non-OADS,/arxiv_data1/oa_pdf/4b/0c/apa-4-54.PMC3921866.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/4b/0c/apa-4-54.PMC3921866.pdf
Managing drug hypersensitivity55 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.54 INTRODUCTION Drug hypersensitivity reactions occur at higher rate in human  immunodeficiency virus (HIV)-positive patients than general  population and cause significant morbidity.,Non-OADS,/arxiv_data1/oa_pdf/4b/0c/apa-4-54.PMC3921866.pdf
"Yunihastuti E, et al.Asia Pacific allergy56 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.54HIV negative control, HIV patients have decreased proportion  of interferon-γ-producing (Th1 type) CD4+ T-cell clones and  increased proportion of IL-4-producing (Th2 type) CD4+ T-cell  clones [5].",Non-OADS,/arxiv_data1/oa_pdf/4b/0c/apa-4-54.PMC3921866.pdf
Managing drug hypersensitivity57 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.54corticosteroids are often used [18].,Non-OADS,/arxiv_data1/oa_pdf/4b/0c/apa-4-54.PMC3921866.pdf
"Yunihastuti E, et al.Asia Pacific allergy58 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.54of pyrimethamine and sulfadiazine compared to pyrimethamine  and clindamycin (39% vs. 29%) [35].",OADS,/arxiv_data1/oa_pdf/4b/0c/apa-4-54.PMC3921866.pdf
Managing drug hypersensitivity59 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.54Nucleoside reverse transcriptase inhibitor  Nucleoside reverse transcriptase inhibitors block reverse  transcriptase activity by competing with the natural substrate  and incorporating into viral DNA to act as chain terminator  in the synthesis of proviral DNA [6].,Non-OADS,/arxiv_data1/oa_pdf/4b/0c/apa-4-54.PMC3921866.pdf
"Yunihastuti E, et al.Asia Pacific allergy60 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.54than 500, this is one of the most compelling HLA/ADR associations  identified ever [56, 57].",Non-OADS,/arxiv_data1/oa_pdf/4b/0c/apa-4-54.PMC3921866.pdf
Managing drug hypersensitivity61 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.54discontinuation in 2% of patients [78].,Non-OADS,/arxiv_data1/oa_pdf/4b/0c/apa-4-54.PMC3921866.pdf
"Yunihastuti E, et al.Asia Pacific allergy62 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.54CHALLENGING MANAGEMENT Diagnosis and management of drug hypersensitivity is  particularly challenging since many patients take multiple drugs  and develop opportunistic infections.",Non-OADS,/arxiv_data1/oa_pdf/4b/0c/apa-4-54.PMC3921866.pdf
"Managing drug hypersensitivity63 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.54the effect of stopping and rechallenging, and exclusion of other  possible causes [2].",Non-OADS,/arxiv_data1/oa_pdf/4b/0c/apa-4-54.PMC3921866.pdf
Available from: http://aidsinfo.nih.gov/contentfiles/ lvguidelines/Adult_OI.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4b/0c/apa-4-54.PMC3921866.pdf
"Yunihastuti E, et al.Asia Pacific allergy64 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.54BMC Med Genomics 2012;5:32.",OADS,/arxiv_data1/oa_pdf/4b/0c/apa-4-54.PMC3921866.pdf
Available from: http://dx.doi.org/10.1097/QAI.0000000000000060.,OADS,/arxiv_data1/oa_pdf/4b/0c/apa-4-54.PMC3921866.pdf
Managing drug hypersensitivity65 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.5440.,Non-OADS,/arxiv_data1/oa_pdf/4b/0c/apa-4-54.PMC3921866.pdf
Available from: http://aidsinfo.nih.gov/ContentFiles/ AdultandAdolescentGL.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4b/0c/apa-4-54.PMC3921866.pdf
Available from: http://www.who.int/hiv/pub/ guidelines/arv2013/download/en/.,Non-OADS,/arxiv_data1/oa_pdf/4b/0c/apa-4-54.PMC3921866.pdf
"Yunihastuti E, et al.Asia Pacific allergy66 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.54Stevens-Johnson syndrome.",OADS,/arxiv_data1/oa_pdf/4b/0c/apa-4-54.PMC3921866.pdf
"Managing drug hypersensitivity67 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.54J, Godard P , Bousquet J. Six-hour trimethoprim-sulfamethoxazole- graded challenge in HIV-infected patients.",Non-OADS,/arxiv_data1/oa_pdf/4b/0c/apa-4-54.PMC3921866.pdf
"Original ArticleAsia Pacific allergypISSN 2233-8276 · eISSN 2233-8268  http://dx.doi.org/10.5415/apallergy.2014.4.1.42 Asia Pac Allergy 2014;4:42-47Age of onset as a risk factor of renal involvement  in Henoch-Schönlein purpura Reni Ghrahani*, Masayu Amanda Ledika, Gartika Sapartini, and Budi Setiabudiawan Division of Allergy-Immunology, Department of Child Health, Faculty of Medicine, Universitas Padjadjaran, Bandung 40161, Indonesia Background:  Henoch-Schönlein purpura (HSP) is the most common vasculitis in children, characterized by triad of symptoms;  palpable purpura without thrombocytopenia, abdominal pain, and arthritis.",Non-OADS,/arxiv_data1/oa_pdf/96/1e/apa-4-42.PMC3921867.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/96/1e/apa-4-42.PMC3921867.pdf
"Risk factor of renal involvement in Henoch-Schönlein purpura43 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.42 in children aged 4–6 years and occurs more frequently in male [1,  2].",Non-OADS,/arxiv_data1/oa_pdf/96/1e/apa-4-42.PMC3921867.pdf
Asia Pacific allergy44 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.42accompanying with other complaints (Table 3).,Non-OADS,/arxiv_data1/oa_pdf/96/1e/apa-4-42.PMC3921867.pdf
Risk factor of renal involvement in Henoch-Schönlein purpura45 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.42Renal involvement There were various degrees of renal abnormality in 28 children  (21.9%).,Non-OADS,/arxiv_data1/oa_pdf/96/1e/apa-4-42.PMC3921867.pdf
Asia Pacific allergy46 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.42prognosis.,OADS,/arxiv_data1/oa_pdf/96/1e/apa-4-42.PMC3921867.pdf
"Risk factor of renal involvement in Henoch-Schönlein purpura47       apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.42Bukovac L, Breda L, Al-Mayouf S, Mihaylova D, Chasnyk V, Sengler  C, Klein-Gitelman M, Djeddi D, Nuno L, Pruunsild C, Brunner J,  Kondi A, Pagava K, Pederzoli S, Martini A, Ruperto N; Paediatric  Rheumatology International Trials Organisation (PRINTO).. EULAR/ PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood  polyarteritis nodosa, childhood Wegener granulomatosis  and childhood Takayasu arteritis: Ankara 2008.",Non-OADS,/arxiv_data1/oa_pdf/96/1e/apa-4-42.PMC3921867.pdf
"Case ReportAsia Pacific allergypISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2014.4.1.68 Asia Pac Allergy 2014;4:68-72Rapid onset of Stevens-Johnson syndrome and  toxic epidermal necrolysis after ingestion of    acetaminophen Eun-Jin Kim†, Hyun Lim†, So Young Park, Sujeong Kim, Sun-Young Yoon, Yun-Jeong Bae, Hyouk-Soo Kwon,   You Sook Cho, Hee-Bom Moon, and Tae-Bum Kim* Division of Allergy and Clinical Immunology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine,  Seoul 138-736, Korea Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare, but life-threatening, severe cutaneous adverse  reactions most frequently caused by exposure to drugs.",Non-OADS,/arxiv_data1/oa_pdf/b3/03/apa-4-68.PMC3921868.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/b3/03/apa-4-68.PMC3921868.pdf
SJS/TEN by acetaminophen69 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.68 toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome  (SJS) [1-4].,Non-OADS,/arxiv_data1/oa_pdf/b3/03/apa-4-68.PMC3921868.pdf
Asia Pacific allergy70 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.68epidermal necrolysis.,Non-OADS,/arxiv_data1/oa_pdf/b3/03/apa-4-68.PMC3921868.pdf
SJS/TEN by acetaminophen71 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.68Early withdrawal of the causative drug is associated with a better  prognosis for patients with either TEN or SJS [12].,Non-OADS,/arxiv_data1/oa_pdf/b3/03/apa-4-68.PMC3921868.pdf
Asia Pacific allergy72 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.68risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.,Non-OADS,/arxiv_data1/oa_pdf/b3/03/apa-4-68.PMC3921868.pdf
Current ReviewAsia Pacific allergypISSN 2233-8276 · eISSN 2233-8268  http://dx.doi.org/10.5415/apallergy.2014.4.1.3 Asia Pac Allergy 2014;4:3-13Changing the paradigm for cough: does ‘cough  hypersensitivity’ aid our understanding?,Non-OADS,/arxiv_data1/oa_pdf/d0/7f/apa-4-3.PMC3921869.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/d0/7f/apa-4-3.PMC3921869.pdf
Asia Pacific allergy4 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.3pictures did not correspond well.,Non-OADS,/arxiv_data1/oa_pdf/d0/7f/apa-4-3.PMC3921869.pdf
"Cough hypersensitivity syndrome5 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.3However, not every cough is reflex; we can also voluntarily  initiate and suppress coughing.",Non-OADS,/arxiv_data1/oa_pdf/d0/7f/apa-4-3.PMC3921869.pdf
Asia Pacific allergy6 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.3hypersensitivity and general atopic tendency but no asthma  [36].,Non-OADS,/arxiv_data1/oa_pdf/d0/7f/apa-4-3.PMC3921869.pdf
"Cough hypersensitivity syndrome7 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.3Patients may have an excessive degree of acid reflux when tested  with an esophageal pH study, and the close temporal relationship  between episodes of acid reflux and the coughing – the so-called  symptom association probability or SAP confirms that relationship  [55].",Non-OADS,/arxiv_data1/oa_pdf/d0/7f/apa-4-3.PMC3921869.pdf
Asia Pacific allergy8 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.3factor to determine cough response to any given stimulation.,OADS,/arxiv_data1/oa_pdf/d0/7f/apa-4-3.PMC3921869.pdf
Cough hypersensitivity syndrome9 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.3DOES THE ‘HYPERSENSITIVITY’ CONCEPT  AID OUR CLINICAL PRACTICE?,Non-OADS,/arxiv_data1/oa_pdf/d0/7f/apa-4-3.PMC3921869.pdf
Asia Pacific allergy10 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.3One 2013;8:e78081.,Non-OADS,/arxiv_data1/oa_pdf/d0/7f/apa-4-3.PMC3921869.pdf
Cough hypersensitivity syndrome11 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.3ID.,Non-OADS,/arxiv_data1/oa_pdf/d0/7f/apa-4-3.PMC3921869.pdf
http://dx.doi.org/10.1007/s00408-013-9543-8.,Non-OADS,/arxiv_data1/oa_pdf/d0/7f/apa-4-3.PMC3921869.pdf
http://dx.doi.org/10.1016/j.jaci.2013.09.016.,OADS,/arxiv_data1/oa_pdf/d0/7f/apa-4-3.PMC3921869.pdf
Asia Pacific allergy12 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.358.,Non-OADS,/arxiv_data1/oa_pdf/d0/7f/apa-4-3.PMC3921869.pdf
Cough hypersensitivity syndrome13 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.3laryngopharyngeal reflux disease in patients with diabetes mellitus.,Non-OADS,/arxiv_data1/oa_pdf/d0/7f/apa-4-3.PMC3921869.pdf
"Asia Pacific allergypISSN 2233-8276 · eISSN 2233-8268 Hypothesis & Experience Original Article  http://dx.doi.org/10.5415/apallergy.2014.4.1.48 Asia Pac Allergy 2014;4:48-53Frequently asked questions in allergy practice Xiang-Xuan Tan1, Peiting Xie1, Jia-Li Kwek1, Sock-Yuen Kwek1, Zihui Yang1, Weiling Soon1, Jern-Lin Leong2, and De-Yun Wang3,* 1Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore 2ASCENT Ear Nose Throat Specialist Group, Mount Elizabeth Medical Centre, Singapore 228510, Singapore 3Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore Background:  Over the last 10-20 years, international guidelines and consensus statements for the management of common allergic  diseases (e.g.",Non-OADS,/arxiv_data1/oa_pdf/84/49/apa-4-48.PMC3921870.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/84/49/apa-4-48.PMC3921870.pdf
"Frequently asked questions in allergy practice49 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.48 and eczema, with individualized impact on patients.",Non-OADS,/arxiv_data1/oa_pdf/84/49/apa-4-48.PMC3921870.pdf
Asia Pacific allergy50 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.48different allergic conditions and 1 regarding the affordability of SLIT.,Non-OADS,/arxiv_data1/oa_pdf/84/49/apa-4-48.PMC3921870.pdf
"Frequently asked questions in allergy practice51 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.48Sixty-two questions (60.2%) could not be answered by information  provided in the ARIA guidelines [1, 2] or the expert panel of speakers  during the course.",Non-OADS,/arxiv_data1/oa_pdf/84/49/apa-4-48.PMC3921870.pdf
Asia Pacific allergy52 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.48a slow pulse rate with a strong central pulse.,Non-OADS,/arxiv_data1/oa_pdf/84/49/apa-4-48.PMC3921870.pdf
"Frequently asked questions in allergy practice53       apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.48Naspitz C, Nekam K, Niggemann B, Nizankowska-Mogilnicka E,  Okamoto Y, Orru MP , Potter P , Price D, Stoloff SW, Vandenplas  O, Viegi G, Williams D. Allergic Rhinitis and its Impact on  Asthma (ARIA) 2008 update (in collaboration with the World  Health Organization, GA(2)LEN and AllerGen).",Non-OADS,/arxiv_data1/oa_pdf/84/49/apa-4-48.PMC3921870.pdf
"apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.48 Asia Pacific allergy pISSN 2233-8276 · eISSN 2233-8268Tan XX, et al.",Non-OADS,/arxiv_data1/oa_pdf/84/49/apa-4-48.PMC3921870.pdf
http://dx.doi.org/10.5415/apallergy.2014.4.1.48 Asia Pac Allergy 2014;4:48-53Supplement – Questio ns asked in the 1st International Basic Allergy Course 1.,Non-OADS,/arxiv_data1/oa_pdf/84/49/apa-4-48.PMC3921870.pdf
apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.48,Non-OADS,/arxiv_data1/oa_pdf/84/49/apa-4-48.PMC3921870.pdf
apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.48 pISSN 2233-8276 · eISSN 2233-8268  http://dx.doi.org/10.5415/apallergy.2014.4.1.48 Asia Pac Allergy 2014;4:48-53It is recommended that antihistamines/intranasal corticosteroids are used in the morning.,Non-OADS,/arxiv_data1/oa_pdf/84/49/apa-4-48.PMC3921870.pdf
"apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.48 Asia Pacific allergy pISSN 2233-8276 · eISSN 2233-8268Tan XX, et al.",Non-OADS,/arxiv_data1/oa_pdf/84/49/apa-4-48.PMC3921870.pdf
"http://dx.doi.org/10.5415/apallergy.2014.4.1.48 Asia Pac Allergy 2014;4:48-53Although it is convenient, is vial-mixing safe and evidence-based?",Non-OADS,/arxiv_data1/oa_pdf/84/49/apa-4-48.PMC3921870.pdf
apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.48 pISSN 2233-8276 · eISSN 2233-8268  http://dx.doi.org/10.5415/apallergy.2014.4.1.48 Asia Pac Allergy 2014;4:48-533.,Non-OADS,/arxiv_data1/oa_pdf/84/49/apa-4-48.PMC3921870.pdf
"apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.48 Asia Pacific allergy pISSN 2233-8276 · eISSN 2233-8268Tan XX, et al.",Non-OADS,/arxiv_data1/oa_pdf/84/49/apa-4-48.PMC3921870.pdf
http://dx.doi.org/10.5415/apallergy.2014.4.1.48 Asia Pac Allergy 2014;4:48-53Why is there a rise in peanut allergies within the last 10 years?,Non-OADS,/arxiv_data1/oa_pdf/84/49/apa-4-48.PMC3921870.pdf
"Original ArticleAsia Pacific allergypISSN 2233-8276 · eISSN 2233-8268  http://dx.doi.org/10.5415/apallergy.2014.4.1.32 Asia Pac Allergy 2014;4:32-36The pH of antiseptic cleansers Kanokvalai Kulthanan, Pitchaya Maneeprasopchoke*, Supenya Varothai, and Piyavadee Nuchkull Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand Background:  Daily bathing with antiseptic cleansers are proposed by some physicians as an adjunctive management of atopic  dermatitis (AD).",Non-OADS,/arxiv_data1/oa_pdf/04/c0/apa-4-32.PMC3921871.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/04/c0/apa-4-32.PMC3921871.pdf
pH of antiseptic cleansers33 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.32 available in the market.,Non-OADS,/arxiv_data1/oa_pdf/04/c0/apa-4-32.PMC3921871.pdf
Asia Pacific allergy34 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.32antiseptic cleansers are an adjunct option to the management of  AD [18].,Non-OADS,/arxiv_data1/oa_pdf/04/c0/apa-4-32.PMC3921871.pdf
"pH of antiseptic cleansers35 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.32dermatitis) change from baseline within day 14, this difference was  no longer statistically significant by day 27.",Non-OADS,/arxiv_data1/oa_pdf/04/c0/apa-4-32.PMC3921871.pdf
Asia Pacific allergy36 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.32eczema and atopic dermatitis and relevant combined topical  therapy: a double-blind multicentre randomized controlled  trial.,Non-OADS,/arxiv_data1/oa_pdf/04/c0/apa-4-32.PMC3921871.pdf
"Original ArticleAsia Pacific allergypISSN 2233-8276 · eISSN 2233-8268  http://dx.doi.org/10.5415/apallergy.2014.4.1.37 Asia Pac Allergy 2014;4:37-41Effects of wheezing in early childhood in the  development of allergic rhinitis in later years Feyzullah Cetinkaya* and Ozgur Ozhan Atalay Department of Pediatrics, Maltepe University School of Medicine, Istanbul 34843, Turkey Background:  Studies on the long-term effects of wheezing in infancy have particularly focused on asthma.",Non-OADS,/arxiv_data1/oa_pdf/19/2d/apa-4-37.PMC3921872.pdf
"http://apallergy.org INTRODUCTION The progression of atopic disorders, generally from eczema in  early childhood to allergic rhinitis and asthma in later childhood  has been described as “atopic march” [1].",Non-OADS,/arxiv_data1/oa_pdf/19/2d/apa-4-37.PMC3921872.pdf
"Cetinkaya F and Atalay OOAsia Pacific allergy38 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.37factors associated with children that experience wheezing in early  ages, some wheezing phenotypes have been defined [2].",Non-OADS,/arxiv_data1/oa_pdf/19/2d/apa-4-37.PMC3921872.pdf
Wheezing in early childhood and rhinitis39       apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.37the exact  cause  has not been  well elucidated yet.,Non-OADS,/arxiv_data1/oa_pdf/19/2d/apa-4-37.PMC3921872.pdf
Cetinkaya F and Atalay OOAsia Pacific allergy40 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.37rhinitis in our study group with persistent wheezing is a result  of a mechanism similar to asthma-allergic rhinitis relationship.,Non-OADS,/arxiv_data1/oa_pdf/19/2d/apa-4-37.PMC3921872.pdf
Wheezing in early childhood and rhinitis41 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.1.373q21.3.,Non-OADS,/arxiv_data1/oa_pdf/19/2d/apa-4-37.PMC3921872.pdf
"The diameter of an aberrant crypt mea - sured at least 3 to 4 times larger than that of a normal crypt Received: 28 May 2013, Accepted: 27 June 2013 *Corresponding author: M Suzui (suzui@med.nagoya-cu.ac.jp) ©2013 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/f0/1c/tox-26-335.PMC3921915.pdf
"Received: 8 May 2013, Accepted: 27 June 2013 *Corresponding author: A Okahara (e-mail: akihiko.okahara@ santen.co.jp) © The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/b5/65/tox-26-343.PMC3921916.pdf
"However, it was Received: 23 May 2013, Accepted: 5 July 2013 *Corresponding author: A Hagiwara (e-mail: hagiwara@dims.co.jp) ©2013 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/e5/98/tox-26-351.PMC3921917.pdf
"Received: 13 May 2013, Accepted: 8 July 2013 *Corresponding author: S Haouem (e-mail: samirzeineb@yahoo.fr) ©2013 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/b5/01/tox-26-359.PMC3921918.pdf
"HSP70 overexpression confers myocardial protection,  as observed by resistance to myocardial ischemic stress and Received: 1 February 2013, Accepted: 16 July 2013 *Corresponding author: S-Q Li (e-mail: sanqiangli2001@163.com) ©2013 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/66/00/tox-26-365.PMC3921919.pdf
co.jp) © The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/15/ae/tox-26-375.PMC3921920.pdf
©2013 The Japanese Society of Toxicologic PathologyThis is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/0c/fd/tox-26-385.PMC3921921.pdf
"metro.tokyo.jp), D Nakae (e-mail: agalennde.dai@nifty.com) ©2013 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/70/f5/tox-26-393.PMC3921922.pdf
"Materials and Methods Ethical considerations The current study was performed principally in con - formity with the Guidelines for the Toxicity Testing of Phar - maceuticals released by the Ministry of Health, Labour and Welfare of Japan (http://www.pmda.go.jp/ich/s/s4_93_8_10.pdf; http://www.pmda.go.jp/ich/s/s4a_99_4_5.pdf).",Non-OADS,/arxiv_data1/oa_pdf/70/f5/tox-26-393.PMC3921922.pdf
"Received: 14 May 2013, Accepted: 23 August 2013 *Corresponding authors: Y Shibui (e-mail: yusuke_shibui@ajino - moto.com) and T Miwa©2013 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/d4/75/tox-26-405.PMC3921923.pdf
"Immunohisto - Received: 4 April 2013, Accepted: 5 July 2013 *Corresponding author: Y Ohmachi (e-mail: y-omachi@nirs.go.jp) ©2013 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/ee/00/tox-26-413.PMC3921924.pdf
"Tissues were fixed in 10% neu - tral buffered formalin and embedded in paraffin, and sec - Received: 13 May 2013, Accepted: 6 July 2013 *Corresponding author: Y Taketa (e-mail: y-taketa@hhc.eisai.co.jp) ©2013 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/28/7c/tox-26-419.PMC3921925.pdf
"Samples were trimmed, fixed in 10% buffered formalin, paraffin-embedded, sectioned at four µm and stained with Received: 25 April 2013, Accepted: 8 July 2013 *Corresponding author: V Castiglioni (e-mail: vittoria.castiglioni@ unimi.it) ©2013 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/75/f4/tox-26-423.PMC3921926.pdf
Jackson Laboratory 1998. from Mouse tumor biology data - base: http://tumor.informatics.jax.org/mtbwi/index.do.,OADS,/arxiv_data1/oa_pdf/75/f4/tox-26-423.PMC3921926.pdf
"Then, ultrathin sections were double-stained with 2% uranyl ac - etate and lead citrate, and examined under a transmission Received: 30 May 2013, Accepted: 16 July 2013 *Corresponding author: Y Miyamoto (e-mail: Youhei_Miyamoto@ nts.toray.co.jp) ©2013 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/19/40/tox-26-429.PMC3921927.pdf
"Claudin-3, claudin-4 and claudin-8 are present in the collecting ducts, whereas the expression of claudin-1 and claudin-2 is limited to the proximal nephron 14 Received: 19 February 2013, Accepted: 3 August 2013 *Corresponding author: T Kojima (e-mail: ktakashi@sapmed.ac.jp) ©2013 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/b9/f5/tox-26-433.PMC3921928.pdf
"Although there were some studies con - cerning the alteration of quantitative nuclear chromatin in chemical-induced carcinogenesis 19–21, more detailed studies Received: 3 June 2013, Accepted: 5 August 2013 *Corresponding author: S Wakui (e-mail: Wakui@azabu-u.ac.jp) ©2013 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/e6/92/tox-26-439.PMC3921929.pdf
ac.jp) ©2013 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/df/33/tox-26-447.PMC3921930.pdf
"E-mail: yslee07@nih.go.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2013 4(6), 293 e300 http://dx.doi.org/10.1016/j.phrp.2013.10.001 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/60/7d/main.PMC3922097.pdf
"E-mail: miyeoun@korea.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2013 4(6), 301 e307 http://dx.doi.org/10.1016/j.phrp.2013.10.002 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/ad/43/main.PMC3922098.pdf
"The business is based on “Shaping the 21 st Century,” part of the 21stcentury development collab- oration strategy that was drafted by Organization for Economic Cooperation and Development (OECD) E-mail: llhhss1018@hanmail.net This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2013 4(6), 308 e315 http://dx.doi.org/10.1016/j.phrp.2013.10.003 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/7f/24/main.PMC3922099.pdf
Acknowledgments This research was supported by a grant from National Research Foundation of Korea (NRF-210-413-B00024)and the Korea Foundation for International Healthcare(KOFIH) (Study Service-6-2012-20) funded by theAdministration.References 1.www.un.org/millenniumgoals/ .http://www.un.org/millenniumgoa ls/bkgd.shtml [accessed: 01.10.12] 2.Albert NL.,Non-OADS,/arxiv_data1/oa_pdf/7f/24/main.PMC3922099.pdf
4.http://www.weforum.org/reports/strategic-infrastructure-steps-prepare- and-accelerate-public-private-partnerships [accessed: 12.5.13] 5.Organization for Economic Cooperation and Development (OECD).,Non-OADS,/arxiv_data1/oa_pdf/7f/24/main.PMC3922099.pdf
7.http://lnweb90.worldbank.org/oed/oeddoclib.nsf/DocUNIDViewForJavaSearch/F97A9075E643981785256C0700753005/$ﬁle/GPPP.pdf [accessed: 01.05.13] 8.http://www.adb.org/documents/public-private-partnership-ppp- handbook [accessed: 05.05.13] 9.Organization for Economic Cooperation and Development (OECD).,Non-OADS,/arxiv_data1/oa_pdf/7f/24/main.PMC3922099.pdf
"10.http://dced.net/page/key-events-publications [accessed: 05.05.13] 11.Kim CB, Han HJ, Park HJ, Lee HS.",Non-OADS,/arxiv_data1/oa_pdf/7f/24/main.PMC3922099.pdf
"E-mail: songmee@hanmail.net This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2013 4(6), 316 e322 http://dx.doi.org/10.1016/j.phrp.2013.10.004 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/5b/c5/main.PMC3922100.pdf
"E-mail: ckang@nih.go.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2013 4(6), 323 e328 http://dx.doi.org/10.1016/j.phrp.2013.10.005 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/58/c8/main.PMC3922101.pdf
Available from: http://www.who.int/csr/disease/ inﬂuenza/2008-9nhemisummaryreport/en/index.html .,Non-OADS,/arxiv_data1/oa_pdf/58/c8/main.PMC3922101.pdf
Available from: http://www.nisn.org/v_anlysis_ guidance_ic50.php .,Non-OADS,/arxiv_data1/oa_pdf/58/c8/main.PMC3922101.pdf
"E-mail: bsyoon@kyonggi.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2013 4(6), 342 e346 http://dx.doi.org/10.1016/j.phrp.2013.10.006 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/86/79/main.PMC3922102.pdf
"E-mail: rnpadhy54@yahoo.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2013 4(6), 347 e357 http://dx.doi.org/10.1016/j.phrp.2013.10.007 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/89/be/main.PMC3922103.pdf
"Available from, http://apps.who.int/medicinedocs/documents [accessed 15.10.13].",OADS,/arxiv_data1/oa_pdf/89/be/main.PMC3922103.pdf
"E-mail: healthgate@bau.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2013 4(6), 329 e341 http://dx.doi.org/10.1016/j.phrp.2013.10.008pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/32/80/main.PMC3922104.pdf
"E-mail: keemeekyung@gmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2013 4(6), 358 e362 http://dx.doi.org/10.1016/j.phrp.2013.10.009pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/2e/0b/main.PMC3922105.pdf
"Despite many studies on HIV/AIDS in Korea, we would still like to see a viral dynamic study on HIV/AIDS, estimating the incidence of the infection using a This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2013 4(6), 291 e292 http://dx.doi.org/10.1016/j.phrp.2013.11.001pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/7c/b2/main.PMC3922106.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/fa/dmt039.PMC3922144.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided theoriginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/2a/dkt427.PMC3922153.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3 .0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/c8/dkt430.PMC3922154.pdf
The data discussed in this publication have been deposited in NCBI’s Gene Expression Omnibus (GEO) 13and are accessible through GEO Series accession number GSE31592 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE31592).,OADS,/arxiv_data1/oa_pdf/5d/c8/dkt430.PMC3922154.pdf
"Acknowledgements 2D-DIGE, MS and microarray experiments were performed at the Central Biotechnology Service at Cardiff University (http://medicine.cf.ac.uk/cbs).",OADS,/arxiv_data1/oa_pdf/5d/c8/dkt430.PMC3922154.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided theoriginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/44/b7/dkt432.PMC3922155.pdf
Determination of susceptibility to ﬂuoroquinolones The MIC of each ﬂuoroquinolone tested was determined by the standar-dized agar doubling-dilution method as described previously by the BSAC (http://www.bsac.org.uk).,Non-OADS,/arxiv_data1/oa_pdf/44/b7/dkt432.PMC3922155.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permitsnon-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/a4/not197.PMC3922510.pdf
2007. http://www.mathworks.co.uk/matlabcentral/ ﬁleexchange/15482-myﬁsher33 (last accessed 15 November 2013).,Non-OADS,/arxiv_data1/oa_pdf/e7/a4/not197.PMC3922510.pdf
"Communicative & Integrative Biology 2013; 6:e26839; http://dx.doi.org/10.4161/cib.26839Dock protein family in brain development   and neurological disease Lei Shi1,2,* 1JnU-HKUST Joint Laboratory for n euroscience and i nnovative Drug Research; Jinan University; Guangdong, PR China; 2Division of Life Science; The Hong Kong University  of Science and Technology; Hong Kong, PR China Keywords:  actin, axon, Cdc42, dedicator of cytokinesis, dendrite, ELMO, guanine nucleotide exchange factor, neurite, Rac,  Rho GTPase, synapse The family of dedicator of cytokinesis (Dock), a protein  family that belongs to the atypical Rho guanine nucleotide  exchange factors (G eFs) for Rac and/or Cdc42 GTPases, plays  pivotal roles in various processes of brain development.",Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
J Cell Sci 2002; 115:4901-13; PMID:12432077 ;  http://dx.doi.org/10.1242/jcs.00219 2.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
J Cell Sci 2005 ; 118:4937 - 46; PMID:16254241 ; http://dx.doi.org/10.1242/ jcs.02671 3.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Nat Rev Mol Cell Biol   2005 ; 6:167-80; PMID :15688002 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Cell Signal   2010 ; 22:175-82; PMID:19796679 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
PLoS One   2011 ; 6:e20988 ; PMID:21829596 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Trends Cell Biol 2007 ; 17:383-93; PMID:17765544 ;  http://dx.doi.org/10.1016/j.tcb.2007.05.001 8.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
J Biol Chem 2004 ; 279:6087 -97;  PMID:14638695 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Nat Neurosci  2008 ; 11:28-35; PMID:18066058 ;  http://dx.doi.org/10.1038/nn202211.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Nat Neurosci  2009 ; 12:268-76;  PMID:19182796 ; http://dx.doi.org/10.1038/ nn.2254 12.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
EMBO J   2012 ; 31:2908 -21; PMID:22588079 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
FEBS Lett  2001 ; 491:193-9;  PMID:11240126 ; http://dx.doi.org/10.1016/ S0014-5793(01)02195-0 14.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
J Biol Chem 2011 ; 286:37615 -24;  PMID:21900250 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Nature  2007 ; 450:430- 4; PMID:17960134 ; http://dx.doi.org/10.1038/ nature06329 16.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Mol Psychiatry  2013 ;  18:943-50; PMID:23628982 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
J Neurosci  2013 ; 33:6964 -78;  PMID:23595754 ; http://dx.doi.org/10.1523/ JNEUROSCI.3978-12.2013 18.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Exp Cell Res   2013 ; 319:2343 -9; PMID:23911989 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Exp Mol Pathol   2013 ; 94:366-71; PMID:23318649 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
J Neurochem 2000 ;  75:109-16; PMID:10854253 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Am J Pathol 2001 ; 159:1597 - 602; PMID:11696419 ; http://dx.doi.org/10.1016/ S0002-9440(10)63005-2 23.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Biochem J  2012 ; 442:413-22;  PMID:22115042 ; http://dx.doi.org/10.1042/ BJ20100993 24.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
J Cell Biol 2002 ; 158:79- 89; PMID:12093789 ; http://dx.doi.org/10.1083/ jcb.200110151 25.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Mol Brain   2013 ; 6:22; PMID:23641686 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Cell Death Differ 2013 ; 20:1250 -6;  PMID:23852370 ; http://dx.doi.org/10.1038/ cdd.2013.91 27.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
"J Neurosci  2009 ; 29:118- 30; PMID:19129390 ; http://dx.doi.org/10.1523/ JNEUROSCI.3985-08.2009 28. de Silva MG, Elliott  K , Dahl  HH, Fitzpatrick   E, Wilcox  S, Delatycki  M, Williamson  R, Efron   D, Lynch  M, Forrest  S. Disruption of a novel  member of a sodium/hydrogen exchanger family  and DOCK3 is associated with an attention deficit  hyperactivity disorder-like phenotype.",Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
J Med Genet   2003 ; 40:733-40; PMID:14569117 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Genes Cells  2012 ; 17:688-97; PMID:22734669 ;  http://dx.doi.org/10.1111/j.1365-2443.2012.01616.x,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Proc Natl Acad Sci U S A   2010 ; 107:7586 -91; PMID:20368433 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
J Neurosci  2012 ; 32:264- 74; PMID:22219288 ; http://dx.doi.org/10.1523/ JNEUROSCI.4884-11.2012 32.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
J Neurosci  2005 ; 25:281-90;  PMID:15647471 ; http://dx.doi.org/10.1523/ JNEUROSCI.3692-04.2005 33.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Mol Biol Cell  2008 ; 19:4660 -74;  PMID:18716063 ; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Biol Psychiatry  2010 ; 68:320- 8; PMID:20346443 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Mol Psychiatry   2011 ; 16:365-82; PMID:20956978 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Int  J Neuropsychopharmacol  2012 ; 15:459-69;  PMID:21682944 ; http://dx.doi.org/10.1017/ S1461145711000903 38.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
J Biol Chem 2013 ; 288:20034 - 45; PMID:23720743 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
J Neurosci Res 2008 ; 86:3052 - 61; PMID :18615735 ; http://dx.doi.org/10.1002/ jnr.21763 40.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Mol Biol Cell  2013 ; 24:1602 -13; PMID:23536706 ;  http://dx.doi.org/10.1091/mbc.E12-11-0782 41.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Neuron  2011 ; 69:482- 97; PMID:21315259 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Neuron   2005 ; 48:605-18; PMID:16301177 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Exp Cell Res  2007 ; 313:791-804; PMID:17196961 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Sci Signal  2013 ; 6:ra15; PMID:23462102 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Neuron  2006 ; 51:727-39;  PMID:16982419 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Nat Neurosci   2012 ; 15:1201 -10; PMID:22842144 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Biochem Cell Biol  2012 ; 90:565-74;  PMID:22475431 ; http://dx.doi.org/10.1139/ o2012-009 48.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
J Cell Biol  2008 ; 181:351-65; PMID:18426980 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
J Neurosci  2011 ; 31:12579 -92;  PMID:21880919 ; http://dx.doi.org/10.1523/ JNEUROSCI.2738-11.2011 50.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Biochem Biophys Res Commun  2005 ; 333:818- 26; PMID:15963462 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Acta Biochim Biophys Sin (Shanghai) 2010 ; 42:266- 73; PMID:20383465 ; http://dx.doi.org/10.1093/ abbs/gmq014 52.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
FEBS Lett  2004 ; 572:159-66; PMID:15304341 ;  http://dx.doi.org/10.1016/j.febslet.2004.06.095 54.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
J Immunol  2013 ; 190:3661 -9; PMID:23455509 ;  http://dx.doi.org/10.4049/jimmunol.1202792 55.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Mol Hum Reprod 2007 ; 13:685- 9; PMID:17644778 ; http://dx.doi.org/10.1093/ molehr/gam04556.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Genomics  2008 ; 91:195-202;  PMID:18060736 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Psychiatr Genet  2007 ; 17:274- 86; PMID:17728666 ; http://dx.doi.org/10.1097/ YPG.0b013e328133f352 60.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Eur J Hum Genet 2013 ; PMID:23632794 ;  http://dx.doi.org/10.1038/ejhg.2013.88 61.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Proc Natl Acad Sci U S A   2008 ; 105:1931 -6; PMID:18245386 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Oncogene  2008 ; 27:5845 - 55; PMID:18641688 ; http://dx.doi.org/10.1038/ onc.2008.202 63.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
BMC Cell  Biol 2013 ; 14:9; PMID:23441967 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Exp Cell Res 2009 ; 315:863- 76; PMID:19118547 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Mol Biol Cell  2008 ; 19:3823 -35;  PMID:18596235 ; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Blood  2003 ; 102:2948 - 50; PMID:12829596 ; http://dx.doi.org/10.1182/ blood-2003-01-0173 67.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Curr Biol  2005 ; 15:371- 7; PMID:15723800 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Nature  2003 ; 424:461-4; PMID:12879077 ;  http://dx.doi.org/10.1038/nature01817 69.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Genes Dev   1998 ; 12:3331 -6; PMID:9808620 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Blood  2002 ; 100:3968 -74; PMID:12393632 ;  http://dx.doi.org/10.1182/blood-2001-11-0032 71.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Genes Dev   2005 ; 19:1-49; PMID :15630019 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
J Cell Biol 2010 ; 190:461- 77; PMID:20679435 ; http://dx.doi.org/10.1083/ jcb.201005141 74.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
PLoS One  2012 ; 7:e46277 ;  PMID:23050005 ; http://dx.doi.org/10.1371/ journal.pone.0046277 76.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
J Biol Chem 2010 ; 285:13211 - 22; PMID:20167601 ; http://dx.doi.org/10.1074/ jbc.M110.102517 78.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Biochem  J 2001 ; 354:73-8; PMID:11171081 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Nat Cell Biol 2005 ; 7:797-807;  PMID:16025104 ; http://dx.doi.org/10.1038/ ncb128080.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
J Cell Biol 2006 ; 174:647- 52; PMID:16943182 ; http://dx.doi.org/10.1083/ jcb.200602142 81.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
IUBMB Life  2008 ; 60:467-72; PMID:18459162 ;  http://dx.doi.org/10.1002/iub.67 82.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Biochem J  2008 ; 409:525-33; PMID:17935486 ;  http://dx.doi.org/10.1042/BJ20071263 83.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
J Clin  Invest  2011 ; 121:4670 -84; PMID:22080864 ;  http://dx.doi.org/10.1172/JCI58559 84.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
Proc Natl Acad Sci U S A 2012 ;  109:3018 -23; PMID:22323579 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/8a/cib-6-e26839.PMC3922786.pdf
"Communicative & Integrative Biology 2013; 6:e26926; http://dx.doi.org/10.4161/cib.26926 *Correspondence to:  Björn Schumacher;  Email: bjoern.schumacher@uni-koeln.de Addendum to: Ermolaeva MA, Segref A, Dak - hovnik A, Ou HL, Schneider JI, Utermöhlen O, Hoppe T, Schumacher B. DNA damage in germ cells induces an innate immune response that triggers systemic stress resistance.",Non-OADS,/arxiv_data1/oa_pdf/35/35/cib-6-e26926.PMC3922787.pdf
Trends Genet  2008; 24:77-85; PMID:18192065; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/35/cib-6-e26926.PMC3922787.pdf
Mol Cell 2000; 5:435- 43; PMID:10882129; http://dx.doi.org/10.1016/S1097-2765(00)80438-4 4.,OADS,/arxiv_data1/oa_pdf/35/35/cib-6-e26926.PMC3922787.pdf
Mutat Res 1988; 208:77-82; PMID:3380112;  http://dx.doi.org/10.1016/S0165-7992(98)90003-3 5.,OADS,/arxiv_data1/oa_pdf/35/35/cib-6-e26926.PMC3922787.pdf
Nature 2013; 501:416-20; PMID:23975097; http://dx.doi.org/10.1038/nature12452 6.,Non-OADS,/arxiv_data1/oa_pdf/35/35/cib-6-e26926.PMC3922787.pdf
PLoS Genet  2011; 7:e1002238; PMID:21901106; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/35/cib-6-e26926.PMC3922787.pdf
Science 2002; 295:502- 5; PMID:11799246; http://dx.doi.org/10.1126/science.1065768,OADS,/arxiv_data1/oa_pdf/35/35/cib-6-e26926.PMC3922787.pdf
Genetics  2006; 172:2269-81; PMID:16415360; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/35/cib-6-e26926.PMC3922787.pdf
Curr Opin Microbiol 2008; 11:251-6; PMID:18567532; http://dx.doi.org/10.1016/j.mib.2008.05.014 11.,OADS,/arxiv_data1/oa_pdf/35/35/cib-6-e26926.PMC3922787.pdf
PLoS Genet 2006; 2:e183; PMID:17096597; http://dx.doi.org/10.1371/journal.pgen.0020183 12.,Non-OADS,/arxiv_data1/oa_pdf/35/35/cib-6-e26926.PMC3922787.pdf
Science 2006; 313:848-51; PMID:16902142;  http://dx.doi.org/10.1126/science.1127059 13.,Non-OADS,/arxiv_data1/oa_pdf/35/35/cib-6-e26926.PMC3922787.pdf
Proc Natl Acad Sci U S A 2011; 108:14944- 9; PMID:21896770; http://dx.doi.org/10.1073/ pnas.1100959108 14.,OADS,/arxiv_data1/oa_pdf/35/35/cib-6-e26926.PMC3922787.pdf
Nature 2005; 436:1186-90; PMID:15995699; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/35/cib-6-e26926.PMC3922787.pdf
Nature  2008; 452:103-7; PMID:18288107; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/35/cib-6-e26926.PMC3922787.pdf
Science 2013; 339:786-91; PMID:23258413; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/35/cib-6-e26926.PMC3922787.pdf
Proc Natl Acad Sci U S A 2001; 98:9237-42; PMID:11470918; http://dx.doi.org/10.1073/ pnas.161293498 18.,OADS,/arxiv_data1/oa_pdf/35/35/cib-6-e26926.PMC3922787.pdf
Eur J Cell Biol 2011; 90:560-4; PMID:21035896; http://dx.doi.org/10.1016/j.ejcb.2010.09.011 19.,OADS,/arxiv_data1/oa_pdf/35/35/cib-6-e26926.PMC3922787.pdf
Nat Cell Biol 2009; 11:973- 9; PMID:19597488; http://dx.doi.org/10.1038/ ncb1909 20.,Non-OADS,/arxiv_data1/oa_pdf/35/35/cib-6-e26926.PMC3922787.pdf
Cell 2010;  143:355-66; PMID:21029859; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/35/cib-6-e26926.PMC3922787.pdf
Nature 2011; 479:547-51; PMID:22080947; http://dx.doi.org/10.1038/nature1059923.,Non-OADS,/arxiv_data1/oa_pdf/35/35/cib-6-e26926.PMC3922787.pdf
Curr Opin Immunol 2012; 24:488-93;  PMID:22565047; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/35/35/cib-6-e26926.PMC3922787.pdf
EMBO J 2003; 22:3783-91; PMID:12881413; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/35/cib-6-e26926.PMC3922787.pdf
Nature 2012; 489:263-8; PMID:22922647;  http://dx.doi.org/10.1038/nature11315 26.,Non-OADS,/arxiv_data1/oa_pdf/35/35/cib-6-e26926.PMC3922787.pdf
Proc Natl Acad Sci U S A 2007;  104:5947-52; PMID:17392428; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/35/cib-6-e26926.PMC3922787.pdf
Nature 2010; 463:1092-5; PMID:20182512; http://dx.doi.org/10.1038/ nature08762 29.,Non-OADS,/arxiv_data1/oa_pdf/35/35/cib-6-e26926.PMC3922787.pdf
World J Gastroenterol 2011; 17:2161-71;  PMID:21633524; http://dx.doi.org/10.3748/wjg.v17.,Non-OADS,/arxiv_data1/oa_pdf/35/35/cib-6-e26926.PMC3922787.pdf
J Exp Med 2010; 207:2921-30; PMID:21115688;  http://dx.doi.org/10.1084/jem.20101102,Non-OADS,/arxiv_data1/oa_pdf/35/35/cib-6-e26926.PMC3922787.pdf
"Commu - nicative & Integrative Biology 2013; 6:e26807; http://dx.doi.org/10.4161/cib.26807 Addendum to: Steinert JR, Campesan S, Richards P , Kyriacou CP , Forsythe ID, Giorgini F. Rab11 rescues synaptic dysfunction and behavioural deficits in a Drosophila model of Huntington’s disease.",Non-OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
Hum Mol Genet 2012; 21:2912-22; PMID:22466800; http://dx.doi.org/10.1093/hmg/dds117,OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
Adv Exp Med Biol  2012; 970:553-72;  PMID:22351072 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
Trends Neurosci 2010; 33:513- 23; PMID:20850189 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
Adv Exp Med Biol 2012; 970:573-601;  PMID:22351073 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
Prion 2009; 3:195-201;   PMID:19887910 ; http://dx.doi.org/10.4161/ pri.3.4.9981 5.,Non-OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
Prog Neurobiol  2012; 97:127-41;  PMID:22037413 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
J Mol Biol  2001; 313:889-901;  PMID:11697911 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
Cell 2003; 112:507-17; PMID:12600314 ; http://dx.doi.org/10.1016/ S0092-8674(03)00118-1 9.,OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
Neuron 1993;  11:789-99;  PMID:8240804 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
J Cell Biol 1996; 135:913-24; PMID:8922376 ; http://dx.doi.org/10.1083/ jcb.135.4.913 12.,Non-OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
J Biol Chem  2002; 277:50415-21;  PMID:12393859 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
Biochem Biophys Res Commun 2012;  421:727-30;  PMID:22542623 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
Neuroreport 2008; 19:1643- 7; PMID:18845944 ; http://dx.doi.org/10.1097/ WNR.0b013e328315cd4c 15.,Non-OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
Mol Cell Biol 2009; 29:6106- 16; PMID:19752198 ; http://dx.doi.org/10.1128/ MCB.00420-09 16.,Non-OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
Neurobiol Dis  2009; 36:374-83;  PMID:19699304 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
"Cell Death Differ 2011; 18:191- 200; PMID:21217767 ; http://dx.doi.org/10.1038/ cdd.2010.127 18. del Toro D, Alberch J, Lázaro-Diéguez F, Martín-Ibáñez R, Xifró X, Egea G, Canals JM.",OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
Mol Biol Cell 2009; 20:1478-92;   PMID:19144827 ; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
J Cell Sci  2008; 121:1649-60;  PMID:18430781 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
Nat Genet 2005; 37:526-31;   PMID :15806102 ; http://dx.doi.org/10.1038/ng1542 21.,OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
Biochem Soc Trans 2012; 40:739-45;   PMID:22817726 ; http://dx.doi.org/10.1042/ BST20120072 23.,Non-OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
Nature 2001;  413:739-43;  PMID:11607033 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
Proc Natl Acad Sci U S A  2004; 101:3224-9;  PMID:14978262 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
Trends Biochem Sci 2013; 38:378-85; PMID:23768628 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
Fly (Austin) 2013;  7:7; PMID:24022020 ; http://dx.doi.org/10.4161/ fly.26279 28.,OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
Hum Mol Genet  2012; 21:2912-22;  PMID:22466800 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
Biochem Soc Trans  2012; 40:1360-7;  PMID:23176481 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
Development 2005; 132:1487- 97; PMID:15728675 ; http://dx.doi.org/10.1242/ dev.01704 36.,OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
Neuron 2011; 69:749- 62; PMID:21338884 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
Neuron  2010; 67:588-602;  PMID:20797536 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
Nat  Struct Mol Biol 2008; 15:658-64; PMID:18618939 ;  http://dx.doi.org/10.1038/nsmb.1451 39.,OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
J Neurosci  2010; 30:4552-61;  PMID:20357106 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
J Cell Biol 2010; 190:1023-37; PMID:20855506 ; http://dx.doi.org/10.1083/ jcb.201003122 43.,OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
Hum Mol Genet 1999; 8:1263-9;   PMID:10369872 ; http://dx.doi.org/10.1093/ hmg/8.7.1263 45.,Non-OADS,/arxiv_data1/oa_pdf/20/5a/cib-6-e26807.PMC3922788.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.042598.113.© 2014 Wlodaver and Staley This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/84/d8/282.PMC3923124.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommer-cial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/84/d8/282.PMC3923124.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.041137.113.© 2014 Kruschel et al.,OADS,/arxiv_data1/oa_pdf/a4/bc/295.PMC3923125.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/a4/bc/295.PMC3923125.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/a4/bc/295.PMC3923125.pdf
"In the light of these findings, it is interesting to compare how many nucleotides precede and follow EBS1 in the different structural subdivisions of group IIB intronsand introns with B-like hybrid structures (see the group IIintron data base; http://www.fp.ucalgary.ca/group2introns/) (Dai et al.",OADS,/arxiv_data1/oa_pdf/a4/bc/295.PMC3923125.pdf
"NMR data were processedusing XWINNMR, Topspin 1.3, and 2.0, from Bruker BioSpin.Resonance assignments were made in Sparky (http://www.cgl.ucsf.edu/home/sparky/).",OADS,/arxiv_data1/oa_pdf/a4/bc/295.PMC3923125.pdf
The electrostatic surface potentials of d3 ′EBS1 and d3′EBS1 IBS1 were calculated with the PDB2PQR version 1.8 web- server (http://nbcr-222.ucsd.edu/pdb2pqr_1.8/) (Dolinsky et al.2004) and visualized with the APBS Tools2 plugin (Baker et al.2001) for PYMOL (http://www.pymol.org).,OADS,/arxiv_data1/oa_pdf/a4/bc/295.PMC3923125.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.040980.113.© 2014 Chen et al.,OADS,/arxiv_data1/oa_pdf/24/11/308.PMC3923126.pdf
"After 12 months, it is avail-able under a Creative Commons License (Attribution-NonCommercial 3.0Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/24/11/308.PMC3923126.pdf
The UCSC genomebrowser (http://genome.ucsc.edu/) was used for making numerousfigures.,OADS,/arxiv_data1/oa_pdf/24/11/308.PMC3923126.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.042432.113.© 2014 Calidas et al.,OADS,/arxiv_data1/oa_pdf/47/97/321.PMC3923127.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/47/97/321.PMC3923127.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/47/97/321.PMC3923127.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.042747.113.© 2014 Strulson et al.,OADS,/arxiv_data1/oa_pdf/58/90/331.PMC3923128.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/58/90/331.PMC3923128.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/58/90/331.PMC3923128.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.042077.113.© 2014 Burenina et al.,OADS,/arxiv_data1/oa_pdf/ed/d3/348.PMC3923129.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/ed/d3/348.PMC3923129.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/ed/d3/348.PMC3923129.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.042572.113.© 2014 Lioy et al.,OADS,/arxiv_data1/oa_pdf/55/d0/382.PMC3923132.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 3.0Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/55/d0/382.PMC3923132.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.041202.113.© 2014 Fukuda et al.,OADS,/arxiv_data1/oa_pdf/53/fa/392.PMC3923133.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/53/fa/392.PMC3923133.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.METHOD 392 RNA 20:392 –405; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/53/fa/392.PMC3923133.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.041244.113.,OADS,/arxiv_data1/oa_pdf/92/8b/406.PMC3923134.pdf
"This article, published in RNA , is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported),as described at http://creativecommons.org/licenses/by-nc/3.0/.METHOD 406 RNA 20:406 –420; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/92/8b/406.PMC3923134.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.042986.113.© 2014 Moritz and Wahle This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http:// rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/d7/10/421.PMC3923135.pdf
"After 12 months, it is availa-ble under a Creative Commons License (Attribution-NonCommercial 3.0Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.METHOD RNA 20:421 –427; Published by Cold Spring Harbor Laboratory Press for the RNA Society 421",Non-OADS,/arxiv_data1/oa_pdf/d7/10/421.PMC3923135.pdf
"Stem Cell Reports Report The TIF1 b-HP1 System Maintains T ranscriptional Integrity of Hematopoietic Stem Cells Satoru Miyagi,1,3Shuhei Koide,1,3Atsunori Saraya,1,3George R. Wendt,1,4Motohiko Oshima,1,3 Takaaki Konuma,1Satoshi Yamazaki,5Makiko Mochizuki-Kashio,1,3Yaeko Nakajima-Takagi,1,3 Changshan Wang,1,3Tetsuhiro Chiba,2Issay Kitabayashi,6Hiromitsu Nakauchi,5and Atsushi Iwama1,3,* 1Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan 2Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan 3JST, CREST, Sanbancho, Chiyoda-ku, Tokyo 102-0075, Japan 4ITO Foundation for International Education Exchange, Shinjuku 160-0023, Japan 5Division of Stem Cell Therapy, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo 108- 8639, Japan 6Division of Hematological Malignancy, National Cancer Center Research Institute, Tokyo 104-0045, Japan *Correspondence: aiwama@faculty.chiba-u.jp http://dx.doi.org/10.1016/j.stemcr.2013.12.008 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, whichpermits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/bf/d2/main.PMC3923190.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, four ﬁgures, and one table and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/bf/d2/main.PMC3923190.pdf
http://dx.doi.org/10.1016/j.sjopt.2013.10.001 Introduction Bilateral congenital dacryocele without intranasal exten- sion is a rare entity.,Non-OADS,/arxiv_data1/oa_pdf/37/d6/main.PMC3923191.pdf
http://dx.doi.org/10.1016/j.sjopt.2013.09.007 Introduction The nasolacrimal duct starts to develop during the fifth week of embryogenesis.1Congenital nasolacrimal duct obstruction (CNLDO) is due to incomplete canalization of the valve of Hasner at the distal part opening in the vast majority of cases.2Around 90% of cases gain patency no longer than a year.3Several studies have been done to estimate the incidence of CNLDO which yielded a variedrange of results between 1.2% and 30%; probably the most widely accepted incidence to be 6% 3–7.,Non-OADS,/arxiv_data1/oa_pdf/ff/d6/main.PMC3923192.pdf
"http://dx.doi.org/10.1016/j.sjopt.2013.12.007 Introduction Lacrimal gland tumors are considered one of the challeng- ing types of tumor which are difficult to study because of their rare incidence as they represent almost only 10% ofthe space occupying orbital lesions.1They are generally di- vided into 4 categories: inflammatory lesions, lymphomas, metastatic cancer, and primary epithelial tumors.",Non-OADS,/arxiv_data1/oa_pdf/24/0b/main.PMC3923193.pdf
http://dx.doi.org/10.1016/j.sjopt.2013.12.002 Introduction We spend almost a third of our life sleeping.,Non-OADS,/arxiv_data1/oa_pdf/ab/a4/main.PMC3923194.pdf
"Stem Cell Reports Report Nanog -Independent Reprogramming to iPSCs with Canonical Factors Ava C. Carter,1,2Brandi N. Davis-Dusenbery,1,2Kathryn Koszka,1Justin K. Ichida,1,3and Kevin Eggan1,* 1The Howard Hughes Medical Institute, Harvard Stem Cell Institute, Stanley Center for Psychiatric Research, Department of Stem Cell and Regenerativ e Biology, Harvard University, 7 Divinity Avenue, Cambridge, MA 02138, USA 2These authors contributed equally to this work 3Present address: Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, Department of Stem Cell Biology and Regenerative Medicine, University of Southern California, 1425 San Pablo Street, BCC 307, Los Angeles, CA 90089, USA *Correspondence: eggan@mcb.harvard.edu http://dx.doi.org/10.1016/j.stemcr.2013.12.010 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, whichpermits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/21/e6/main.PMC3923195.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes four ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2013.,Non-OADS,/arxiv_data1/oa_pdf/21/e6/main.PMC3923195.pdf
"http://dx.doi.org/10.1016/j.sjopt.2013.12.004 Introduction Balloon dacryoplasty is a term used for a set of minimally invasive lacrimal procedures that utilizes specially designed balloons, targeted at different points in the lacrimal systemfor a wide range of indications.",Non-OADS,/arxiv_data1/oa_pdf/0e/88/main.PMC3923196.pdf
"http://dx.doi.org/10.1016/j.sjopt.2013.12.001 Introduction Epiphora due to primary acquired nasolacrimal duct obstruction (PANDO) is usually treated via external dacryo- cystorhinostomy first described by Toti in 1904 where accessto the sac and nasal cavity is via a skin incision.1Dupuy-Du- temps and Bourget, later described a dacryocystorhinostomy (DCR) technique where mucosal anastomosis, with suturing of the nasal and saccal flaps, was done.2External DCR is still performed in a similar way with minor alterations.3–8The suc- Peer review under responsibility of Saudi Ophthalmological Society, King Saud University Production and hosting by ElsevierAccess this article online: www.saudiophthaljournal.com www.sciencedirect.comReceived 2 December 2013; accepted 2 December 2013; available online 12 December 2013. aOphthalmic Plastic and Reconstructive Surgery Department, Istanbul Beyoglu Eye Research and Training Hospital, Galata, 34349 Istanbul, Turkey bOphthalmology Department, Istanbul Beyoglu Eye Research and Training Hospital, Galata, 34349 Istanbul, Turkey cMedeniyet University, Faculty of Medicine, Ophthalmology Department, 34730 Istanbul, Turkey ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/c6/f9/main.PMC3923197.pdf
"http://dx.doi.org/10.1016/j.sjopt.2013.09.004 Introduction The human lacrimal gland is an essential component of the lacrimal functional unit (LFU) which comprises of the lacrimalgland, the ocular surface (cornea, conjunctiva and the meibo- mian gland) and the associated sensory and motor nerves (Figure 1 ).",Non-OADS,/arxiv_data1/oa_pdf/ce/a9/main.PMC3923198.pdf
http://dx.doi.org/10.1016/j.sjopt.2013.08.003 Introduction Acquired nasolacrimal duct obstruction (NLDO) is caused by chronic inflammation.,Non-OADS,/arxiv_data1/oa_pdf/12/8b/main.PMC3923199.pdf
"http://dx.doi.org/10.1016/j.sjopt.2013.11.003 Introduction Canaliculitis is an inflammation of the lacrimal canaliculi caused by infection1,2or as a complication of punctal plug insertion.3–5It is often misdiagnosed6leading to a delay in diagnosis.7Thus, this diagnosis is the one that should be thought of as a potential etiology in various scenarios.",Non-OADS,/arxiv_data1/oa_pdf/4b/8c/main.PMC3923200.pdf
http://dx.doi.org/10.1016/j.sjopt.2013.09.005 Introduction Epiphora and discharge secondary to nasolacrimal duct obstruction are common and troublesome problems among patients presenting to an ophthalmologist.,Non-OADS,/arxiv_data1/oa_pdf/4d/c9/main.PMC3923202.pdf
"http://dx.doi.org/10.1016/j.sjopt.2013.12.003 Introduction Dry eye is a disease which starts with unpleasant levels of symptoms of dryness of eyes and an uncomfortable feeling, greatly preventing people from performing daily activitieswhen the disease worsens.",Non-OADS,/arxiv_data1/oa_pdf/2a/17/main.PMC3923205.pdf
http://www.reviewofcontactlenses.com/content/d/dry_eye/c/27245/ .,Non-OADS,/arxiv_data1/oa_pdf/2a/17/main.PMC3923205.pdf
http://www.allergan.com/products/eye_care/restasis.htm2012 .,Non-OADS,/arxiv_data1/oa_pdf/2a/17/main.PMC3923205.pdf
http://www.eyeworld.,Non-OADS,/arxiv_data1/oa_pdf/2a/17/main.PMC3923205.pdf
"In: http://www.ncbi.nlm.nih.gov/ gene?Db=gene&Cmd=ShowDetailView&TermToSearch=4318 , editor.",OADS,/arxiv_data1/oa_pdf/2a/17/main.PMC3923205.pdf
"http://dx.doi.org/10.1016/j.sjopt.2013.11.002 Introduction Congenital anomalies of the lacrimal excretory system are mainly confined to the lower end of the nasolacrimalduct (NLD), namely, congenital nasolacrimal duct obstruction (CNLDO), which causes a relatively common clinical problem affecting up to 20% of newborns.",Non-OADS,/arxiv_data1/oa_pdf/3c/4c/main.PMC3923206.pdf
Clin Exp Ophthalmol 2013. http://dx.doi.org/10.1111/ceo.1210 Epub ahead of print.Nasal endoscopy in the management of congenital nasolacrimal duct obstruction 11,Non-OADS,/arxiv_data1/oa_pdf/3c/4c/main.PMC3923206.pdf
http://dx.doi.org/10.1016/j.sjopt.2013.09.006 Introduction Chronic canaliculitis is an uncommon infection usually caused byActinomyces and less commonly by other organisms.,Non-OADS,/arxiv_data1/oa_pdf/f5/a9/main.PMC3923207.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4094 | DOI: 10.1038/srep04094 11,Non-OADS,/arxiv_data1/oa_pdf/97/63/srep04094.PMC3923208.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4094 | DOI: 10.1038/srep04094 12",Non-OADS,/arxiv_data1/oa_pdf/97/63/srep04094.PMC3923208.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/34/49/srep04050.PMC3923209.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4050 | DOI: 10.1038/srep04050 6",Non-OADS,/arxiv_data1/oa_pdf/34/49/srep04050.PMC3923209.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/19/0c/srep04087.PMC3923210.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4087 | DOI: 10.1038/srep04087 8",Non-OADS,/arxiv_data1/oa_pdf/19/0c/srep04087.PMC3923210.pdf
Prepared for: USACE; Available at: http://nwpapps.usace.army.mil/environment/ docs/afep/jda/SynthesisofRadioTelemetryHydroacousticandSurvival StudiesofJuvenileSalmonatJohnDayDam19802000.pdf [Accessed 22 January2014].,OADS,/arxiv_data1/oa_pdf/9c/75/srep04090.PMC3923211.pdf
Prepared for: USACE; Available at: http://www.pnnl.gov/main/publications/ external/technical_reports/PNNL-22152.pdf [Accessed 22 January 2014].,Non-OADS,/arxiv_data1/oa_pdf/9c/75/srep04090.PMC3923211.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4090 | DOI: 10.1038/srep04090 8",Non-OADS,/arxiv_data1/oa_pdf/9c/75/srep04090.PMC3923211.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4082 | DOI: 10.1038/srep04082 6",Non-OADS,/arxiv_data1/oa_pdf/79/7d/srep04082.PMC3923212.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a7/2b/srep04086.PMC3923214.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4086 | DOI: 10.1038/srep04086 6",Non-OADS,/arxiv_data1/oa_pdf/a7/2b/srep04086.PMC3923214.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a5/f3/srep04091.PMC3923217.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4091 | DOI: 10.1038/srep04091 4",Non-OADS,/arxiv_data1/oa_pdf/a5/f3/srep04091.PMC3923217.pdf
"Stem Cell Reports Erratum Germline T ransgenic Methods for T racking Cells and T esting Gene Function during Regeneration in the Axolotl Shahryar Khattak, Maritta Schuez, Tobias Richter, Dunja Knapp, Saori L. Haigo, Tatiana Sandoval-Guzma ´n, Kristyna Hradlikova, Annett Duemmler, Ryan Kerney, and Elly M. Tanaka * *Correspondence: elly.tanaka@crt-dresden.de http://dx.doi.org/10.1016/j.stemcr.2014.01.017 (Stem Cell Reports 1, 90–103; June 4, 2013) The following was omitted from Acknowledgments section of the original article: Elly Tanaka was also funded by the ERC Advanced Investigator Award.",Non-OADS,/arxiv_data1/oa_pdf/49/3a/main.PMC3923218.pdf
"http://dx.doi.org/10.1016/j.stemcr.2013.12.009 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/d1/33/main.PMC3923219.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, ﬁve ﬁgures, and three tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/d1/33/main.PMC3923219.pdf
"http://dx.doi.org/10.1016/j.stemcr.2013.12.011 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, whichpermits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/1f/15/main.PMC3923220.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures and four ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2013.12.011 .,Non-OADS,/arxiv_data1/oa_pdf/1f/15/main.PMC3923220.pdf
"Stem Cell Reports Report Rapid Cellular Phenotyping of Human Pluripotent Stem Cell-Derived Cardiomyocytes using a Genetically Encoded Fluorescent Voltage Sensor Jordan S. Leyton-Mange,1Robert W. Mills,1Vincenzo S. Macri,1Min Young Jang,1Faraz N. Butte,1 Patrick T. Ellinor,1and David J. Milan1,* 1Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA 02129, USA *Correspondence: dmilan@partners.org http://dx.doi.org/10.1016/j.stemcr.2014.01.003 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/88/df/main.PMC3923221.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes four ﬁgures and two moviesand can be found with this article online at http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/88/df/main.PMC3923221.pdf
"Stem Cell Reports Report Identiﬁcation of Speciﬁc Cell-Surface Markers of Adipose-Derived Stem Cells from Subcutaneous and Visceral Fat Depots Wee Kiat Ong,1Chuen Seng Tan,2Kai Li Chan,1Grace Gandi Goesantoso,1Xin Hui Derryn Chan,1 Edmund Chan,3Jocelyn Yin,3Chia Rou Yeo,3Chin Meng Khoo,3Jimmy Bok Yan So,4Asim Shabbir,4 Sue-Anne Toh,3Weiping Han,5,6and Shigeki Sugii1,5,* 1Fat Metabolism and Stem Cell Group, Laboratory of Metabolic Medicine, Singapore Bioimaging Consortium, A *STAR, Helios, 11 Biopolis Way, Singapore 138667, Singapore 2Saw Swee Hock School of Public Health, National University of Singapore, MD3, 16 Medical Drive, Singapore 117597, Singapore 3Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, MD6, 14 Medical Drive, Singapore 117599, Singapore 4Department of Surgery, National University Hospital, 5 Lower Kent Ridge Road, Singapore 119074, Singapore 5Cardiovascular and Metabolic Disorders Program, Duke-NUS Graduate Medical School, 8 College Road, Singapore 169857, Singapore 6Laboratory of Metabolic Medicine, Singapore Bioimaging Consortium and Metabolism in Human Diseases Unit, Institute of Molecular and Cell Biology, A*STAR, Singapore 138667, Singapore *Correspondence: shigeki_sugii@sbic.a-star.edu.sg http://dx.doi.org/10.1016/j.stemcr.2014.01.002 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/44/1e/main.PMC3923222.pdf
"Sta-tistical consideration for the three-stage approach is described inSupplemental Information .SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures, four tables, and Stage Selection Criteriaand Statistical Consideration and can be found with this article on- line at http://dx.doi.org/10.1016/j.stemcr.2014.01.002 .",Non-OADS,/arxiv_data1/oa_pdf/44/1e/main.PMC3923222.pdf
"Caves,2and Norman J. Maitland1,* 1YCR Cancer Research Unit, Department of Biology, University of York, York, North Yorkshire YO10 5DD, UK 2York Centre for Complex Systems Analysis and Department of Biology, University of York, York, North Yorkshire YO10 5DD, UK 3Department of Urology, Castle Hill Hospital, Cottingham, Humberside HU16 5JQ, UK 4Hull York Medical School, University of Hull, Hull, Humberside HU6 7RX, UK 5Present address: Leeds Institute of Cancer and Pathology, St James’s University Hospital, Beckett Street, Leeds LS9 7TF, UK 6Present address: Stem Cells and Brain Tumour Group, Section of Oncology and Clinical Research, Leeds Institute of Cancer and Pathology, Wellcome Tru st Brenner Building, St James’s University Hospital, Leeds LS9 7TF, UK*Correspondence: n.j.maitland@york.ac.uk http://dx.doi.org/10.1016/j.stemcr.2014.01.001 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/60/b0/main.PMC3923223.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures, and one table and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.",Non-OADS,/arxiv_data1/oa_pdf/60/b0/main.PMC3923223.pdf
"Stem Cell Reports Article Small-Molecule Induction Promotes Corneal Epithelial Cell Differentiation from Human Induced Pluripotent Stem Cells Alexandra Mikhailova,1,2Tanja Ilmarinen,1,2Hannu Uusitalo,3,4and Heli Skottman1,2,* 1Institute of Biomedical Technology, University of Tampere, Tampere 33520, Finland 2BioMediTech, Tampere 33520, Finland 3SILK, Department of Ophthalmology, University of Tampere, Tampere 33520, Finland 4TAUH Eye Center, Tampere University Hospital, Tampere 33520, Finland *Correspondence: heli.skottman@uta.ﬁ http://dx.doi.org/10.1016/j.stemcr.2013.12.014 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, whichpermits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/fb/d1/main.PMC3923224.pdf
"Resultswere considered signiﬁcant at p < 0.05.SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, three ﬁgures, and two tables and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/fb/d1/main.PMC3923224.pdf
"Stem Cell Reports Article Characterization of Human Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium Cell Sheets Aiming for Clinical Application Hiroyuki Kamao,1,2Michiko Mandai,1Satoshi Okamoto,1Noriko Sakai,1Akiko Suga,1Sunao Sugita,1 Junichi Kiryu,2and Masayo Takahashi1,* 1Laboratory for Retinal Regeneration, RIKEN Center for Developmental Biology, Kobe, Hyogo 650-0047, Japan 2Department of Ophthalmology, Kawasaki Medical School, Kurashiki, Okayama 701-0114, Japan *Correspondence: mretina@cdb.riken.jp http://dx.doi.org/10.1016/j.stemcr.2013.12.007 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/7a/95/main.PMC3923225.pdf
"All data are avail- able from the Gene Expression Omnibus (GEO) repository at the National Center for Biotechnology Information (NCBI) archives Series (GSE50738, http://www.ncbi.nlm.",OADS,/arxiv_data1/oa_pdf/7a/95/main.PMC3923225.pdf
"For further details, see the GEO database(Series GSE50738, http://www.ncbi.nlm.nih.gov/geo/query/acc.",OADS,/arxiv_data1/oa_pdf/7a/95/main.PMC3923225.pdf
"SUPPLEMENTAL INFORMATION Supplemental information includes Supplemental Experimental Procedures, two ﬁgures, one table, and three movies, and canbe found with this article online at http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/7a/95/main.PMC3923225.pdf
"Stem Cell Reports Article Derivation and Maintenance of Murine T rophoblast Stem Cells under Deﬁned Conditions Caroline Kubaczka,1Claire Senner,2,3Marcos J. Arau ´zo-Bravo,4Neha Sharma,1Peter Kuckenberg,1,7 Astrid Becker,5Andreas Zimmer,5Oliver Bru ¨stle,6Michael Peitz,6Myriam Hemberger,2,3 and Hubert Schorle1,* 1Department of Developmental Pathology, Institute of Pathology, University of Bonn, 53127 Bonn, Germany 2Epigenetics Programme, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK 3Centre for Trophoblast Research, University of Cambridge, Cambridge CB2 3EG, UK 4Max Planck Institute for Molecular Biomedicine, Group Laboratory of Computational Biology and Bioinformatics, 48149 Mu ¨nster, Germany 5Life and Brain Center, Institute of Molecular Psychiatry, University of Bonn, 53127 Bonn, Germany 6Life and Brain Center, Institute of Reconstructive Neurobiology, University of Bonn and Hertie Foundation, 53127 Bonn, Germany 7Present address: MACHEREY-NAGEL GmbH, D-52355 Dueren, Germany *Correspondence: hubert.schorle@ukb.uni-bonn.de http://dx.doi.org/10.1016/j.stemcr.2013.12.013 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, whichpermits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/2a/a1/main.PMC3923226.pdf
"Reads were mapped to the mouse genome build NCBIM37,and ﬁnal data analysis was performed using SeqMonk software(http://www.bioinformatics.ac.uk/projects/ ).ACCESSION NUMBERS Microarray data determined in the course of this work were depos- ited in National Center for Biotechnology Information’s GeneExpression Omnibus (GEO) database ( Edgar et al., 2002 ) and are accessible through GEO Series accession number GSE47719.",OADS,/arxiv_data1/oa_pdf/2a/a1/main.PMC3923226.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, ﬁve ﬁgures, and ﬁve tables and can be found with thisarticle online at http://dx.doi.org/10.1016/j.stemcr.2013.12.013 .",Non-OADS,/arxiv_data1/oa_pdf/2a/a1/main.PMC3923226.pdf
"Charles Murtaugh,3 and Ramesh A. Shivdasani1,4,* 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA 2Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, MA 02215, USA 3Department of Human Genetics, University of Utah, Salt Lake City, UT 84112, USA 4Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02215, USA 5These authors contributed equally to this work *Correspondence: ramesh_shivdasani@dfci.harvard.edu http://dx.doi.org/10.1016/j.stemcr.2013.12.012 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, whichpermits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/26/c0/main.PMC3923227.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, two ﬁgures, and one table and can be found withthis article online at http://dx.doi.org/10.1016/j.stemcr.2013.",OADS,/arxiv_data1/oa_pdf/26/c0/main.PMC3923227.pdf
"Stem Cell Reports Report In Vivo T argeting of Adult Neural Stem Cells in the Dentate Gyrus by a Split-Cre Approach Ruth Beckervordersandforth,1,2,*Aditi Deshpande,3Iris Scha ¨ffner,2,4Hagen B. Huttner,5Alexandra Lepier,3 Dieter Chichung Lie,2and Magdalena Go ¨tz1,3,6 1Institute of Stem Cell Research, Helmholtz Center Munich, Ingolsta ¨dter Landstrasse 1, 85764 Neuherberg/Munich, Germany 2Emil-Fischer Centre, Institute of Biochemistry, Friedrich-Alexander University Erlangen-Nuremberg, Fahrstrasse 17, 91054 Erlangen, Germany 3Department of Physiological Genomics, Institute of Physiology, Ludwig-Maximilian University of Munich, Schillerstrasse 46, 80336 Munich, Germa ny 4Institute of Developmental Genetics, Helmholtz Center Munich, Ingolsta ¨dter Landstrasse 1, 85764 Neuherberg/Munich, Germany 5Department of Neurology, Friedrich-Alexander University Erlangen-Nuremberg, Schwabachanlage 6, 91054 Erlangen, Germany 6Munich Cluster for Systems Neurology (SyNergy), 80336 Munich, Germany *Correspondence: beckervorder@biochem.uni-erlangen.de http://dx.doi.org/10.1016/j.stemcr.2014.01.004 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, whichpermits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/d9/ed/main.PMC3923228.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experi-mental Procedures, two ﬁgures, and one table and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",Non-OADS,/arxiv_data1/oa_pdf/d9/ed/main.PMC3923228.pdf
"C2 curated gene sets Collection of sets collected from heterogenic sources but with a focus on the pathway databases BioCarta (http://www.biocarta.com), KEGG (http://www.genome.jp/kegg), Pathway interaction database (http://pid.nci.nih.gov), Reactome (http://www.reactome.org), SigmaAldrich (http://www.",OADS,/arxiv_data1/oa_pdf/01/3b/srep04092.PMC3923229.pdf
"sigmaaldrich.com/life-science.html), Signaling gateway (http://www.signaling-gateway.org), signal transduction KE (http://stke.sciencemag.org), SuperArray (http://www.superarray.com),manually curated gene sets from the MYC Target Gene Database (http://www.myccancergene.org/site/mycTargetDB.asp) It also includes some sets identified by a mammalian microarray study 31.",OADS,/arxiv_data1/oa_pdf/01/3b/srep04092.PMC3923229.pdf
C7 immunologic signatures Manual curation of gene sets originating in unspecified human and mouse immunology studies generated by the Human Immunology Project (http://www.immuneprofiling.org) Table 2 |Wilcoxon Rank Sum test of high scoring gene sets (NES .,Non-OADS,/arxiv_data1/oa_pdf/01/3b/srep04092.PMC3923229.pdf
"(http://www.broadinstitute.org/gsea/msigdb/index.jsp)These collections, all together, are referred to as MSigDB 17.",OADS,/arxiv_data1/oa_pdf/01/3b/srep04092.PMC3923229.pdf
"at ,http://www.R-project.org .. 22.",Non-OADS,/arxiv_data1/oa_pdf/01/3b/srep04092.PMC3923229.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/01/3b/srep04092.PMC3923229.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4092 | DOI: 10.1038/srep04092 7",Non-OADS,/arxiv_data1/oa_pdf/01/3b/srep04092.PMC3923229.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/16/71/srep04093.PMC3923230.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4093 | DOI: 10.1038/srep04093 4",Non-OADS,/arxiv_data1/oa_pdf/16/71/srep04093.PMC3923230.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9a/1c/srep04084.PMC3923231.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4084 | DOI: 10.1038/srep04084 9",Non-OADS,/arxiv_data1/oa_pdf/9a/1c/srep04084.PMC3923231.pdf
"Gene associations, gene expression, and gene networks The UCSC genome browser (http://gen ome.ucsc.edu), dbSNP (single- nucleotide polymorphism database) (http://www.ncbi.nlm .nih.gov/pro- jects/SNP), and GeneCards version 3 were used to search the candidateSNPs for gene associations and gene expression in human skin.",OADS,/arxiv_data1/oa_pdf/25/34/jid2013381a.PMC3923276.pdf
Gene Paint (http://www.genepaint.org) w as used to search gene expression patterns in mice and humans.,OADS,/arxiv_data1/oa_pdf/25/34/jid2013381a.PMC3923276.pdf
Gen eMANIA (http://geneMANIA.org) was used to search for gene interactions in the most signiﬁcant SNPs.,OADS,/arxiv_data1/oa_pdf/25/34/jid2013381a.PMC3923276.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ALS Chang et al.",Non-OADS,/arxiv_data1/oa_pdf/25/34/jid2013381a.PMC3923276.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/DJ Fu et al.",Non-OADS,/arxiv_data1/oa_pdf/73/83/jid2013356a.PMC3923277.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/b5/jit572.PMC3923544.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseOctober 2013 |  80  | e50658 | Page 1 of 6Video Article A Decellularization Methodology for the Production of a Natural Acellular Intestinal Matrix Panagiotis Maghsoudlou*1, Giorgia Totonelli*1, Stavros P Loukogeorgakis1, Simon Eaton1, Paolo De Coppi1 1Surgery Unit, Institute of Child Health and Great Ormond Street Hospital, University College London *These authors contributed equally Correspondence to: Paolo De Coppi at p.decoppi@ucl.ac.uk URL: http://www.jove.com/video/50658 DOI: doi:10.3791/50658 Keywords: Bioengineering, Issue 80, Tissue Engineering, Manufactured Materials, Biocompatible Materials, materials fabrication, Decellularization, scaffold, artificial intestine, natural acellular matrix Date Published: 10/7/2013 Citation: Maghsoudlou, P., Totonelli, G., Loukogeorgakis, S.P., Eaton, S., De Coppi, P. A Decellularization Methodology for the Production of a Natural Acellular Intestinal Matrix.",Non-OADS,/arxiv_data1/oa_pdf/4f/c7/jove-80-50658.PMC3923547.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/50658/ Introduction Tissue engineering (TE) provides a therapeutic alternative to organ transplantation, bypassing issues of immunosuppression and organ shortage.",Non-OADS,/arxiv_data1/oa_pdf/4f/c7/jove-80-50658.PMC3923547.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/14/75/ijnrd-7-069.PMC3923610.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nephrology and Renovascular Disease 2014:7 69–73International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  69Sho Rt Repo Rtopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/ 10.2147/IJNRD.S5354 1Descriptive study of clinical profile and benefit   of therapy in childhood hypercalciuria Mahalingam Vijayakumar prahlad Nageswaran o Manimegalai tirukalathi Ekambaram Sudha Shweta priyadarshini Department of p ediatric Nephrology  and pediatrics, Mehta Children’s  hospital, Chennai, tamilnadu, India Correspondence: Mahalingam  Vijayakumar   Mehta Children’s hospital,   2e McNichols Road, third Lane,   Chetpet, Chennai 600 031,   tamilnadu, India   email doctormvk@gmail.co mAbstract:  Clinical, biochemical, and ultrasonographic findings in 91 consecutive children  presenting with hypercalciuria were analyzed along with the results of treatment to determine  the clinical profile of hypercalciuria and its outcome.",Non-OADS,/arxiv_data1/oa_pdf/14/75/ijnrd-7-069.PMC3923610.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/14/75/ijnrd-7-069.PMC3923610.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/14/75/ijnrd-7-069.PMC3923610.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/af/7a/tcrm-10-077.PMC3923611.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 77–86Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  77O R I G I N A L  R E S E A R C H open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/TCRM.S5742 9Clinical differences between H3N2 and H1N1  influenza 2012 and lower respiratory tract  infection found using a statistical classification  approach Dimitris Petridis1 Paul Zarogoulidis2,3 Anastasios Kallianos4 Ioannis Kioumis2 Georgia Trakada5 Dionysios Spyratos2 Antonis Papaiwannou2 Konstantinos Porpodis2 Haidong Huang6 Aggeliki Rapti4 Wolfgang Hohenforst- Schmidt7 Konstantinos Zarogoulidis2 1Department of Food Technology, Alexander  T echnological Educational Institute of  Thessaloniki, Thessaloniki, Greece;   2Pulmonary Department, “G Papanikolaou”  General Hospital, Aristotle University  of Thessaloniki, Thessaloniki, Greece;   3Department of Interventional Pneumology,   Ruhrlandklinik, West German Lung Center,   University Hospital, University Duisburg- Essen, Essen, Germany; 42nd Pulmonary  Department, “Sotiria” Hospital for Chest  Diseases, Athens, Greece; 5Department  of Clinical Therapeutics, Division of  Pneumonolog y, Medical School, National  University of Athens, Athens, Greece;   6Department of Respiratory Diseases,   Changhai Hospital/First Affiliated Hospital  of the Second Military Medical University,   Shanghai, People’s Republic of China;    7II Medical Department, “Coburg” Regional  Clinic, University of Wüerzburg, Coburg,   Germany Correspondence: Paul Zarogoulidis   Pulmonary Department, “G Papanikolaou”  General Hospital, Aristotle University of   Thessaloniki, Thessaloniki, Greece   Tel +30 697 727 1974   Fax +30 231 099 2433   Email pzarog@hotmail.co mBackground : Influenza A H1N1 and H3N2 are two influenza waves that have been identified  in past years.",Non-OADS,/arxiv_data1/oa_pdf/af/7a/tcrm-10-077.PMC3923611.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/af/7a/tcrm-10-077.PMC3923611.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/af/7a/tcrm-10-077.PMC3923611.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/37/3f/ppa-8-167.PMC3923612.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 167–177Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  167OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/PPA.S5618 7survey of the use of warfarin and the newer  anticoagulant dabigatran in patients   with atrial fibrillation Jiyoon c choi1 Marco d DiBonaventura2 lewis Kopenhafer2 Winnie W nelson3 1lifescan, inc, West chester, PA,  2health sciences Practice, Kantar  health, new York, nY, 3Janssen  scientific Affairs llc, raritan,   nJ, UsA correspondence: Winnie W nelson   Janssen Scientific Affairs, LLC,   1000 Us highway 202 south,   room 3264, raritan, nJ 08869, UsA   Tel +1 908 927 6265   Fax +1 908 927 3166   email wnelson@its.jnj.co mBackground:  Oral dabigatran was recently approved as an alternative to warfarin for prevention  of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.",Non-OADS,/arxiv_data1/oa_pdf/37/3f/ppa-8-167.PMC3923612.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/37/3f/ppa-8-167.PMC3923612.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/37/3f/ppa-8-167.PMC3923612.pdf
"Available from:  http://emedicine.medscape.com/article/151066-overview#showal l.  Accessed January 3, 2013.",Non-OADS,/arxiv_data1/oa_pdf/37/3f/ppa-8-167.PMC3923612.pdf
Available from: http://www.boehringer-ingelheim.com/ news/news_releases /press_releases/2010/20_october_2010_ dabigatran.,Non-OADS,/arxiv_data1/oa_pdf/37/3f/ppa-8-167.PMC3923612.pdf
"Available from: http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ ucm278646.ht m. Accessed December 24, 2012.",Non-OADS,/arxiv_data1/oa_pdf/37/3f/ppa-8-167.PMC3923612.pdf
"Available  from: http://www.webmd.com/heart-disease/atrial-fibrillation/ news/20121231/fda-blood-thinner-eliqui s. Accessed March 8, 2013.",Non-OADS,/arxiv_data1/oa_pdf/37/3f/ppa-8-167.PMC3923612.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c7/28/copd-9-163.PMC3923613.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 163–177International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  163RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S4236 2Biomarkers in chronic obstructive pulmonary  disease: confusing or useful?,Non-OADS,/arxiv_data1/oa_pdf/c7/28/copd-9-163.PMC3923613.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/c7/28/copd-9-163.PMC3923613.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/28/copd-9-163.PMC3923613.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/51/54/ijwh-6-185.PMC3923614.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 185–194International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  185RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S3813 3Dyslipidemia in women: etiology and management Binh An P Phan1 Peter P T oth2–4 1Loyola University Chicago Stritch  School of Medicine, Division of  Cardiology, Loyola University Medical  Center, Maywood, IL, USA; 2CGH  Medical Center, Sterling, 3University  of Illinois School of Medicine, Peoria,   IL, USA; 4Michigan State University  College of Osteopathic Medicine,   east Lansing, MI, USA Correspondence: Peter P Toth   CGH Main Clinic, 101 east Miller Road,  Sterling, IL 61081, USA   Tel +1 815 632 5093   email peter.toth@cghmc.co mAbstract:  Dyslipidemia is highly prevalent among women.",Non-OADS,/arxiv_data1/oa_pdf/51/54/ijwh-6-185.PMC3923614.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/51/54/ijwh-6-185.PMC3923614.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/51/54/ijwh-6-185.PMC3923614.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/75/54/copd-9-179.PMC3923615.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 179–186International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  179OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/ COPD.S5541 9Effect of levofloxacin on neutrophilic airway  inflammation in s table COPD: a randomized,  double-blind, placebo-controlled trial Roshan Siva1 Mona Bafadhel2 William Monteiro3 Christopher E Brightling3 Ian D Pavord2 1Department of Respiratory Medicine,   Croydon University Hospital,   Croydon Health Services NHS Trust,   london, 2Department of Respiratory  Medicine, nuffield Department of  Clinical Medicine, University of  Oxford, Old road Campus, Oxford,   3Institute for Lung Health, NIHR  Respiratory Biomedical Research  Unit, Department of Infection,   Immunity and Inflammation, University  of Leicester, Leicester, UK Correspondence: Ian D Pavord   Department of Respiratory Medicine,  NDM Research Building, Nuffield  Department of Medicine, University  of Oxford, Old road Campus, Oxford  OX3 7FZ, UK   Tel +44 1865 612897   email ian.pavord@ndm.ox.ac.u kRationale:  Airway inflammation persists after smoking cessation in established chronic  obstructive pulmonary disease (COPD), suggesting that other factors drive the airway inflam - matory response.",Non-OADS,/arxiv_data1/oa_pdf/75/54/copd-9-179.PMC3923615.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/75/54/copd-9-179.PMC3923615.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/54/copd-9-179.PMC3923615.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/02/54/ott-7-193.PMC3923616.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 193–201OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  193Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5668 8Dichloroacetate modulates cytokines toward T  helper 1 function via induction of the interleukin- 12–interferon- γ pathway  Mujtaba M Badr1,2 nidal a Qinna1,2 Fadi Qadan2 Khalid Z Matalka1,2 1Department of Pharmacology   and Biomedical sciences, Faculty   of Pharmacy and Medical sciences,    2Petra University Pharmaceutical  center, University of Petra,    amman, Jordan correspondence: Khalid Z Matalka   Department of Pharmacology and   Biomedical sciences, Faculty of   Pharmacy and Medical sciences, Petra   University Pharmaceutical center,   University of Petra, airport street,   PO Box 961343,  amman 11196, Jordan   Tel +962 6 571 5546   Fax +962 6 571 5561   email kzm@uop.edu.j oBackground:  Dichloroacetate (DCA) is one of the new, promising anticancer drugs.",Non-OADS,/arxiv_data1/oa_pdf/02/54/ott-7-193.PMC3923616.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/02/54/ott-7-193.PMC3923616.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/02/54/ott-7-193.PMC3923616.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/dd/b1/opth-8-355.PMC3923617.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 355–362Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  355Original rESEarCHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5846 8The comparison of intravitreal triamcinolone  and bevacizumab in patients with macular edema  secondary to branch retinal vein occlusion gokcen gokce1 gungor Sobaci2 ali Hakan Durukan2 Fazil Cuneyt Erdurman3 1Department of Ophthalmology,   Sarıkamis Military Hospital, Kars,   T urkey; 2Faculty of Medicine,   Department of Ophthalmology,   Gulhane Military Medical Academy,   ankara, T urkey; 3Department of  Ophthalmology, Canakkale Military  Hospital, Canakkale, T urkey Correspondence: gokcen gokce   Department of Ophthalmology, Sarıkamis   Military Hospital, Osman Pasa Street,   36500, Sarikamis , Kars, Turkey   Tel +90 505 492 7620   Email drgokcengokce@gmail.co mPurpose:  This study was conducted to compare the efficacy and safety of intravitreal  triamcinolone acetonide (IVTA) and intravitreal bevacizumab (IVB) in the treatment of macu - lar edema related to branch retinal vein occlusion (BRVO), using the new optical coherence  tomography parameters.",Non-OADS,/arxiv_data1/oa_pdf/dd/b1/opth-8-355.PMC3923617.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/dd/b1/opth-8-355.PMC3923617.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/b1/opth-8-355.PMC3923617.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4f/e0/amep-5-025.PMC3923618.pdf
Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpAdvances in Medical Education and Practice 2014:5 25–26Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  25LEttEropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/ 10.2147/AMEP .S6073 8technology: changing the focus   of medical education?,Non-OADS,/arxiv_data1/oa_pdf/4f/e0/amep-5-025.PMC3923618.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/4f/e0/amep-5-025.PMC3923618.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4f/e0/amep-5-025.PMC3923618.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0c/e0/dddt-8-197.PMC3923619.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 197–207Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  197Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S4940 9Omalizumab, an anti-immunoglobulin e antibody:  state of the art Cristoforo incorvaia1 Marina Mauro2 Marina Russello2 Chiara Formigoni3 Gian Galeazzo Riario- Sforza1 erminia Ridolo4 1Allergy/Pulmonary Rehabilitation,   istituti Clinici di Perfezionamento  Hospital, Milan, italy; 2Allergy Unit,   3Scientific Library, Sant’Anna Hospital,   Como, italy; 4Department of Clinical  and experimental Medicine, University  of Parma, Parma, italy Correspondence: Cristoforo incorvaia   Allergy/Pulmonary Rehabilitation, iCP   Hospital, via Bignami 1, 20126 Milan, italy   Tel +39 02 5799 3289   Fax +39 02 5799 3759   email cristoforo.incorvaia@gmail.co mAbstract:  A large number of trials show that the anti-immunoglobulin (Ig) E antibody  omalizumab  is very effective in patients with severe allergic asthma.",Non-OADS,/arxiv_data1/oa_pdf/0c/e0/dddt-8-197.PMC3923619.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/0c/e0/dddt-8-197.PMC3923619.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0c/e0/dddt-8-197.PMC3923619.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/bb/89/427.PMC3923634.pdf
This grant program is targeted to providing addi - tional opportunities for young investigators who are “making the  transition from working under a supervisor to being independent  researchers in their own right”( http://erc.europa.eu/starting-grants).,Non-OADS,/arxiv_data1/oa_pdf/bb/89/427.PMC3923634.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/90/1f/429.PMC3923635.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/eb/87/431.PMC3923636.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a5/1b/441.PMC3923637.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a9/c6/457.PMC3923638.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f2/63/470.PMC3923639.pdf
"(F , G) Topological prediction of AQP4- Δ4 with predicted  transmembrane regions and probability graphs by TMHMM (www.cbs.dtu.dk/services/TMHMM/) and (G) OCTOPUS  (http://octopus.cbr.su.se/).",Non-OADS,/arxiv_data1/oa_pdf/f2/63/470.PMC3923639.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/0f/ea/481.PMC3923640.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/43/f2/495.PMC3923641.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/44/ea/508.PMC3923642.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/ab/95/522.PMC3923643.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/9e/bc/532.PMC3923644.pdf
"Gene annotation co-occurrence analysis Gene identifiers corresponding to the list of 57 putative genes regu - lated by APE1 were submitted to GeneCodis (http://genecodis.cnb   .csic.es/), a Web-based tool for ontological analysis (Carmona-Saez Name Sequence (5 ′ to 3′) nCaRE-B (PTH) TTTTTGAGACAGGGTCTCACTCTG nCaRE-B1 (APE1) TTTTGAGACAGTCTCAGCTCTG nCaRE-B2 (APE1) TTTTGAGACAGAGTTTCACTCTTG",OADS,/arxiv_data1/oa_pdf/9e/bc/532.PMC3923644.pdf
", 2010).Potential secondary structures for SIRT1-B nCaRE-B oligonucle - otide were determined by using the mfold Web Server program  (http://mfold.rna.albany.edu/?q =mfold).",OADS,/arxiv_data1/oa_pdf/9e/bc/532.PMC3923644.pdf
"Communicative & Integrative Biology 2013; 6:e27635; http://dx.doi.org/10.4161/cib.27635Exocyst proteins in cytokinesis Regulation by Rab1 1 hélia n eto, Gemma Balmer, and Gwyn Gould* henry Wellcome Laboratory of Cell Biology; i nstitute of m olecular, Cell, and Systems Biology; College of m edical, Veterinary, and Life Sciences; u niversity of Glasgow; Glasgow u K Keywords:  Rab11, abscission, endosome, exocyst, mitosis the Exocyst is an octameric protein complex comprised of Sec3, Sec5, Sec6, Sec8, Sec10, Sec15, Exo70, and Exo84  subunits.1, 2 this complex was first identified in budding yeast where it acts to target vesicles to the bud tip and the  cleavage furrow.3 here, we show that all Exocyst subunits are required for cytokinesis in mammalian cells.",Non-OADS,/arxiv_data1/oa_pdf/35/8e/cib-6-e27635.PMC3923785.pdf
Protoplasma 2012; 249:587- 97; PMID:21997494 ; http://dx.doi.org/10.1007/ s00709-011-0330-1 2.,Non-OADS,/arxiv_data1/oa_pdf/35/8e/cib-6-e27635.PMC3923785.pdf
Traffic  2012 ; 13:898-907; PMID:22420621 ;  http://dx.doi.org/10.1111/j.1600-0854.2012.01353.x 3.,OADS,/arxiv_data1/oa_pdf/35/8e/cib-6-e27635.PMC3923785.pdf
J Cell Biol 1998 ; 142:609- 12; PMID :9700152 ; http://dx.doi.org/10.1083/ jcb.142.3.609 5.,OADS,/arxiv_data1/oa_pdf/35/8e/cib-6-e27635.PMC3923785.pdf
Cell 1998 ; 92:559-71; PMID:9491896 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/8e/cib-6-e27635.PMC3923785.pdf
J Biol Chem 2003 ; 278:51743 - 8; PMID:14525976 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/35/8e/cib-6-e27635.PMC3923785.pdf
J Cell Biol 2013 ; 201:673- 80; PMID:23690179 ; http://dx.doi.org/10.1083/ jcb.201212103 9.,OADS,/arxiv_data1/oa_pdf/35/8e/cib-6-e27635.PMC3923785.pdf
J Cell Sci 2005 ;  118:1139 -50; PMID:15728258 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/8e/cib-6-e27635.PMC3923785.pdf
Science   2004 ; 305:61-6; PMID:15166316 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/8e/cib-6-e27635.PMC3923785.pdf
Cell 2005 ; 123:75- 87; PMID:16213214 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/35/8e/cib-6-e27635.PMC3923785.pdf
Mol Biol Cell  2005 ; 16:849- 60; PMID :15601896 ; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/35/8e/cib-6-e27635.PMC3923785.pdf
EMBO J 2005 ; 24:3389 - 99; PMID:16148947 ; http://dx.doi.org/10.1038/ sj.emboj.7600803 14.,Non-OADS,/arxiv_data1/oa_pdf/35/8e/cib-6-e27635.PMC3923785.pdf
J Biol Chem 2004 ; 279:43027 - 34; PMID:15292201 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/35/8e/cib-6-e27635.PMC3923785.pdf
J Cell Biol 2003 ; 163:1111- 21; PMID:14662749 ; http://dx.doi.org/10.1083/ jcb.200305029 16.,Non-OADS,/arxiv_data1/oa_pdf/35/8e/cib-6-e27635.PMC3923785.pdf
J Biol Chem   2006 ; 281:38609 -16; PMID:17028198 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/8e/cib-6-e27635.PMC3923785.pdf
Pairwise sequence alignment was performed using the Needle program (http://www.ebi.ac.uk/Tools/psa/emboss_needle/).,OADS,/arxiv_data1/oa_pdf/07/fd/cib-6-e27496.PMC3923788.pdf
"Communicative & Integrative Biology 2013; 6:e27496; http://dx.doi.org/10.4161/cib.27496Variability of non-symbiotic and truncated  hemoglobin genes from the genome   of cultivated monocots Gustavo r odríguez- alonso and r aúl a rredondo-Peter* Laboratorio de Biofísica y Biología m olecular; Departamento de Bioquímica y Biología m olecular; Facultad de Ciencias; u niversidad autónoma del Estado de m orelos;  Cuernavaca, m orelos, m éxico Abbreviations: Hb, hemoglobin; MCL, maximum composite likelihood; nsHb, non-symbiotic hemoglobin; tHb, truncated  hemoglobin Keywords:  GC content,  cereals, globin, neutral selection non-symbiotic (ns hb) and truncated (t hb) hemoglobins ( hbs) have been detected in a variety of land plants.",Non-OADS,/arxiv_data1/oa_pdf/07/fd/cib-6-e27496.PMC3923788.pdf
e27496-2 Communicative & i ntegrative Biology Volume 6 issue 6D value12 using the DNAsp program (http://www.ub.edu/ dnasp/).,Non-OADS,/arxiv_data1/oa_pdf/07/fd/cib-6-e27496.PMC3923788.pdf
Gene  2007; 398:78-85;  PMID:17540516 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/fd/cib-6-e27496.PMC3923788.pdf
Commun Integr Biol   2012 ; 5:527-30; PMID:23336017 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/fd/cib-6-e27496.PMC3923788.pdf
Plant Sci  2012 ; 191-192 :71-81;  PMID:22682566 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/07/fd/cib-6-e27496.PMC3923788.pdf
Proc Natl Acad Sci U S A 2001 ;  98:10119 -24; PMID :11526234 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/fd/cib-6-e27496.PMC3923788.pdf
Biopolymers  2009 ; 91:1083 - 96; PMID:19441024 ; http://dx.doi.org/10.1002/ bip.21256 7.,Non-OADS,/arxiv_data1/oa_pdf/07/fd/cib-6-e27496.PMC3923788.pdf
Mol Biol Evol  2011 ; 28:2731 -9;  PMID :21546353 ; http://dx.doi.org/10.1093/ molbev/msr12112.,Non-OADS,/arxiv_data1/oa_pdf/07/fd/cib-6-e27496.PMC3923788.pdf
Mol Biol Evol  2008 ;  25:1482 -7; PMID:18420592 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/fd/cib-6-e27496.PMC3923788.pdf
"OncoImmunology 2013; 2:e26704; http://dx.doi.org/10.4161/onci.26704High-affinity peptide-based anticancer  vaccination to overcome resistance   to immunostimulatory antibodies David C Binder1,2,* and h ans s chreiber1,2,3,* 1Committee on Cancer Biology; The u niversity of Chicago; Chicago, IL usa ; 2Department of Pathology; The u niversity of Chicago; Chicago, IL usa ;   3Committee on Immunology; The u niversity of Chicago; Chicago, IL usa Keywords:  vaccination, salmonella, PD-1, CTLA-4, rescue, T cell we tested how to eradicate long-established immunogenic tumors that were resistant to the monoclonal antibody- mediated blockade of PD-L1 (PD-1 ligand 1) and cytotoxic T lymphocyte-associated protein 4 (CTL a4).",Non-OADS,/arxiv_data1/oa_pdf/03/20/onci-2-e26704.PMC3923789.pdf
N Engl J Med 2010; 363:711-23; PMID:20525992 ;  http://dx.doi.org/10.1056/NEJMoa10034662.,OADS,/arxiv_data1/oa_pdf/03/20/onci-2-e26704.PMC3923789.pdf
N Engl J Med 2012; 366:2443-54; PMID:22658127 ;  http://dx.doi.org/10.1056/NEJMoa12006903.,OADS,/arxiv_data1/oa_pdf/03/20/onci-2-e26704.PMC3923789.pdf
N Engl J Med  2013; 369:122-33;  PMID:23724867 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/20/onci-2-e26704.PMC3923789.pdf
Sci Transl Med  2012; 4:127ra37;  PMID:22461641 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/03/20/onci-2-e26704.PMC3923789.pdf
Cancer Immunol Res 2013; 1:123-33; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/20/onci-2-e26704.PMC3923789.pdf
Cancer Cell 2013; 23:516-26;  PMID:23597565 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/03/20/onci-2-e26704.PMC3923789.pdf
"Nat Med 2013; 19:747-52;   PMID:23644516 ; http://dx.doi.org/10.1038/nm.3161 8. van Rooij N, van Buuren MM, Philips D, Velds A,  Toebes M, Heemskerk B, van Dijk LJ, Behjati S, Hilkmann H, El Atmioui D, et al.",OADS,/arxiv_data1/oa_pdf/03/20/onci-2-e26704.PMC3923789.pdf
J Clin Oncol 2013; Forthcoming; PMID:24043743 ;  http://dx.doi.org/10.1200/JCO.2012.47.7521 9.,Non-OADS,/arxiv_data1/oa_pdf/03/20/onci-2-e26704.PMC3923789.pdf
Oncoimmunology 2012; 1:409-18;  PMID:22754759 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/20/onci-2-e26704.PMC3923789.pdf
Nature 1983; 304:165-7; PMID:6602947 ;  http://dx.doi.org/10.1038/304165a0,Non-OADS,/arxiv_data1/oa_pdf/03/20/onci-2-e26704.PMC3923789.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2013 |  79  | e50610 | Page 1 of 9Video Article The Tomato/GFP-FLP/FRT Method for Live Imaging of Mosaic Adult Drosophila  Photoreceptor Cells Pierre Dourlen1,2, Clemence Levet1, Alexandre Mejat1, Alexis Gambis3, Bertrand Mollereau1 1Laboratory of Molecular Biology of the Cell, Ecole Normale Supérieure de Lyon 2INSERM U744, Institut Pasteur de Lille, Université Lille-Nord de France 3Howard Hughes Medical Institute, Laboratory of Apoptosis and Cancer, The Rockefeller University Correspondence to: Pierre Dourlen at pierre.dourlen@pasteur-lille.fr , Bertrand Mollereau at bertrand.mollereau@ens-lyon.fr URL: http://www.jove.com/video/50610 DOI: doi:10.3791/50610 Keywords: Developmental Biology, Issue 79, Eye, Photoreceptor Cells, Genes, Developmental, neuron, visualization, degeneration, development, live imaging, Drosophila , photoreceptor, cornea neutralization, mitotic recombination Date Published: 9/20/2013 Citation: Dourlen, P., Levet, C., Mejat, A., Gambis, A., Mollereau, B.",Non-OADS,/arxiv_data1/oa_pdf/d8/81/jove-79-50610.PMC3923918.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/50610/ Introduction The Drosophila  retina is composed of about 800 ommatidial units ( Figure 1A ), which are precisely organized, with a clearly defined axis of polarity ( Figure 1B ).",Non-OADS,/arxiv_data1/oa_pdf/d8/81/jove-79-50610.PMC3923918.pdf
The structure of the cornea can be visualized precisely by scanning electron microscopy and was used in a large-scale genetic screen by the URCFG consortium (http://www.bruinfly.ucla.edu)10.,OADS,/arxiv_data1/oa_pdf/d8/81/jove-79-50610.PMC3923918.pdf
"This method allows the high-throughput, rapid and precise identification of mutant PRs in mosaic clones, at single-cell resolution ( http://www.ens-lyon.fr/LBMC/ApoDrosoDatabase/).",Non-OADS,/arxiv_data1/oa_pdf/d8/81/jove-79-50610.PMC3923918.pdf
This work utilized the BruinFly collection of FRT-recombined mutations (http://www.bruinfly.ucla.edu).,OADS,/arxiv_data1/oa_pdf/d8/81/jove-79-50610.PMC3923918.pdf
/C2112014 McCann and Baserga This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/2f/5b/211.PMC3923963.pdf
[Keywords : nucleolus; nucleolar organizer region (NOR); UBF; mitotic bookmarking; pseudo-NOR; neo-NOR] 4Corresponding author E-mail susan.baserga@yale.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.237610.114.,Non-OADS,/arxiv_data1/oa_pdf/2f/5b/211.PMC3923963.pdf
"This article, published in Genes &Development ,i s available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by- nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/b3/23/214.PMC3923964.pdf
Article and publication date are online at http://www.genesdev.or g/cgi/doi/10.1101/ga d.234336.113.,Non-OADS,/arxiv_data1/oa_pdf/b3/23/214.PMC3923964.pdf
The GenoList database (http://genolist.pasteur.fr) was used to interrogatebacterial genomes and determine the distribution of potential /C010 hexam- ers between genes and noncoding DNA.,OADS,/arxiv_data1/oa_pdf/b3/23/214.PMC3923964.pdf
"This article, published in Genes &Development ,i s available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by- nc/3.0/.1Corresponding author E-mail brian.mcstay@nuigalway.ieArticle published online ahead of print.",Non-OADS,/arxiv_data1/oa_pdf/fa/02/220.PMC3923965.pdf
Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.234591.113.,Non-OADS,/arxiv_data1/oa_pdf/fa/02/220.PMC3923965.pdf
"This article, published in Genes &Development ,i s available under a Creative Commons Li cense (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by- nc/3.0/.1These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/39/91/231.PMC3923966.pdf
2Corresponding author E-mail lidia.vasilieva@bioch.ox.ac.uk Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.,Non-OADS,/arxiv_data1/oa_pdf/39/91/231.PMC3923966.pdf
/C2112014 Thurtle and Rine This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/31/b9/245.PMC3923967.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 3.0 Un ported), as described at http:// creativecommons.org/licenses/by-nc/3.0/.1Corresponding author E-mail jrine@berkeley.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.230532.113.",Non-OADS,/arxiv_data1/oa_pdf/31/b9/245.PMC3923967.pdf
"Duplicate reads were removed using Picard (http://picard.sourceforge.net), and per-base read countswere determined using SAMtools (Li et al.",OADS,/arxiv_data1/oa_pdf/31/b9/245.PMC3923967.pdf
All graphs were created using R (http://www.R-project.org).,OADS,/arxiv_data1/oa_pdf/31/b9/245.PMC3923967.pdf
The genome-wide correlations weredetermined by pairwise comparison of the same 100-bp slidingwindows between the appropriate data sets and then determining the Pearson correlation in R (http://www.R-project.org).,OADS,/arxiv_data1/oa_pdf/31/b9/245.PMC3923967.pdf
"This article, published in Genes &Development ,i s available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/ by-nc/3.0/.5Corresponding authors E-mail jlw@stowers.orgE-mail sma@stowers.org Article is online at http://www.genes dev.org/cgi/doi/10.1101/gad.225151.113.",Non-OADS,/arxiv_data1/oa_pdf/b4/9d/259.PMC3923968.pdf
"Large-scale transcriptome analyses available on Flybase.org indicate that transcriptsare provided maternally to the embryo and are later detected at moderate levels in most stages of develop- ment and in a variety of tissues (Berkeley Drosophila Genome Project, http://insitu.fruitfly.org).",Non-OADS,/arxiv_data1/oa_pdf/b4/9d/259.PMC3923968.pdf
"RNAi– phiC31 construct and insertion data submitted by theVienna Drosophila RNAi Center.http://flybase.org/reports/ FBrf0208510.html.Kohler A, Schneider M, Cabal GG, Nehrbass U, Hurt E. 2008.",OADS,/arxiv_data1/oa_pdf/b4/9d/259.PMC3923968.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http:// creativecommons.org/licenses/by-nc/3.0/.4Corresponding author E-mail jjzhu@virginia.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.232470.113.",Non-OADS,/arxiv_data1/oa_pdf/77/17/273.PMC3923969.pdf
11Corresponding authors E-mail cbirch@mdc-berlin.deE-mail matthias.selbach@mdc-berlin.de Article is online at http://www.genes dev.org/cgi/doi/ 10.1101/gad.230045.113.,Non-OADS,/arxiv_data1/oa_pdf/29/97/290.PMC3923970.pdf
Published by Elsevier B.V.  http://dx.doi.org/10.1016/j.bbr.2013.12.009Open access under CC BY-NC-ND license.,Non-OADS,/arxiv_data1/oa_pdf/e1/89/main.PMC3923974.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Researchers and Editors at the Heart of Science Communication Armen Yuri Gasparyan Departments of Rheumatology and Research and Development, Dudley Group NHS Foundation Trust (A Teaching Trust of the University of Birmingham, UK), Russells Hall Hospital, Dudley, West Midlands, UKhttp://dx.doi.org/10.3346/jkms.2014.29.2.161  • J Korean Med Sci 2014; 29: 161-163 Writing and editing scholarly articles for prestigious interna - tional journals is a daunting task for novice researchers and  seasoned authors alike.",Non-OADS,/arxiv_data1/oa_pdf/62/4d/jkms-29-161.PMC3923991.pdf
"Gasparyan AY • Researchers and Editors at the Heart of Science Communication 162  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.161of Thomson Reuters that rank journals by analyzing citations  from the Scopus and the Web of Science (WoS) databases, re - spectively.",Non-OADS,/arxiv_data1/oa_pdf/62/4d/jkms-29-161.PMC3923991.pdf
"Gasparyan AY • Researchers and Editors at the Heart of Science Communication http://jkms.org   163 http://dx.doi.org/10.3346/jkms.2014.29.2.161 In conclusion, science editing is becoming increasingly com - plex and interconnected with specialized professional fields.",Non-OADS,/arxiv_data1/oa_pdf/62/4d/jkms-29-161.PMC3923991.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Prevention of Venous Thromboembolism, 2nd Edition: Korean  Society of Thrombosis and Hemostasis Evidence-Based Clinical  Practice Guidelines In 2010, we proposed the first Korean Guidelines for the Prevention of Venous  Thromboembolism (VTE).",Non-OADS,/arxiv_data1/oa_pdf/86/18/jkms-29-164.PMC3923992.pdf
"Received: 28 October 2013 Accepted: 29 November 2013 Address for Correspondence: Doyeun Oh, MD  Department of Internal Medicine, School of Medicine, CHA  University, 59 Yatap-ro, Bundang-gu, Seongnam 463-712, Korea  Tel: +82.31-780-5217, Fax: +82.31-780-5208 E-mail: doh@cha.ac.kr This work was supported by a grant from Korean Ministry of  Health and Welfare (NSCR-2012-A102).http://dx.doi.org/10.3346/jkms.2014.29.2.164  • J Korean Med Sci 2014; 29: 164-171 INTRODUCTION Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and  pulmonary embolism (PE), is a major cause of morbidity and mortality in hospitalized  patients.",Non-OADS,/arxiv_data1/oa_pdf/86/18/jkms-29-164.PMC3923992.pdf
"• Prevention of Venous Thromboembolism, 2nd Edition http://jkms.org   165 http://dx.doi.org/10.3346/jkms.2014.29.2.164tion of the Western lifestyle.",Non-OADS,/arxiv_data1/oa_pdf/86/18/jkms-29-164.PMC3923992.pdf
"• Prevention of Venous Thromboembolism, 2nd Edition 166  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.164Table 2.",Non-OADS,/arxiv_data1/oa_pdf/86/18/jkms-29-164.PMC3923992.pdf
"• Prevention of Venous Thromboembolism, 2nd Edition http://jkms.org   167 http://dx.doi.org/10.3346/jkms.2014.29.2.164erate-quality evidence; and Grade 2C as a weak recommenda - tion with low- or very-low-quality evidence (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/86/18/jkms-29-164.PMC3923992.pdf
"• Prevention of Venous Thromboembolism, 2nd Edition 168  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.164NEUROSURGERY Neurosurgical patients are at an increased risk of both throm - bosis and bleeding.",Non-OADS,/arxiv_data1/oa_pdf/86/18/jkms-29-164.PMC3923992.pdf
"• Prevention of Venous Thromboembolism, 2nd Edition http://jkms.org   169 http://dx.doi.org/10.3346/jkms.2014.29.2.164(Grade 2C).",Non-OADS,/arxiv_data1/oa_pdf/86/18/jkms-29-164.PMC3923992.pdf
"• Prevention of Venous Thromboembolism, 2nd Edition 170  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.164failure, myocardial infarction, cerebrovascular attack, metastat - ic cancer, or previous VTE, we recommend pharmacological  prophylaxis or mechanical prophylaxis (Grade 2C).",Non-OADS,/arxiv_data1/oa_pdf/86/18/jkms-29-164.PMC3923992.pdf
ORCID Soo-Mee Bang  http://orcid.org/0000-0002-0938-3007 Moon Ju Jang http://orcid.org/0000-0001-7440-7573 Kyoung Ha Kim http://orcid.org/0000-0001-8842-4761Ho-Young Yhim http://orcid.org/0000-0002-1252-5336 Yeo-Kyeoung Kim http://orcid.org/0000-0001-5447-4285 Seung-Hyun Nam http://orcid.org/0000-0002-5736-2606 Hun Gyu Hwang http://orcid.org/0000-0001-9304-7219 Sung Hwa Bae http://orcid.org/0000-0002-5279-6341 Sung-Hyun Kim http://orcid.org/0000-0002-5051-2413 Yeung-Chul Mun http://orcid.org/0000-0002-1882-3983 Yang-Ki Kim http://orcid.org/0000-0003-4221-6689 Inho Kim http://orcid.org/0000-0002-3135-6312 Won-Il Choi http://orcid.org/0000-0001-7705-0098 Chul Won Jung http://orcid.org/0000-0002-5474-6807 Nam-Kyong Choi  http://orcid.org/0000-0003-1153-9928 Doyeun Oh http://orcid.org/0000-0002-6981-3144 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/86/18/jkms-29-164.PMC3923992.pdf
"• Prevention of Venous Thromboembolism, 2nd Edition http://jkms.org   171 http://dx.doi.org/10.3346/jkms.2014.29.2.16410.",Non-OADS,/arxiv_data1/oa_pdf/86/18/jkms-29-164.PMC3923992.pdf
Available at http://www.eventure-online.com/eventure/publicAb - stractView.do?id=215660&congressId=6839 [accessed on 6 January 2013].,Non-OADS,/arxiv_data1/oa_pdf/86/18/jkms-29-164.PMC3923992.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Duplicate Publication Rate Decline in Korean Medical Journals The purpose of this study was to examine trends in duplicate publication in Korean medical  articles indexed in the KoreaMed database from 2004 to 2009, before and after a  campaign against scientific misconduct launched by the Korean Association of Medical  Journal Editors in 2006.",Non-OADS,/arxiv_data1/oa_pdf/f2/ea/jkms-29-172.PMC3923993.pdf
"Keywords:  Publishing Ethics; Duplicate Publication as Topic; Periodicals as Topic; Trends;  Korea Soo Young Kim,1,* Chong-Woo Bae,2,*  Chang Kok Hahm,3,* and Hye Min Cho4 1Department of Family Medicine, Kandong Sacred  Hospital, Hallym University College of Medicine,  Seoul; 2Department of Pediatrics, Kyung Hee  University School of Medicine, Seoul; 3Health  Promotion Center, Chung-Ang University Hospital,  Seoul; 4Infolumi Co., Seongnam; *Committee for  Publication Ethics, the Korean Association of  Medical Journal Editors, Seoul, Korea Received: 8 September 2013 Accepted: 18 November 2013 Address for Correspondence: Chong-Woo Bae, MD Department of Pediatrics, Kyung Hee University Hospital at  Gangdong, 892 Dongnam-ro, Gangdong-gu, Seoul 134-727,  Korea  Tel: +82.2-440-6130, Fax: +82.2-440-7175 E-mail: baecw@khnmc.or.krhttp://dx.doi.org/10.3346/jkms.2014.29.2.172  • J Korean Med Sci 2014; 29: 172-175 INTRODUCTION According to the updated recommendations of the Interna - tional Committee of Medical Journal Editors (ICMJE), “dupli - cate publication is publication of a paper that overlaps substan - tially with one already published, without clear, visible refer - ence to the previous publication” (1).",Non-OADS,/arxiv_data1/oa_pdf/f2/ea/jkms-29-172.PMC3923993.pdf
• Duplicate Publications in Korean Medical Journals  http://jkms.org   173 http://dx.doi.org/10.3346/jkms.2014.29.2.172Table 1.,Non-OADS,/arxiv_data1/oa_pdf/f2/ea/jkms-29-172.PMC3923993.pdf
• Duplicate Publications in Korean Medical Journals  174  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.172Table 3.,Non-OADS,/arxiv_data1/oa_pdf/f2/ea/jkms-29-172.PMC3923993.pdf
"• Duplicate Publications in Korean Medical Journals  http://jkms.org   175 http://dx.doi.org/10.3346/jkms.2014.29.2.172to the medical community, and published a guide book of pub - lication ethics in 2008, which was revised in 2013 (16).",Non-OADS,/arxiv_data1/oa_pdf/f2/ea/jkms-29-172.PMC3923993.pdf
DISCLOSURE The authors have no conflicts of interest to disclose.ORCID Soo Young Kim http://orcid.org/0000-0002-3205-9408 Chong-Woo Bae  http://orcid.org/0000-0002-0965-5674 REFERENCES 1. International Committee of Medical Journal Editors.,Non-OADS,/arxiv_data1/oa_pdf/f2/ea/jkms-29-172.PMC3923993.pdf
Available at http://www.icmje.org/publish - ing_d.html [accessed on 19 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/f2/ea/jkms-29-172.PMC3923993.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Relationship between Dietary Mercury Intake and Blood  Mercury Level in Korea This study was performed to evaluate the effect of dietary factors for mercury exposure by  comparing with blood mercury concentration.",Non-OADS,/arxiv_data1/oa_pdf/f0/24/jkms-29-176.PMC3923994.pdf
"Keywords:  Blood Mercury; Food Analysis; Dietary Exposure; Seafood; Adult; KoreaChang-Hun You,1 Byoung-Gwon Kim,1,2  Yu-Mi Kim,1,2 Sang-Ah Lee,3   Rock-Bum Kim,1,2 Jeong-Wook Seo,1   and Young-Seoub Hong1,2  1Department of Preventive Medicine, and  2Environmental Health Center, Dong-A University,  Busan; 3Department of Preventive Medicine, College  of Medicine, Kangwon University, Chuncheon, Korea Received: 29 July 2013 Accepted: 29 November 2013 Address for Correspondence: Young-Seoub Hong, MD Department of Preventive Medicine, College of Medicine,  Dong-A University, 26 Daesingongwon-ro, Seo-gu,   Busan 602-715 , Korea Tel: +82.51-240-2888, Fax: +82.51-253-5729 E-mail: yshong@dau.ac.kr This study was supported by the Dong-A University research  fund 2014.http://dx.doi.org/10.3346/jkms.2014.29.2.176  • J Korean Med Sci 2014; 29: 176-182 INTRODUCTION Mercury is an important environmental and health issue to  take priority in the harmful material list published by The US  Agency for toxic substances and disease registry (ATSDR) (1).",Non-OADS,/arxiv_data1/oa_pdf/f0/24/jkms-29-176.PMC3923994.pdf
"• Dietary Uptake and Blood Level of Mercury http://jkms.org   177 http://dx.doi.org/10.3346/jkms.2014.29.2.176tus, residential district (coastal or in-land area) and amalgam  treatment.",Non-OADS,/arxiv_data1/oa_pdf/f0/24/jkms-29-176.PMC3923994.pdf
• Dietary Uptake and Blood Level of Mercury 178  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.176Table 1.,Non-OADS,/arxiv_data1/oa_pdf/f0/24/jkms-29-176.PMC3923994.pdf
• Dietary Uptake and Blood Level of Mercury http://jkms.org   179 http://dx.doi.org/10.3346/jkms.2014.29.2.176the food groups.,Non-OADS,/arxiv_data1/oa_pdf/f0/24/jkms-29-176.PMC3923994.pdf
"• Dietary Uptake and Blood Level of Mercury 180  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.1768), but Choi et al.",Non-OADS,/arxiv_data1/oa_pdf/f0/24/jkms-29-176.PMC3923994.pdf
• Dietary Uptake and Blood Level of Mercury http://jkms.org   181 http://dx.doi.org/10.3346/jkms.2014.29.2.176was not clarified yet.,Non-OADS,/arxiv_data1/oa_pdf/f0/24/jkms-29-176.PMC3923994.pdf
ORCID Chang-Hun You http://orcid.org/0000-0001-6844-4394 Byoung-Gwon Kim http://orcid.org/0000-0002-1762-6320 Yu-Mi Kim http://orcid.org/0000-0003-1123-8690 Sang-Ah Lee http://orcid.org/0000-0002-5079-9733 Rock-Bum Kim http://orcid.org/0000-0001-5868-0465 Jeong-Wook Seo http://orcid.org/0000-0002-1909-6714 Young-Seoub Hong http://orcid.org/0000-0002-9037-3761 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/f0/24/jkms-29-176.PMC3923994.pdf
Available at http://www.ats - dr.cdc.gov/SPL/resources [accessed on 1 June 2013].,OADS,/arxiv_data1/oa_pdf/f0/24/jkms-29-176.PMC3923994.pdf
• Dietary Uptake and Blood Level of Mercury 182  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.176lut Bull 2007; 54: 669-77.,Non-OADS,/arxiv_data1/oa_pdf/f0/24/jkms-29-176.PMC3923994.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357In Vitro Bacteriostatic Effects of Rifampin on Orientia  tsutsugamushi We performed an in vitro cell culture experiment to ascertain whether rifampin exhibits  bactericidal effects against Orientia tsutsugamushi , the causative agent of scrub typhus.",Non-OADS,/arxiv_data1/oa_pdf/07/47/jkms-29-183.PMC3923995.pdf
"Keywords:  Antibiotic Susceptibility Test; Azithromycin; Drug Resistance, Bacterial;  Orientia tsutsugamushi ; Rifampin; Scrub Typhus Jae-Hyoung Im,1 Ji Hyeon Baek,1   Jin-Soo Lee,1 Moon-Hyun Chung,1   Sun Myoung Lee,2 and Jae-Seung Kang3 1Department of Internal Medicine, 2Translation  Research Center, and 3Department of Microbiology,  Inha University School of Medicine, Incheon, Korea Received: 21 September 2013 Accepted: 25 December 2013 Address for Correspondence: Moon-Hyun Chung, MD Department of Internal Medicine, Inha University Hospital,   27 Inhang-ro, Jung-gu, Incheon 400-711, Korea Tel: +82.32-890-2202, Fax: +82.32-882-6578 E-mail: mhchungid@daum.net This work was supported by an Inha University Research Grant.http://dx.doi.org/10.3346/jkms.2014.29.2.183  • J Korean Med Sci 2014; 29: 183-189 INTRODUCTION Scrub typhus is an easily treatable illness if antibiotics such as  chloramphenicol, doxycycline, azithromycin, or rifampin are  used properly in therapy.",Non-OADS,/arxiv_data1/oa_pdf/07/47/jkms-29-183.PMC3923995.pdf
• Bacteriostatic Effects of Rifampin on Orientia tsutsugamushi 184  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.183tion of ECV304 cells was assessed by immunofluorescence (IF)  staining to be approximately equal in each experiment.,OADS,/arxiv_data1/oa_pdf/07/47/jkms-29-183.PMC3923995.pdf
"• Bacteriostatic Effects of Rifampin on Orientia tsutsugamushi http://jkms.org   185 http://dx.doi.org/10.3346/jkms.2014.29.2.183trations of antibiotics that are not clinically tolerable and there - fore cannot be achieved, and then continuing these cultures in  medium not containing antibiotics, analogous to the experi - ments in mice performed previously (3,5).",Non-OADS,/arxiv_data1/oa_pdf/07/47/jkms-29-183.PMC3923995.pdf
• Bacteriostatic Effects of Rifampin on Orientia tsutsugamushi 186  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.183Fig.,Non-OADS,/arxiv_data1/oa_pdf/07/47/jkms-29-183.PMC3923995.pdf
"• Bacteriostatic Effects of Rifampin on Orientia tsutsugamushi http://jkms.org   187 http://dx.doi.org/10.3346/jkms.2014.29.2.183at a relatively lower concentration (10 µg/mL), whereas such  effects were observed at rather higher concentrations of rifam- pin (80 µg/mL) or chloramphenicol (80 µg/mL or more).",Non-OADS,/arxiv_data1/oa_pdf/07/47/jkms-29-183.PMC3923995.pdf
• Bacteriostatic Effects of Rifampin on Orientia tsutsugamushi 188  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.183Fig.,Non-OADS,/arxiv_data1/oa_pdf/07/47/jkms-29-183.PMC3923995.pdf
• Bacteriostatic Effects of Rifampin on Orientia tsutsugamushi http://jkms.org   189 http://dx.doi.org/10.3346/jkms.2014.29.2.183immunofluorescent spots were observed in a few fields and  even such weak positive signals were considered positive for  analyses.,Non-OADS,/arxiv_data1/oa_pdf/07/47/jkms-29-183.PMC3923995.pdf
ORCID Jae-Hyoung Im http://orcid.org/0000-0001-9395-0221  Ji Hyeon Baek http://orcid.org/0000-0002-1783-6950 Jin-Soo Lee http://orcid.org/0000-0001-7862-5519 Moon-Hyun Chung http://orcid.org/0000-0003-2905-3459 Sun Myoung Lee http://orcid.org/0000-0002-1327-0689 Jae-Seung Kang http://orcid.org/0000-0003-2730-3709  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/07/47/jkms-29-183.PMC3923995.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Cost-of-Illness and Quality of Life in Patients with Ankylosing  Spondylitis at a Tertiary Hospital in Korea The objectives of this study were to estimate the cost-of-illness (COI) and health-related  quality of life (HRQOL) in patients with ankylosing spondylitis (AS) in Korea and to evaluate  the effects of socio-demographic and clinical factors on the COI and the HRQOL.",Non-OADS,/arxiv_data1/oa_pdf/62/23/jkms-29-190.PMC3923996.pdf
"R31-2008- 000-10103-0 from the World Class University program of the  Ministry of Education, Science and Technology and the National  Research Foundation of Republic of Korea.http://dx.doi.org/10.3346/jkms.2014.29.2.190  • J Korean Med Sci 2014; 29: 190-197 INTRODUCTION Ankylosing spondylitis (AS) is a chronic, progressive inflamma - tory disease characterized by structural changes accompanied  by pain and stiffness of the back, peripheral joints and inflam - mation of extra-articular sites such as the eyes, heart and lungs  (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/62/23/jkms-29-190.PMC3923996.pdf
"• Cost-of-Illness and Quality of Life in Ankylosing Spondylitis  http://jkms.org   191 http://dx.doi.org/10.3346/jkms.2014.29.2.190mixed results (14, 15).",Non-OADS,/arxiv_data1/oa_pdf/62/23/jkms-29-190.PMC3923996.pdf
• Cost-of-Illness and Quality of Life in Ankylosing Spondylitis  192  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.190H-1007-167-325).,Non-OADS,/arxiv_data1/oa_pdf/62/23/jkms-29-190.PMC3923996.pdf
• Cost-of-Illness and Quality of Life in Ankylosing Spondylitis  http://jkms.org   193 http://dx.doi.org/10.3346/jkms.2014.29.2.190Table 2.,Non-OADS,/arxiv_data1/oa_pdf/62/23/jkms-29-190.PMC3923996.pdf
• Cost-of-Illness and Quality of Life in Ankylosing Spondylitis  194  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.190Table 5.,Non-OADS,/arxiv_data1/oa_pdf/62/23/jkms-29-190.PMC3923996.pdf
"• Cost-of-Illness and Quality of Life in Ankylosing Spondylitis  http://jkms.org   195 http://dx.doi.org/10.3346/jkms.2014.29.2.190tients with RA (KRW 3.2 million), while the indirect cost for pa - tients with AS (KRW 4.7 million) was only about 34% higher than  that for patients with RA (KRW 3.5 million).",Non-OADS,/arxiv_data1/oa_pdf/62/23/jkms-29-190.PMC3923996.pdf
• Cost-of-Illness and Quality of Life in Ankylosing Spondylitis  196  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.190ACKNOWLEDGMENTS We would like to thank Hye-Kyung Son at Hallym Medical Foun- dation who participated in data collection and statistical analysis.,Non-OADS,/arxiv_data1/oa_pdf/62/23/jkms-29-190.PMC3923996.pdf
ORCID Tae-Jin Lee http://orcid.org/0000-0003-2539-3579 Bo-Hyun Park http://orcid.org/0000-0003-0315-2256  Joon Wan Kim http://orcid.org/0000-0002-7845-4382 Kichul Shin http://orcid.org/0000-0002-6749-7598 Eun Bong Lee http://orcid.org/0000-0003-0703-1208 Yeong-Wook Song http://orcid.org/0000-0002-5384-3437  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/62/23/jkms-29-190.PMC3923996.pdf
Available at http://www.kosis.kr  [accessed on 30 April 2010].,Non-OADS,/arxiv_data1/oa_pdf/62/23/jkms-29-190.PMC3923996.pdf
• Cost-of-Illness and Quality of Life in Ankylosing Spondylitis  http://jkms.org   197 http://dx.doi.org/10.3346/jkms.2014.29.2.19029.,Non-OADS,/arxiv_data1/oa_pdf/62/23/jkms-29-190.PMC3923996.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Differences in Clinical Manifestations and Outcomes between  Adult and Child Patients with Henoch-Schönlein Purpura We aimed to investigate differences in clinical manifestations and outcomes between adult  and child patients with Henoch-Schönlein purpura (HSP), and to analyze the factors  associated with poor prognosis for HSP nephritis.",Non-OADS,/arxiv_data1/oa_pdf/3f/b0/jkms-29-198.PMC3923997.pdf
"Received: 17 August 2013 Accepted: 19 November 2013 Address for Correspondence: Yong-Beom Park, MD Division of Rheumatology, Department of Internal Medicine,  Yonsei University College of Medicine, 50 Yonsei-ro,  Seodaemun-gu, Seoul 120-752, Korea Tel: +82.2-2228-1967, Fax: +82.2-393-5420  E-mail: yongbpark@yuhs.achttp://dx.doi.org/10.3346/jkms.2014.29.2.198  • J Korean Med Sci 2014; 29: 198-203 INTRODUCTION Henoch-Schönleinpurpura (HSP) is a systemic vasculitis in - volving small vessels with the deposition of immune complexes  containing IgA (1).",Non-OADS,/arxiv_data1/oa_pdf/3f/b0/jkms-29-198.PMC3923997.pdf
"• Henoch-Schönlein Purpura in Adults and Children http://jkms.org   199 http://dx.doi.org/10.3346/jkms.2014.29.2.198can College of Rheumatology (ACR) criteria requires 2 of the  following 4 phenomena: a) palpable purpura, non-thrombocy - topenic; b) age ≤ 20 yr at disease onset; c) bowel angina; and d)  histologic changes showing granulocytes in the walls of arteri - oles or venules (13).",Non-OADS,/arxiv_data1/oa_pdf/3f/b0/jkms-29-198.PMC3923997.pdf
• Henoch-Schönlein Purpura in Adults and Children 200  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.198symptom was abdominal pain in both groups.,Non-OADS,/arxiv_data1/oa_pdf/3f/b0/jkms-29-198.PMC3923997.pdf
"• Henoch-Schönlein Purpura in Adults and Children http://jkms.org   201 http://dx.doi.org/10.3346/jkms.2014.29.2.198insufficiency at the time of the diagnosis was found to be an in - dependent risk factor for progression to chronic renal failure  (OR, 34; 95% CI, 3.70-312.09; P= 0.002).",Non-OADS,/arxiv_data1/oa_pdf/3f/b0/jkms-29-198.PMC3923997.pdf
• Henoch-Schönlein Purpura in Adults and Children 202  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.198occurred more often in children.,Non-OADS,/arxiv_data1/oa_pdf/3f/b0/jkms-29-198.PMC3923997.pdf
ORCID Jin-su Park http://orcid.org/0000-0003-4228-3750  Yong-Beom Park http://orcid.org/0000-0003-4695-8620   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/3f/b0/jkms-29-198.PMC3923997.pdf
• Henoch-Schönlein Purpura in Adults and Children http://jkms.org   203 http://dx.doi.org/10.3346/jkms.2014.29.2.198dictive factors for renal sequelae in adults with Henoch-Schönlein pur - pura.,Non-OADS,/arxiv_data1/oa_pdf/3f/b0/jkms-29-198.PMC3923997.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Role of Bone Scintigraphy in the Diagnosis of Rheumatoid  Arthritis According to the 2010 ACR/EULAR Classification  Criteria We aimed to investigate the role of bone scintigraphy (BS) in the diagnosis of rheumatoid  arthritis (RA) as a supplement to the 2010 American College of Rheumatology (ACR)/  European League Against Rheumatism (EULAR) criteria.",Non-OADS,/arxiv_data1/oa_pdf/50/05/jkms-29-204.PMC3923998.pdf
"*This study was supported by the Korea Healthcare Technology  R&D Project, Ministry of Health and Welfare, Republic of Korea  (A102065).http://dx.doi.org/10.3346/jkms.2014.29.2.204  • J Korean Med Sci 2014; 29: 204-209 INTRODUCTION Early diagnosis of rheumatoid arthritis (RA) is crucial because  increasing evidence suggests that prompt treatment leads to a  better outcome and prognosis (1-3).",Non-OADS,/arxiv_data1/oa_pdf/50/05/jkms-29-204.PMC3923998.pdf
• Bone Scintigraphy in Rheumatoid Arthritis Diagnosis http://jkms.org   205 http://dx.doi.org/10.3346/jkms.2014.29.2.204the 2010 criteria in the diagnosis of RA during the initial work- up of patients with joint symptoms.,Non-OADS,/arxiv_data1/oa_pdf/50/05/jkms-29-204.PMC3923998.pdf
• Bone Scintigraphy in Rheumatoid Arthritis Diagnosis 206  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.204view board of the Hanyang University Hospital (HYUH IRB 2010- R-53).,Non-OADS,/arxiv_data1/oa_pdf/50/05/jkms-29-204.PMC3923998.pdf
"• Bone Scintigraphy in Rheumatoid Arthritis Diagnosis http://jkms.org   207 http://dx.doi.org/10.3346/jkms.2014.29.2.204were not eligible according to the 2010 criteria, BS-assisted di - agnosis identified two cases of RA, whereas the 2010 criteria as - sessed by physician only failed to identify any patients with RA.",Non-OADS,/arxiv_data1/oa_pdf/50/05/jkms-29-204.PMC3923998.pdf
• Bone Scintigraphy in Rheumatoid Arthritis Diagnosis 208  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.204tional structural information (12).,Non-OADS,/arxiv_data1/oa_pdf/50/05/jkms-29-204.PMC3923998.pdf
ORCID Ji Young Kim http://orcid.org/0000-0003-2199-4529 Soo-Kyung Cho http://orcid.org/0000-0003-4493-8837  Minkyung Han http://orcid.org/0000-0002-5011-5557  Yun Young Choi http://orcid.org/0000-0002-7535-4343   Sang-Cheol Bae http://orcid.org/0000-0003-4658-1093   Yoon-Kyoung Sung http://orcid.org/0000-0001-6691-8939 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/50/05/jkms-29-204.PMC3923998.pdf
• Bone Scintigraphy in Rheumatoid Arthritis Diagnosis http://jkms.org   209 http://dx.doi.org/10.3346/jkms.2014.29.2.20411.,Non-OADS,/arxiv_data1/oa_pdf/50/05/jkms-29-204.PMC3923998.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Utilization Patterns of Disease-Modifying Antirheumatic Drugs  in Elderly Rheumatoid Arthritis Patients This study was conducted to investigate disease-modifying antirheumatic drug (DMARD)  utilization in Korean elderly patients with rheumatoid arthritis (RA).",Non-OADS,/arxiv_data1/oa_pdf/45/76/jkms-29-210.PMC3923999.pdf
"Keywords:  Utilization; Antirheumatic Agents; Arthritis, Rheumatoid; DatabaseXue-Mei Jin,1 Joongyub Lee,2   Nam-Kyong Choi,2,3 Jong-Mi Seong,1,4  Ju-Young Shin,4 Ye-Jee Kim,1   Mi-Sook Kim,1 Bo Ram Yang,1   and Byung-Joo Park1,4 1Department of Preventive Medicine, College of  Medicine, Seoul National University, Seoul; 2Medical  Research Collaborating Center, Seoul National  University Hospital, Seoul; 3Institute of Environmental  Medicine, Seoul National University Medical Research  Center, Seoul; 4Korea Institute of Drug Safety and  Risk Management, Seoul, Korea Received: 3 September 2013 Accepted: 22 November 2013 Address for Correspondence: Byung-Joo Park, MD Department of Preventive Medicine, Seoul National University  College of Medicine, 103 Daehak-ro, Jongno-gu,   Seoul 110-799, Korea Tel: +82.2-740-8325, Fax: +82.2-740-4830 E-mail: bjpark@snu.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.2.210  • J Korean Med Sci 2014; 29: 210-216 INTRODUCTION Rheumatoid arthritis (RA) causes chronic inflammatory syno - vitis.",Non-OADS,/arxiv_data1/oa_pdf/45/76/jkms-29-210.PMC3923999.pdf
"• Disease-Modifying Antirheumatic Drugs in Elderly Rheumatoid Arthritis Patients http://jkms.org   211 http://dx.doi.org/10.3346/jkms.2014.29.2.210M05-M06) on different days and excluded patients who were  diagnosed with human immunodeficiency virus (ICD-10: B20- B24) or cancer (ICD-10: C00-C97, D00-D09).",Non-OADS,/arxiv_data1/oa_pdf/45/76/jkms-29-210.PMC3923999.pdf
"• Disease-Modifying Antirheumatic Drugs in Elderly Rheumatoid Arthritis Patients 212  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.210participants was 72.5 ± 5.8 yr, and 130,524 (78.4%) of the pati- ents were women.",OADS,/arxiv_data1/oa_pdf/45/76/jkms-29-210.PMC3923999.pdf
"• Disease-Modifying Antirheumatic Drugs in Elderly Rheumatoid Arthritis Patients http://jkms.org   213 http://dx.doi.org/10.3346/jkms.2014.29.2.210treated in smaller cities and rural areas: The proportions were  16.9%, 11.9%, and 3.5%, respectively, and showed a decreasing  trend ( P< 0.01).",Non-OADS,/arxiv_data1/oa_pdf/45/76/jkms-29-210.PMC3923999.pdf
• Disease-Modifying Antirheumatic Drugs in Elderly Rheumatoid Arthritis Patients 214  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.210 HCQ was the most commonly used DMARD.,Non-OADS,/arxiv_data1/oa_pdf/45/76/jkms-29-210.PMC3923999.pdf
• Disease-Modifying Antirheumatic Drugs in Elderly Rheumatoid Arthritis Patients http://jkms.org   215 http://dx.doi.org/10.3346/jkms.2014.29.2.210tions that should reflect the medication use in RA treatment  among representative populations in the real world.,Non-OADS,/arxiv_data1/oa_pdf/45/76/jkms-29-210.PMC3923999.pdf
ORCID Xue-Mei Jin http://orcid.org/0000-0003-1132-7271 Joongyub Lee http://orcid.org/0000-0003-2784-3772    Nam-Kyong Choi http://orcid.org/0000-0003-1153-9928 Jong-Mi Seong http://orcid.org/0000-0001-6681-4291 Ju-Young Shin http://orcid.org/0000-0002-2791-1037 Ye-Jee Kim http://orcid.org/0000-0002-3307-2970    Mi-Sook Kim http://orcid.org/0000-0002-4505-9167 Bo Ram Yang http://orcid.org/0000-0002-8771-8829    Byung-Joo Park http://orcid.org/0000-0003-4630-4942 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/45/76/jkms-29-210.PMC3923999.pdf
Available at http://www.hira.or.kr/dummy.do?pgmid=HIRA,Non-OADS,/arxiv_data1/oa_pdf/45/76/jkms-29-210.PMC3923999.pdf
• Disease-Modifying Antirheumatic Drugs in Elderly Rheumatoid Arthritis Patients 216  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.210A020045030000&cmsurl=/cms/information/05/03/03/1192956_13609.,Non-OADS,/arxiv_data1/oa_pdf/45/76/jkms-29-210.PMC3923999.pdf
Available at http://www.whocc.no/atc_ddd_index [accessed  on 24 July 2013].,OADS,/arxiv_data1/oa_pdf/45/76/jkms-29-210.PMC3923999.pdf
Available at http://www.hira.or.kr/eng/activity/01/01/activity01_01.,OADS,/arxiv_data1/oa_pdf/45/76/jkms-29-210.PMC3923999.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Patterns of Lymph Node Recurrence after Radical Surgery  Impacting on Survival of Patients with pT1-3N0M0 Thoracic  Esophageal Squamous Cell Carcinoma The aim of this study was to investigate how patterns of lymph nodes recurrence after  radical surgery impact on survival of patients with pT1-3N0M0 thoracic esophageal  squamous cell carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/d4/5d/jkms-29-217.PMC3924000.pdf
"Keywords:  Esophageal Squamous Cell Carcinoma; Thorax; Lymph Node Recurrence;  Tomography, X-Ray Computed; Radical EsophagectomyXiao-li Chen,1,2 Tian-wu Chen,1   Zhi-jia Fang,3 Xiao-ming Zhang,1   Zhen-lin Li,3 Hang Li,1 Hong-jie Tang,1   Li Zhou,1 Dan Wang,1 Zishu Zhang4 1Sichuan Key Laboratory of Medical Imaging, and  Department of Radiology, Affiliated Hospital of  North Sichuan Medical College, Nanchong, Sichuan;  2Department of Radiology, Sichuan Cancer Hospital  and Institute (The Second People’s Hospital of  Sichuan Province), Chengdu, Sichuan; 3Department  of Radiology, West China Hospital of Sichuan  University, Chengdu, Sichuan, China; 4Department  of Radiology, University of Michigan Health System,  Ann Arbor, MI, USA Received: 3 September 2013 Accepted: 19 November 2013 Address for Correspondence: Tian-wu Chen, MD Department of Radiology, Affiliated Hospital of North Sichuan  Medical College, 63# Wenhua Road, Shunqing District,  Nanchong, Sichuan 637000, China Tel: +86-817-2262236, Fax: +86-817-2262236 E-mail: tianwuchen_nsmc@163.com This study was supported by the Science Foundation for  Distinguished Young Scholars of Sichuan Province in China  (grant No.2010JQ0039), and the Scientific Research Project of  the Sichuan Province Health Office in China (grant No.100146).http://dx.doi.org/10.3346/jkms.2014.29.2.217  • J Korean Med Sci 2014; 29: 217-223 INTRODUCTION Esophageal carcinoma (EC), a malignant tumor occurring in  the epithelium of esophagus, is the eighth most common can - cer worldwide and the sixth most common cause of cancer-re - lated mortality (1).",Non-OADS,/arxiv_data1/oa_pdf/d4/5d/jkms-29-217.PMC3924000.pdf
"• Lymph Node Recurrence of Esophageal Cancer 218  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.217MATERIALS AND METHODS Patients selection From Feburuary 2001 to May 2005, 180 patients with TESCC  were enrolled in the study.",Non-OADS,/arxiv_data1/oa_pdf/d4/5d/jkms-29-217.PMC3924000.pdf
"• Lymph Node Recurrence of Esophageal Cancer http://jkms.org   219 http://dx.doi.org/10.3346/jkms.2014.29.2.217sus to keep the accuracy of imaging analysis, focusing on the  presence of LN recurrence, and the stations and fields of LNs  involved.",Non-OADS,/arxiv_data1/oa_pdf/d4/5d/jkms-29-217.PMC3924000.pdf
"• Lymph Node Recurrence of Esophageal Cancer 220  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.217DISCUSSION As previously reported, the most significant prognostic factor  for patients with EC was the preoperative LNs involved, and the  fields of the LNs involved before curative resection were nega - tively related to the survival rate (6, 7, 9).",Non-OADS,/arxiv_data1/oa_pdf/d4/5d/jkms-29-217.PMC3924000.pdf
"• Lymph Node Recurrence of Esophageal Cancer http://jkms.org   221 http://dx.doi.org/10.3346/jkms.2014.29.2.217tomic regions including the neck, thorax and abdomen (18).",Non-OADS,/arxiv_data1/oa_pdf/d4/5d/jkms-29-217.PMC3924000.pdf
"• Lymph Node Recurrence of Esophageal Cancer 222  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.217rate was not significantly improved by postoperative chemo - therapy, although the 5-yr disease-free survival rate and risk re - duction were remarkably improved (22).",Non-OADS,/arxiv_data1/oa_pdf/d4/5d/jkms-29-217.PMC3924000.pdf
• Lymph Node Recurrence of Esophageal Cancer http://jkms.org   223 http://dx.doi.org/10.3346/jkms.2014.29.2.217or extent of the lymph node metastasis?,Non-OADS,/arxiv_data1/oa_pdf/d4/5d/jkms-29-217.PMC3924000.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Prevalence and Risk Factors for Iron Deficiency Anemia in the  Korean Population: Results of the Fifth Korea National Health  and Nutrition Examination Survey This study assessed the prevalence of, and risk factors for, iron deficiency (ID) and iron  deficiency anemia (IDA) among participants of the fifth Korean Health and Nutrition  Examination Survey, 2010.",Non-OADS,/arxiv_data1/oa_pdf/ea/bd/jkms-29-224.PMC3924001.pdf
"Keywords:  Anemia, Iron Deficiency; KoreaJeong-Ok Lee,1 Ju Hyun Lee,2   Soyeon Ahn,2 Jin Won Kim,1   Hyun Chang,1 Yu Jung Kim,1   Keun-Wook Lee,1 Jee Hyun Kim,1   Soo-Mee Bang,1 and Jong Seok Lee1 1Department of Internal Medicine, Seoul National  University Bundang Hospital, Seoul National  University College of Medicine, Seongnam; 2Medical  Research Collaborating Center, Seoul National  University Bundang Hospital, Seongnam, Korea  Received: 1 August 2013 Accepted: 14 November 2013 Address for Correspondence: Soo-Mee Bang, MD Department of Internal Medicine, Seoul National University  Bundang Hospital, Seoul National University College of  Medicine, 82 Gumi-ro 173 Beon-gil, Bundang-gu,   Seongnam 463-707, Korea  Tel: +82.31-787-7038, Fax: +82.31-787-4098  E-mail: smbang7@snu.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.2.224  • J Korean Med Sci 2014; 29: 224-229 INTRODUCTION Iron deficiency (ID) is the most common nutritional deficiency  and is a major cause of morbidity and mortality that is respon - sible for the majority of cases of anemia, ~20% of perinatal and  ~10% of maternal mortalities in developing countries (1).",Non-OADS,/arxiv_data1/oa_pdf/ea/bd/jkms-29-224.PMC3924001.pdf
• Prevalence of Iron Deficiency Anemia in the Korean Population  http://jkms.org   225 http://dx.doi.org/10.3346/jkms.2014.29.2.224added to KNHANES in 2010 (KNHANES V-1).,Non-OADS,/arxiv_data1/oa_pdf/ea/bd/jkms-29-224.PMC3924001.pdf
"• Prevalence of Iron Deficiency Anemia in the Korean Population  226  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.224Severity and characteristics of anemia The mean Hb of the 569 anemic individuals was 11.1 ± 1.1 g/dL  (range, 6.9-12.9); anemia was mild in 486 (85.4%), moderate in  82 (14.4%), and severe in only 1 (0.2%).",OADS,/arxiv_data1/oa_pdf/ea/bd/jkms-29-224.PMC3924001.pdf
• Prevalence of Iron Deficiency Anemia in the Korean Population  http://jkms.org   227 http://dx.doi.org/10.3346/jkms.2014.29.2.224Table 3.,Non-OADS,/arxiv_data1/oa_pdf/ea/bd/jkms-29-224.PMC3924001.pdf
"• Prevalence of Iron Deficiency Anemia in the Korean Population  228  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.224IDA was associated with low income, underweight, insufficient  dietary iron or vitamin C intake (according to the recommend - ed nutritional intake) (Table 5).",Non-OADS,/arxiv_data1/oa_pdf/ea/bd/jkms-29-224.PMC3924001.pdf
"• Prevalence of Iron Deficiency Anemia in the Korean Population  http://jkms.org   229 http://dx.doi.org/10.3346/jkms.2014.29.2.224wide analysis of the prevalence of ID and IDA in Koreans, as  defined by serum iron and iron-binding capacity and can pro - vide important basic information for planning national health  policy to reduce IDA, particularly in susceptible populations.",Non-OADS,/arxiv_data1/oa_pdf/ea/bd/jkms-29-224.PMC3924001.pdf
ORCID Jeong-Ok Lee http://orcid.org/0000-0001-9402-6372 Ju Hyun Lee http://orcid.org/0000-0001-9728-1846    Soyeon Ahn http://orcid.org/0000-0003-3440-2027 Jin Won Kim http://orcid.org/0000-0002-1357-7015   Hyun Chang http://orcid.org/0000-0002-5203-7513 Yu Jung Kim http://orcid.org/0000-0002-5037-0523    Keun-Wook Lee http://orcid.org/0000-0002-8491-703X Jee Hyun Kim http://orcid.org/0000-0003-1336-3620    Soo-Mee Bang http://orcid.org/0000-0002-0938-3007  Jong Seok Lee http://orcid.org/0000-0002-7336-7124  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ea/bd/jkms-29-224.PMC3924001.pdf
Available at http://www.who.int/whr/2002/en  [accessed on 1 May 2013].,OADS,/arxiv_data1/oa_pdf/ea/bd/jkms-29-224.PMC3924001.pdf
Available at http://www.who.int/nutrition/publi - cations/micronutrients/anaemia_iron_deficiency/WHO_NHD_01.3/en  [accessed on 1 May 2013].,Non-OADS,/arxiv_data1/oa_pdf/ea/bd/jkms-29-224.PMC3924001.pdf
Available at http://knhanes.cdc.go.kr/knhanes/index.do [accessed  on 1 May 2013].,Non-OADS,/arxiv_data1/oa_pdf/ea/bd/jkms-29-224.PMC3924001.pdf
Available at http://www.who.int/vmnis/publications/anaemia_ prevalence/en [accessed on 1 May 2013].,Non-OADS,/arxiv_data1/oa_pdf/ea/bd/jkms-29-224.PMC3924001.pdf
Available at http://www.kns.or.kr/frontpage.asp?catalogid=kns2008&la nguage=ko [accessed on 1 May 2013].,Non-OADS,/arxiv_data1/oa_pdf/ea/bd/jkms-29-224.PMC3924001.pdf
Avail - able at http://www.who.int/nutrition/publications/micronutrients/ana- emia_iron_deficiency/9789241596107/en [accessed on 1 May 2013].,Non-OADS,/arxiv_data1/oa_pdf/ea/bd/jkms-29-224.PMC3924001.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Tempol Attenuates Renal Fibrosis in Mice with Unilateral Ureteral  Obstruction: The Role of PI3K–Akt–FoxO3a Signaling This study investigated whether tempol, an anti-oxidant, protects against renal injury by  modulating phosphatidylinositol 3-kinase (PI3K)-Akt-Forkhead homeobox O (FoxO)  signaling.",Non-OADS,/arxiv_data1/oa_pdf/41/d3/jkms-29-230.PMC3924002.pdf
"http://dx.doi.org/10.3346/jkms.2014.29.2.230  • J Korean Med Sci 2014; 29: 230-237 INTRODUCTION Patients with chronic kidney disease (CKD) show evidence of  increased oxidative stress, including by-products of the interac - tions between reactive-oxygen species (ROS) and lipids, amino  acids, proteins, carbohydrates, and nucleic acids (1).",Non-OADS,/arxiv_data1/oa_pdf/41/d3/jkms-29-230.PMC3924002.pdf
• PI3K-Akt-FoxO3a Signaling in Renal Fibrosis http://jkms.org   231 http://dx.doi.org/10.3346/jkms.2014.29.2.230obstruction (UUO).,Non-OADS,/arxiv_data1/oa_pdf/41/d3/jkms-29-230.PMC3924002.pdf
• PI3K-Akt-FoxO3a Signaling in Renal Fibrosis 232  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.230eas in the obstructed kidney of UUO-tempol mice were signifi - cantly decreased compared to those of UUO-control mice on  both day 3 and day 7 ( P< 0.05) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/41/d3/jkms-29-230.PMC3924002.pdf
"• PI3K-Akt-FoxO3a Signaling in Renal Fibrosis http://jkms.org   233 http://dx.doi.org/10.3346/jkms.2014.29.2.230(control vs tempol: day 3, 0.60 ± 0.06 vs 0.72 ± 0.13 fold, P= 0.14;  day 7, 0.31 ± 0.05 vs 0.74 ± 0.24 fold, P= 0.02) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/41/d3/jkms-29-230.PMC3924002.pdf
• PI3K-Akt-FoxO3a Signaling in Renal Fibrosis 234  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.230 ShamTUNELUC3 UT3 UC7 UT7 Fig.,Non-OADS,/arxiv_data1/oa_pdf/41/d3/jkms-29-230.PMC3924002.pdf
• PI3K-Akt-FoxO3a Signaling in Renal Fibrosis http://jkms.org   235 http://dx.doi.org/10.3346/jkms.2014.29.2.230 PI3K 85 kDa 60 kDa 60 kDa 43 kDa Sham UC3 UT3 UC7 UT7Phospho-Ser473 Akt Total Akt β-actin API3K/β-actin (fold)  Sham Day 3 Day 71.5 1 0.5 0UUO-control UUO-tempol * † B Phospho-Ser473 Akt/ Total Akt (fold)  Sham Day 3 Day 71.2 0.8 0.4 0UUO-control UUO-tempol * † C Fig.,Non-OADS,/arxiv_data1/oa_pdf/41/d3/jkms-29-230.PMC3924002.pdf
"• PI3K-Akt-FoxO3a Signaling in Renal Fibrosis 236  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.230FoxO4, and FoxO6, and FoxO3a protein is a regulator of detoxi - fication of ROS, DNA repair, cell cycle and growth, and cellular  death and survival (18).",Non-OADS,/arxiv_data1/oa_pdf/41/d3/jkms-29-230.PMC3924002.pdf
ORCID Hye Eun Yoon http://orcid.org/0000-0002-6347-7282  Seok Joon Shin http://orcid.org/0000-0001-7642-2849 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/41/d3/jkms-29-230.PMC3924002.pdf
• PI3K-Akt-FoxO3a Signaling in Renal Fibrosis http://jkms.org   237 http://dx.doi.org/10.3346/jkms.2014.29.2.23096: 857-68.,Non-OADS,/arxiv_data1/oa_pdf/41/d3/jkms-29-230.PMC3924002.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Risk of Bladder Cancer among Patients with Diabetes Treated  with a 15 mg Pioglitazone Dose in Korea: A Multi-Center  Retrospective Cohort Study It has not yet been determined whether chronic exposure to relatively low doses of  pioglitazone increases risk of bladder cancer.",Non-OADS,/arxiv_data1/oa_pdf/cd/e4/jkms-29-238.PMC3924003.pdf
"The  funders had no role in the study design, data collection and  analysis, decision to publish, or preparation of the manuscript.http://dx.doi.org/10.3346/jkms.2014.29.2.238  • J Korean Med Sci 2014; 29: 238-242 INTRODUCTION  It has previously been suggested that the use of pioglitazone can increase the risk of  developing bladder cancer in a dose-response manner (1-5).",Non-OADS,/arxiv_data1/oa_pdf/cd/e4/jkms-29-238.PMC3924003.pdf
"• Pioglitazone and Bladder Cancer in Korean Diabetic Patients http://jkms.org   239 http://dx.doi.org/10.3346/jkms.2014.29.2.238MATERIALS AND METHODS Study subjects We extracted a clinical database of diabetic patients with two or  more clinic visits between November 2005 and June 2011 from  the electronic medical records of four tertiary referral hospitals  in Korea (Samsung Medical Center, Severance Hospital, Asan  Medical Center, and Seoul St. Mary’s Hospital, Seoul, Korea).",OADS,/arxiv_data1/oa_pdf/cd/e4/jkms-29-238.PMC3924003.pdf
• Pioglitazone and Bladder Cancer in Korean Diabetic Patients 240  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.238Table 2.,Non-OADS,/arxiv_data1/oa_pdf/cd/e4/jkms-29-238.PMC3924003.pdf
"• Pioglitazone and Bladder Cancer in Korean Diabetic Patients http://jkms.org   241 http://dx.doi.org/10.3346/jkms.2014.29.2.238der cancer found on Cox regression analysis in this study is not  surprising, because most previous studies including the studies  conducted in the Kaiser Permanente Northern California (KPNC)  cohort (2) and the Taiwanese cohort (5) did not demonstrated  the significance of association between ever use of pioglitazone  and increased incidence of bladder cancer.",Non-OADS,/arxiv_data1/oa_pdf/cd/e4/jkms-29-238.PMC3924003.pdf
• Pioglitazone and Bladder Cancer in Korean Diabetic Patients 242  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.238proliferator-activated receptors (PPARs) in human urinary bladder car - cinoma and growth inhibition by its agonists.,Non-OADS,/arxiv_data1/oa_pdf/cd/e4/jkms-29-238.PMC3924003.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Sleep Disturbances and Glucoregulation in Patients with Type 2  Diabetes We investigated the frequency of sleep disturbances and the association between sleep  disturbances and glucoregulation in type 2 diabetic patients.",Non-OADS,/arxiv_data1/oa_pdf/5b/9d/jkms-29-243.PMC3924004.pdf
http://dx.doi.org/10.3346/jkms.2014.29.2.243  • J Korean Med Sci 2014; 29: 243-247 INTRODUCTION Sleep disturbances and chronic sleep shortage have become  very common in modern society.,Non-OADS,/arxiv_data1/oa_pdf/5b/9d/jkms-29-243.PMC3924004.pdf
• Sleep Disturbances and Type 2 Diabetes 244  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.243rean version of the Beck Depression Inventory (K-BDI) were  applied to all patients.,Non-OADS,/arxiv_data1/oa_pdf/5b/9d/jkms-29-243.PMC3924004.pdf
• Sleep Disturbances and Type 2 Diabetes http://jkms.org   245 http://dx.doi.org/10.3346/jkms.2014.29.2.243nessed apnea was observed in 18.1% of the study population.,Non-OADS,/arxiv_data1/oa_pdf/5b/9d/jkms-29-243.PMC3924004.pdf
• Sleep Disturbances and Type 2 Diabetes 246  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.243and sleep maintenance complaints were reported by 40% of  patients.,Non-OADS,/arxiv_data1/oa_pdf/5b/9d/jkms-29-243.PMC3924004.pdf
• Sleep Disturbances and Type 2 Diabetes http://jkms.org   247 http://dx.doi.org/10.3346/jkms.2014.29.2.243Verschuren WM.,Non-OADS,/arxiv_data1/oa_pdf/5b/9d/jkms-29-243.PMC3924004.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Clinical Characteristics and Outcomes of Acute Hepatitis A in  Korea: A Nationwide Multicenter Study  The aim of this study was to investigate the clinical characteristics of acute hepatitis A  during a recent outbreak in Korea.",Non-OADS,/arxiv_data1/oa_pdf/69/4b/jkms-29-248.PMC3924005.pdf
"Keywords:  Hepatitis A; Morbidity; MortalitySo Young Kwon,1 Sang Hoon Park,2   Jong Eun Yeon,3 Sook Hyang Jeong,4   Oh Sang Kwon,5 Jin Woo Lee,6   Hong Soo Kim,7 Yeon Seok Seo,8   Young Seok Kim,9 Joo Hyun Sohn,10   Hyung Joon Yim,11 Jong Young Choi,12  Myung Seok Lee,2 Young Oh Kweon,13   Jae Youn Cheong,14 Haak Cheoul Kim,15  Heon Ju Lee,16 Soon Koo Baik,17   Hyonggin An,18 and Kwan Soo Byun3  1Department of Internal Medicine, Konkuk University  School of Medicine, Seoul; 2Department of Internal  Medicine, Hallym Univesity College of Medicine, Hallym  Univesity Kangnam Sacred Heart Hospital, Seoul;  3Department of Internal Medicine, Korea University  College of Medicine, Korea University Guro Hospital,  Seoul; 4Department of Internal Medicine, Seoul  National University College of Medicine, Seoul National  University Bundang Hospital, Seongnam; 5Department  of Internal Medicine, Gachon University Graduate  School of Medicine, Gachon University Gil Medical  Center, Incheon; 6Department of Internal Medicine,  Inha University School of Medicine, Inha University  Hospital, Incheon; 7Department of Internal Medicine,  Soonchunhyang University College of Medicine,  Soonchunhyang University Cheonan Hospital, Cheona;  8Department of Internal Medicine, Korea University  College of Medicine, Korea University Anam Hospital,  Seoul; 9Department of Internal Medicine,  Soonchunhyang University College of Medicine,  Soonchunhyang University Bucheon Hospital, Bucheon;  10Department of Internal Medicine, Hanyang University  College of Medicine, Hanyang University Guri Hospital,  Guri; 11Department of Internal Medicine, Korea  University College of Medicine, Korea University Ansan  Hospital, Ansan; 12Department of Internal Medicine,  The Catholic University of Korea School of Medicine,  The Catholic University of Korea St. Mary’s Hosptial,  Seoul; 13Department of Internal Medicine, Kyungpook  National University College of Medicine, Kyungpook  National University Hospital, Daegu; 14Department of  Internal Medicine, Ajou University School of Medicine,  Ajou University Hospital, Suwon; 15Department of  Internal Medicine, Wonkwang University School of  Medicine, Wonkwang University Hospital, Iksan;  16Department of Internal Medicine, Yeungnam  University College of Medicine, Yeungnam University  Medical Center, Daegu; 17Department of Internal  Medicine, Yonsei University Wonju College of Medicine,  Yonsei University Wonju Christian Hospital, Wonju;  18Department of Biostatistics, Korea University College  of Medicine, Seoul, Korea  Received: 21 October 2013 Accepted: 29 November 2013 Address for Correspondence: Kwan Soo Byun, MD Department of Internal Medicine, Liver Center, Korea University  Guro Hospital, 148 Gurodong-ro, Guro-gu, Seoul 152-703,  Korea Tel: +82.2-2030-5027, Fax: +82.2-2030-5029 E-mail: kwsbyun@unitel.co.kr This work was supported by 2008 KASL research funding.http://dx.doi.org/10.3346/jkms.2014.29.2.248  • J Korean Med Sci 2014; 29: 248-253 INTRODUCTION The seroprevalence of hepatitis A differs by region according to urbanization and envi ­ ronmental hygiene.",Non-OADS,/arxiv_data1/oa_pdf/69/4b/jkms-29-248.PMC3924005.pdf
"• Clinical Characteristics and Outcomes of Hepatitis A  http://jkms.org   249 http://dx.doi.org/10.3346/jkms.2014.29.2.248MATERIALS AND METHODS Patients Consecutive patients with acute hepatitis A, who visited hospi ­ tals during the period between June 2007 and May 2009, were  included in this study.",Non-OADS,/arxiv_data1/oa_pdf/69/4b/jkms-29-248.PMC3924005.pdf
• Clinical Characteristics and Outcomes of Hepatitis A  250  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.2481.,Non-OADS,/arxiv_data1/oa_pdf/69/4b/jkms-29-248.PMC3924005.pdf
"• Clinical Characteristics and Outcomes of Hepatitis A  http://jkms.org   251 http://dx.doi.org/10.3346/jkms.2014.29.2.248DISCUSSION This study demonstrated that symptomatic hepatitis A occurr­ ed primarily in adult populations, the mortality rate including  death or liver transplantation was 0.47%, and a significant num ­ ber of patients experienced complication of renal impairment  or prolonged cholestasis.",Non-OADS,/arxiv_data1/oa_pdf/69/4b/jkms-29-248.PMC3924005.pdf
• Clinical Characteristics and Outcomes of Hepatitis A  252  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.248tions of hepatitis A were not rare.,Non-OADS,/arxiv_data1/oa_pdf/69/4b/jkms-29-248.PMC3924005.pdf
"• Clinical Characteristics and Outcomes of Hepatitis A  http://jkms.org   253 http://dx.doi.org/10.3346/jkms.2014.29.2.248University Hospital, Busan, Korea), Byung Cheol Song (Jeju Na ­ tional University Hospital, Jeju, Korea), Yoon Jun Kim (Seoul  National University Hospital, Seoul, Korea).",Non-OADS,/arxiv_data1/oa_pdf/69/4b/jkms-29-248.PMC3924005.pdf
ORCID So Young Kwon http://orcid.org/0000-0003-4290-1950  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/69/4b/jkms-29-248.PMC3924005.pdf
Available at http://stat.cdc.go.kr [accessed on 1 Oc - tober 2010].,OADS,/arxiv_data1/oa_pdf/69/4b/jkms-29-248.PMC3924005.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Impact of Enzyme Replacement Therapy on Linear Growth in  Korean Patients with Mucopolysaccharidosis Type II (Hunter  Syndrome) Hunter syndrome (or mucopolysaccharidosis type II [MPS II]) arises because of a deficiency  in the lysosomal enzyme iduronate-2-sulfatase.",Non-OADS,/arxiv_data1/oa_pdf/fa/cb/jkms-29-254.PMC3924006.pdf
"http://dx.doi.org/10.3346/jkms.2014.29.2.254  • J Korean Med Sci 2014; 29: 254-260 INTRODUCTION Hunter syndrome (or mucopolysaccharidosis type II [MPS II], OMIM# 309900) is a rare  and life-limiting X-linked recessive disorder that affects approximately 1 in 77,000- 94,000 newborn boys (1-3).",Non-OADS,/arxiv_data1/oa_pdf/fa/cb/jkms-29-254.PMC3924006.pdf
"• Enzyme Replacement Therapy and Growth in Hunter Syndrome http://jkms.org   255 http://dx.doi.org/10.3346/jkms.2014.29.2.254 To date, few studies have investigated the effect of ERT on the  growth of individuals with MPS II (6, 15).",Non-OADS,/arxiv_data1/oa_pdf/fa/cb/jkms-29-254.PMC3924006.pdf
• Enzyme Replacement Therapy and Growth in Hunter Syndrome 256  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.254velocities of these patients are not presented as figures because  of a lack of data on the heights of the subjects prior to undergo - ing ERT.,Non-OADS,/arxiv_data1/oa_pdf/fa/cb/jkms-29-254.PMC3924006.pdf
"• Enzyme Replacement Therapy and Growth in Hunter Syndrome http://jkms.org   257 http://dx.doi.org/10.3346/jkms.2014.29.2.254treatment were -0.047 and -0.007, respectively: difference in the  slope, 0.04; P< 0.001) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/fa/cb/jkms-29-254.PMC3924006.pdf
"• Enzyme Replacement Therapy and Growth in Hunter Syndrome 258  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.254terms of z-scores between the two groups according the type of  mutation (difference in z-score at the start of ERT, -0.705; P=  0.666) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/fa/cb/jkms-29-254.PMC3924006.pdf
• Enzyme Replacement Therapy and Growth in Hunter Syndrome http://jkms.org   259 http://dx.doi.org/10.3346/jkms.2014.29.2.254Fig.,Non-OADS,/arxiv_data1/oa_pdf/fa/cb/jkms-29-254.PMC3924006.pdf
• Enzyme Replacement Therapy and Growth in Hunter Syndrome 260  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.254their growth curves in this study.,Non-OADS,/arxiv_data1/oa_pdf/fa/cb/jkms-29-254.PMC3924006.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Influence of Bottle-Feeding on Serum Bisphenol A Levels in  Infants Exposure to endocrine disrupting chemicals (EDCs), particularly during developmental  periods, gives rise to a variety of adverse health outcomes.",Non-OADS,/arxiv_data1/oa_pdf/46/c4/jkms-29-261.PMC3924007.pdf
"Keywords:  Bisphenol A; Infant; Endocrine Disrupting Chemical; Baby Bottle; Bottle- FeedingYoung-Jun Rhie,1 Hyo-Kyoung Nam,1  Yeon Joung Oh,2 Ho-Seong Kim,3   and Kee-Hyoung Lee1 1Department of Pediatrics, Korea University College  of Medicine, Seoul; 2Departments of Pediatrics,  Hallym University College of Medicine, Seoul;  3Department of Pediatrics, Yonsei University College  of Medicine, Seoul, Korea Received: 30 September 2013 Accepted: 15 November 2013 Address for Correspondence: Kee-Hyoung Lee, MD Department of Pediatrics, Korea University College of Medicine,  73 Inchon-ro, Seongbuk-gu, Seoul 136-705, Korea Tel: +82.2-920-6604, Fax: +82.2-922-7476 E-mail: khlee218@kumc.or.krhttp://dx.doi.org/10.3346/jkms.2014.29.2.261  • J Korean Med Sci 2014; 29: 261-264 INTRODUCTION Endocrine disrupting chemicals (EDCs) are compounds exist - ed in the environment, and mimic or interfere the effects of en - dogenous hormones such as estrogens, androgens, progestins,  and thyroid, hypothalamic, and pituitary hormones (1).",Non-OADS,/arxiv_data1/oa_pdf/46/c4/jkms-29-261.PMC3924007.pdf
"• Serum Bisphenol A Levels in Infants 262  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.261bottle-fed were assigned to the breast-fed group (n = 30), and  those who had recently been bottle-fed for at least three months  were assigned to the bottle-fed group (n = 30).",Non-OADS,/arxiv_data1/oa_pdf/46/c4/jkms-29-261.PMC3924007.pdf
"• Serum Bisphenol A Levels in Infants http://jkms.org   263 http://dx.doi.org/10.3346/jkms.2014.29.2.261DISCUSSION To the best of our knowledge, this study is the first attempt to  measure serum BPA levels in infants.",Non-OADS,/arxiv_data1/oa_pdf/46/c4/jkms-29-261.PMC3924007.pdf
ORCID Young-Jun Rhie http://orcid.org/0000-0002-1250-6469  Hyo-Kyoung Nam http://orcid.org/0000-0003-1512-2062  Yeon Joung Oh http://orcid.org/0000-0002-1664-8480  Ho-Seong Kim http://orcid.org/0000-0003-1135-099X  Kee-Hyoung Lee  http://orcid.org/0000-0002-4319-9019  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/46/c4/jkms-29-261.PMC3924007.pdf
• Serum Bisphenol A Levels in Infants 264  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.261demic.,Non-OADS,/arxiv_data1/oa_pdf/46/c4/jkms-29-261.PMC3924007.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Microarray Analysis for Genes Associated with Angiogenesis in  Diabetic OLETF Keratocytes The purpose of this study was to identify the differences in angiogenesis gene expression  between normal and diabetic keratocytes stimulated with interleukin-1 α (IL-1α) and tumor  necrosis factor- α (TNF-α).",Non-OADS,/arxiv_data1/oa_pdf/27/62/jkms-29-265.PMC3924008.pdf
"Keywords:  Angiogenesis; Cytokines; Inflammation; Corneal Keratocyte; Microarray  Analysis; OLETF Jun-Mo Park,1 Young Min Park,2   Wook Jung,2 Ji-Eun Lee,2   and Jong-Soo Lee2 1Department of Ophthalmology, Busan St. Mary’s  Hospital, Busan; 2Department of Ophthalmology,  School of Medicine, Pusan National University and  Medical Research Institute, Pusan National  University Hospital, Busan, Korea Received: 19 August 2013 Accepted: 19 November 2013 Address for Correspondence: Jong-Soo Lee, MD Department of Ophthalmology, School of Medicine, Pusan  National University, and Medical Research Institute, Pusan  National University Hospital, 179 Gudeok-ro, Seo-gu,   Busan 602-739, Korea Tel: +82.51-240-7323, Fax: +82.51-242-7341 E-mail: jongsool@pusan.ac.kr This study was supported by Biomedical Research Institute,  Pusan National University Hospital.http://dx.doi.org/10.3346/jkms.2014.29.2.265  • J Korean Med Sci 2014; 29: 265-271 INTRODUCTION Angiogenesis is essential for many physiological processes in ­ cluding wound healing, cell regeneration, tissue growth and de­ velopment, and embryonic development, and plays a very im ­ portant role in the development of proliferative diabetic retino­ pathy, a serious complication of diabetes (1­3).",Non-OADS,/arxiv_data1/oa_pdf/27/62/jkms-29-265.PMC3924008.pdf
"• Angiogenesis Genes in Diabetic Keratocytes 266  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.265For the microarray experiments, cells between the third and  fourth generation of serial culture were collected and stored at  ­70°C.",OADS,/arxiv_data1/oa_pdf/27/62/jkms-29-265.PMC3924008.pdf
• Angiogenesis Genes in Diabetic Keratocytes http://jkms.org   267 http://dx.doi.org/10.3346/jkms.2014.29.2.265 Newly expressed genes after TNF ­α treatment are shown in  Table 3.,Non-OADS,/arxiv_data1/oa_pdf/27/62/jkms-29-265.PMC3924008.pdf
• Angiogenesis Genes in Diabetic Keratocytes 268  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.265Table 2.,Non-OADS,/arxiv_data1/oa_pdf/27/62/jkms-29-265.PMC3924008.pdf
"• Angiogenesis Genes in Diabetic Keratocytes http://jkms.org   269 http://dx.doi.org/10.3346/jkms.2014.29.2.265sion of VEGF and potentiates VEGF ­mediated angiogenic ac ­ tivity through an up­regulation in kinase domain region in en ­ dothelial cells (12, 13).",Non-OADS,/arxiv_data1/oa_pdf/27/62/jkms-29-265.PMC3924008.pdf
"• Angiogenesis Genes in Diabetic Keratocytes 270  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.265 After TNF ­α treatment, 14 angiogenesis ­related genes are new ­ ly expressed.",Non-OADS,/arxiv_data1/oa_pdf/27/62/jkms-29-265.PMC3924008.pdf
ORCID Jun­Mo Park http://orcid.org/0000-0002-3942-3989  Young Min Park http://orcid.org/0000-0001-8495-9224  Wook Jung http://orcid.org/0000-0003-2364-9526  Ji­Eun Lee http://orcid.org/0000-0002-4927-2854  Jong­ Soo Lee http://orcid.org/0000-0002-1052-2924  REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/27/62/jkms-29-265.PMC3924008.pdf
• Angiogenesis Genes in Diabetic Keratocytes http://jkms.org   271 http://dx.doi.org/10.3346/jkms.2014.29.2.26510.,Non-OADS,/arxiv_data1/oa_pdf/27/62/jkms-29-265.PMC3924008.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Decreasing Incidence of Trichophyton mentagrophytes  in Korea:  Analysis of 6,250 Cases during the Last 21-Year-Period (1992-2012)  Trichophyton mentagrophytes  is the second common dermatophyte in Korea.",Non-OADS,/arxiv_data1/oa_pdf/fe/18/jkms-29-272.PMC3924009.pdf
"Keywords:  Epidemiology; Mycology; Trichophyton Weon Ju Lee,1 Kyung Hea Park,1   Mi So Kim,1 Seok-Jong Lee,1   Do Won Kim,1 Yong Jun Bang,2   and Jae Bok Jun2 1Department of Dermatology, Kyungpook National  University School of Medicine, Daegu; 2Institute of  Medical Mycology, Catholic Skin Clinic, Daegu,  Korea  Received: 8 August 2013 Accepted: 19 November 2013 Address for Correspondence: Weon Ju Lee, MD  Department of Dermatology, Kyungpook National University  School of Medicine, 200 Dongduk-ro, Jung-gu, Daegu 700-721,  Korea Tel: +82.53-420-5838, Fax: +82.53-426-0770 E-mail: weonju@knu.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.2.272  • J Korean Med Sci 2014; 29: 272-276 INTRODUCTION  Trichophyton mentagrophytes  is the second most common der - matophyte in Korea (1-3).",Non-OADS,/arxiv_data1/oa_pdf/fe/18/jkms-29-272.PMC3924009.pdf
"• Decreasing Incidence of Trichophyton mentagrophytes in Korea  http://jkms.org   273 http://dx.doi.org/10.3346/jkms.2014.29.2.272Age and sex distribution There was 1,610 patients (25.8%) in forties, which represented  the peak in the age distribution, 1,424 (22.8%) were in their thir - ties, and 1,011 (16.2%) were in their fifties.",Non-OADS,/arxiv_data1/oa_pdf/fe/18/jkms-29-272.PMC3924009.pdf
• Decreasing Incidence of Trichophyton mentagrophytes in Korea  274  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.272 A B Fig.,Non-OADS,/arxiv_data1/oa_pdf/fe/18/jkms-29-272.PMC3924009.pdf
• Decreasing Incidence of Trichophyton mentagrophytes in Korea  http://jkms.org   275 http://dx.doi.org/10.3346/jkms.2014.29.2.272Fig.,Non-OADS,/arxiv_data1/oa_pdf/fe/18/jkms-29-272.PMC3924009.pdf
• Decreasing Incidence of Trichophyton mentagrophytes in Korea  276  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.272was highest in summer (16).,Non-OADS,/arxiv_data1/oa_pdf/fe/18/jkms-29-272.PMC3924009.pdf
ORCID Weon Ju Lee http://orcid.org/0000­0001­5708­1305 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/fe/18/jkms-29-272.PMC3924009.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357National Trends of Hip Arthroscopy in Korea Hip arthroscopy has been reported to be useful and promising for the treatment of hip  pathologies.",Non-OADS,/arxiv_data1/oa_pdf/01/ba/jkms-29-277.PMC3924010.pdf
"Keywords:  Hip Arthroscopy; Trends; EpidemiologyYoung-Kyun Lee,1 Yong-Chan Ha,2  Byung-Ho Yoon,1 and Kyung-Hoi Koo1 1Department of Orthopaedic Surgery, Seoul National  University Bundang Hospital, Seongnam;  2Department of Orthopaedic Surgery, Chung-Ang  University College of Medicine, Seoul, Korea Received: 22 April 2013 Accepted: 8 July 2013 Address for Correspondence: Yong-Chan Ha, MD Department of Orthopaedic Surgery, Chung-Ang University  College of Medicine, 102 Heukseok-ro, Dongjak-gu,   Seoul 156-755, Korea Tel: +82.2-6299-1577, Fax: +82.2-822-1710 E-mail: hayongch@naver.com http://dx.doi.org/10.3346/jkms.2014.29.2.277  • J Korean Med Sci 2014; 29: 277-280 INTRODUCTION  Hip arthroscopy has been reported to be a useful and promis - ing treatment of intra/extra-articular pathologies of the hip (1- 8).",Non-OADS,/arxiv_data1/oa_pdf/01/ba/jkms-29-277.PMC3924010.pdf
• Hip Arthroscopy in Korea 278  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.277Table 1.,Non-OADS,/arxiv_data1/oa_pdf/01/ba/jkms-29-277.PMC3924010.pdf
Numbers of men and women were  obtained from the ‘Statistics Korea’ web site (http://www.kosis.,OADS,/arxiv_data1/oa_pdf/01/ba/jkms-29-277.PMC3924010.pdf
"• Hip Arthroscopy in Korea http://jkms.org   279 http://dx.doi.org/10.3346/jkms.2014.29.2.277troduced early, the development of hip arthroscopy has been  relatively delayed due to steep learning curves, deeply located  surgical field, and the confined working space (17-19).",Non-OADS,/arxiv_data1/oa_pdf/01/ba/jkms-29-277.PMC3924010.pdf
• Hip Arthroscopy in Korea 280  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.277were performed in hospitals.,Non-OADS,/arxiv_data1/oa_pdf/01/ba/jkms-29-277.PMC3924010.pdf
ORCID Young-Kyun Lee http://orcid.org/0000-0001-6564-4294   Yong-Chan Ha http://orcid.org/0000-0002-6249-0581 Byung-Ho Yoon http://orcid.org/0000-0001-8518-6331  Kyung-Hoi Koo http://orcid.org/0000-0001-5251-2911  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/01/ba/jkms-29-277.PMC3924010.pdf
Available at http://www.kosis.kr [ac - cessed on 22 April 2013].,Non-OADS,/arxiv_data1/oa_pdf/01/ba/jkms-29-277.PMC3924010.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Incidence and Risk Factors of Symptomatic Peripartum Diastasis  of Pubic Symphysis  This study was undertaken to determine incidence, associated risk factors, and clinical  outcomes of a diastasis of pubic symphysis.",Non-OADS,/arxiv_data1/oa_pdf/96/7d/jkms-29-281.PMC3924011.pdf
http://dx.doi.org/10.3346/jkms.2014.29.2.281  • J Korean Med Sci 2014; 29: 281-286 INTRODUCTION  Diastasis of the pubic symphysis is an uncommon peripartum  complication that might result in a serious distress to the pa - tient (1-3).,Non-OADS,/arxiv_data1/oa_pdf/96/7d/jkms-29-281.PMC3924011.pdf
"• Incidence of Diastasis of Pubic Symphysis 282  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.2814,554 babies were subjects of our study.",Non-OADS,/arxiv_data1/oa_pdf/96/7d/jkms-29-281.PMC3924011.pdf
"• Incidence of Diastasis of Pubic Symphysis http://jkms.org   283 http://dx.doi.org/10.3346/jkms.2014.29.2.281 In univariate analysis, there were no significant differences  between the diastasis patient group and postpartum patients  without diastasis group with regard to age ( P= 0.887), gesta - tional age ( P= 0.502), gender of baby ( P= 0.132), and body  weight of baby ( P= 0.752).",OADS,/arxiv_data1/oa_pdf/96/7d/jkms-29-281.PMC3924011.pdf
• Incidence of Diastasis of Pubic Symphysis 284  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.281 A B Fig.,Non-OADS,/arxiv_data1/oa_pdf/96/7d/jkms-29-281.PMC3924011.pdf
"• Incidence of Diastasis of Pubic Symphysis http://jkms.org   285 http://dx.doi.org/10.3346/jkms.2014.29.2.281cm is usually associated with an skin-rupture of sacroiliac joint  and instability of the pelvic ring (2), which necessitates a surgi - cal intervention (17, 20).",Non-OADS,/arxiv_data1/oa_pdf/96/7d/jkms-29-281.PMC3924011.pdf
• Incidence of Diastasis of Pubic Symphysis 286  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.281criteria of diastasis of symphysis pubis after normal delivery.,Non-OADS,/arxiv_data1/oa_pdf/96/7d/jkms-29-281.PMC3924011.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Patient Preference and Satisfaction with Their Involvement in the  Selection of an Anesthetic Method for Surgery This prospective study aimed to evaluate the satisfaction of patients who participated in  the decision-making process for selecting an anesthesia method for surgery; the patients’  preferred role (active, collaborative or passive) in the decision-making; and the patients’  preferred choice of anesthetic method.",Non-OADS,/arxiv_data1/oa_pdf/d8/31/jkms-29-287.PMC3924012.pdf
"Keywords:  Anesthesia; Decision Making; Patient-Centered Care; Patient Participation Sung Mi Hwang, Jae Jun Lee, Ji Su Jang,  Gi Ho Gim, Min Chul Kim,   and So Young Lim  Department of Anesthesiology and Pain Medicine,  College of Medicine, Hallym University, Chuncheon,  Korea  Received: 4 October 2013 Accepted: 29 November 2013 Address for Correspondence: Jae Jun Lee, MD Department of Anesthesiology and Pain Medicine, Chuncheon  Sacred Heart Hospital, 77 Sakju-ro, Chuncheon 200-704, Korea  Tel: +82.33-240-5353, Fax: +82.33-251-0941 E-mail: iloveu59@hallym.or.krhttp://dx.doi.org/10.3346/jkms.2014.29.2.287  • J Korean Med Sci 2014; 29: 287-291 INTRODUCTION Patient-centered care encompasses the physician’s response to  the preferences of patients regarding treatment (1).",Non-OADS,/arxiv_data1/oa_pdf/d8/31/jkms-29-287.PMC3924012.pdf
"• Involvement in the Choice of an Anesthesia    288  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.287upper extremities, and spinal anesthesia versus general anes - thesia in cases involving the lower extremities.",Non-OADS,/arxiv_data1/oa_pdf/d8/31/jkms-29-287.PMC3924012.pdf
• Involvement in the Choice of an Anesthesia  http://jkms.org   289 http://dx.doi.org/10.3346/jkms.2014.29.2.287Table 1.,Non-OADS,/arxiv_data1/oa_pdf/d8/31/jkms-29-287.PMC3924012.pdf
"• Involvement in the Choice of an Anesthesia    290  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.287decision-making roles might be influenced by the fact that we  surveyed healthy patients, and their choices were not likely to  affect their lives.",Non-OADS,/arxiv_data1/oa_pdf/d8/31/jkms-29-287.PMC3924012.pdf
ORCID Sung Mi Hwang http://orcid.org/0000-0002-33141-544X Jae Jun Lee http://orcid.org/0000-0002-5418-500X Ji Su Jang http://orcid.org/0000-0001-9534-919X Gi Ho Gim http://orcid.org/0000-0001-6413-9667 Min Chul Kim http://orcid.org/0000-0002-3217-2179 So Young Lim http://orcid.org/0000-0003-0598-4574 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d8/31/jkms-29-287.PMC3924012.pdf
• Involvement in the Choice of an Anesthesia  http://jkms.org   291 http://dx.doi.org/10.3346/jkms.2014.29.2.287Ethics 2008; 34: 775-9.,Non-OADS,/arxiv_data1/oa_pdf/d8/31/jkms-29-287.PMC3924012.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Acute Myocardial Infarction after Radiofrequency Catheter  Ablation of Typical Atrial Flutter A 53-yr-old man underwent radiofrequency ablation to treat persistent atrial flutter.",Non-OADS,/arxiv_data1/oa_pdf/8c/e2/jkms-29-292.PMC3924013.pdf
"Keywords:  Atrial Flutter; Catheter Ablation; Myocardial InfarctionSehyo Yune,1 Woo Joo Lee,1   Ji-won Hwang,1 Eun Kim,1 Jung Min Ha,1  and June Soo Kim2 1Department of Medicine, 2Division of Cardiolgy,  Department of Medicine, Samsung Medical Center,  Sungkyunkwan University School of Medicine,  Seoul, Korea Received: 9 May 2013 Accepted: 24 July 2013 Address for Correspondence: June Soo Kim, MD Division of Cardiolgy, Department of Medicine, Samsung  Medical Center, Sungkyunkwan University School of Medicine,  81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea Tel: +82.2-3410-3414, Fax: +82.2-3410-3849 E-mail: js58.kim@samsung.comhttp://dx.doi.org/10.3346/jkms.2014.29.2.292  • J Korean Med Sci 2014; 29: 292-295 INTRODUCTION Radiofrequency catheter ablation is a common technique used  worldwide to treat typical atrial flutter.",Non-OADS,/arxiv_data1/oa_pdf/8c/e2/jkms-29-292.PMC3924013.pdf
• Acute MI after RFCA of Typical Atrial Flutter http://jkms.org   293 http://dx.doi.org/10.3346/jkms.2014.29.2.292 Fig.,Non-OADS,/arxiv_data1/oa_pdf/8c/e2/jkms-29-292.PMC3924013.pdf
"• Acute MI after RFCA of Typical Atrial Flutter 294  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.292DISCUSSION To our knowledge, there have been five similar cases of right  coronary artery occlusion during or after cavotricuspid isthmus  ablation for typical atrial flutter (1-5), but the exact mechanism  is still unclear.",Non-OADS,/arxiv_data1/oa_pdf/8c/e2/jkms-29-292.PMC3924013.pdf
ORCID Sehyo Yune http://orcid.org/0000-0002-9223-3586 Woo Joo Lee  http://orcid.org/0000-0002-4790-3560 Ji-won Hwang http://orcid.org/0000-0002-7098-3546 Eun Kim http://orcid.org/0000-0001-9401-7388 Jung Min Ha http://orcid.org/0000-0002-0075-4449 June Soo Kim http://orcid.org/0000-0001-7569-6450,Non-OADS,/arxiv_data1/oa_pdf/8c/e2/jkms-29-292.PMC3924013.pdf
• Acute MI after RFCA of Typical Atrial Flutter http://jkms.org   295 http://dx.doi.org/10.3346/jkms.2014.29.2.292REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8c/e2/jkms-29-292.PMC3924013.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Iliocaval Fistula Presenting with Paradoxical Pulmonary  Embolism Combined with High-Output Heart Failure  Successfully Treated by Endovascular Stent-Graft Repair: Case  Report A 51-yr-old man presented exertional dyspnea as a consequence of iliocaval fistula  combined with paradoxical pulmonary embolism and high-output heart failure.",Non-OADS,/arxiv_data1/oa_pdf/c5/26/jkms-29-296.PMC3924014.pdf
"Keywords:  Arteriovenous Fistula; Pulmonary Embolism; AngioplastySoo Jin Na,1 Yoon-Seok Koh,1   Tae-Hoon Kim,1 Sun-Chul Park,2   Woo-Seung Shin,1 Ho-Jong Chun,3   and Jong-Min Lee1 1Cardiovascular Center and Division of Cardiology,  2Divison of Vascular Surgery, 3Divison of  Interventional Radiology, Uijeongbu St. Mary’s  Hospital, College of Medicine, The Catholic  University of Korea, Uijeongbu, Korea Received: 13 May 2013 Accepted: 5 September 2013 Address for Correspondence: Yoon-Seok Koh, MD Division of Cardiology, Department of Internal Medicine,   College of Medicine, Uijeongbu St. Mary’s Hospital, The Catholic  University of Korea, 271 Cheonbo-ro, Uijeongbu 480-717, Korea Tel: +82.31-820-3707, Fax: +82.31-847-0461 E-mail: kyoonseok@catholic.ac.kr http://dx.doi.org/10.3346/jkms.2014.29.2.296  • J Korean Med Sci 2014; 29: 296-300 INTRODUCTION Spontaneous abdominal arteriovenous fistula is a very uncom - mon clinical condition found in only 1% of all abdominal aortic  aneurysm (1).",Non-OADS,/arxiv_data1/oa_pdf/c5/26/jkms-29-296.PMC3924014.pdf
• Endovascular Repair of Iliocaval Fistula  http://jkms.org   297 http://dx.doi.org/10.3346/jkms.2014.29.2.296L).,Non-OADS,/arxiv_data1/oa_pdf/c5/26/jkms-29-296.PMC3924014.pdf
• Endovascular Repair of Iliocaval Fistula  298  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.296and ventricular size was normalized.,Non-OADS,/arxiv_data1/oa_pdf/c5/26/jkms-29-296.PMC3924014.pdf
• Endovascular Repair of Iliocaval Fistula  http://jkms.org   299 http://dx.doi.org/10.3346/jkms.2014.29.2.296Fig.,Non-OADS,/arxiv_data1/oa_pdf/c5/26/jkms-29-296.PMC3924014.pdf
• Endovascular Repair of Iliocaval Fistula  300  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.296203-5.,Non-OADS,/arxiv_data1/oa_pdf/c5/26/jkms-29-296.PMC3924014.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Successful Pregnancy in a Patient with Autosomal Dominant  Polycystic Kidney Disease on Long-Term Hemodialysis Recent advances in dialysis and a multidisciplinary approach to pregnant patients with  advanced chronic kidney disease provide a better outcome.",Non-OADS,/arxiv_data1/oa_pdf/2d/a4/jkms-29-301.PMC3924015.pdf
"Keywords:  Pregnancy; Renal Dialysis; Polycystic Kidney, Autosomal Dominant Ji Hye Jung,1 Min Jeong Kim,1   Hye Jin Lim,1 Su-Ah Sung,1   So-Young Lee,1 Dae Woon Kim,2   Kyu Beck Lee,3 and Young-Hwan Hwang1 Departments of 1Internal Medicine, 2Obstetrics and  Gynecology, Eulji General Hospital, Seoul; 3Division  of Nephrology, Kangbuk Samsung Hospital,  Sungkyunkwan University School of Medicine,  Seoul, Korea Received: 25 April 2013 Accepted: 1 August 2013 Address for Correspondence: Young-Hwan Hwang, MD Department of Internal Medicine, Eulji General Hospital,  14 Hangeulbiseok-gil, Nowon-gu, Seoul 139-872, Korea Tel: +82.2-970-8630, Fax: +82.2-972-0068  E-mail: ondahl@eulji.ac.kr http://dx.doi.org/10.3346/jkms.2014.29.2.301  • J Korean Med Sci 2014; 29: 301-304 INTRODUCTION Pregnancy in patients with end-stage renal disease (ESRD) is  rare, and kidney disease before pregnancy is associated with  poor fetal outcome.",Non-OADS,/arxiv_data1/oa_pdf/2d/a4/jkms-29-301.PMC3924015.pdf
"• Pregnancy in ADPKD on Hemodialysis 302  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.301the second trimester to secure the intraabdominal space, but  the risk was determined to outweigh the benefits in this case.",Non-OADS,/arxiv_data1/oa_pdf/2d/a4/jkms-29-301.PMC3924015.pdf
"• Pregnancy in ADPKD on Hemodialysis http://jkms.org   303 http://dx.doi.org/10.3346/jkms.2014.29.2.301cessful pregnancy in a patient with Group C disease, and other  cases have also been reported (6-9).",Non-OADS,/arxiv_data1/oa_pdf/2d/a4/jkms-29-301.PMC3924015.pdf
ORCID Ji Hye Jung http://orcid.org/0000-0003-1371-2763 Min Jeong Kim http://orcid.org/0000-0001-8398-7020 Hye Jin Lim http://orcid.org/0000-0003-4477-5847 Su-Ah Sung http://orcid.org/0000-0001-8434-9944  So-Young Lee http://orcid.org/0000-0003-1415-0598 Dae Woon Kim http://orcid.org/0000-0003-3474-5257 Kyu Beck Lee http://orcid.org/0000-0002-3904-5404  Young-Hwan Hwang http://orcid.org/0000-0001-8935-2659  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/2d/a4/jkms-29-301.PMC3924015.pdf
• Pregnancy in ADPKD on Hemodialysis 304  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.3018.,Non-OADS,/arxiv_data1/oa_pdf/2d/a4/jkms-29-301.PMC3924015.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357A Case of Nonisland Pedicled Foot Fillet Flap for Below-Knee  Amputation Stump Wound: Treatment Option for Compartment  Syndrome after Fibular Free Flap Surgery  Despite the frequent use of the fibular free flap, there have been no reports of severe  compartment syndrome of the donor leg that necessitated limb amputation.",Non-OADS,/arxiv_data1/oa_pdf/45/60/jkms-29-305.PMC3924016.pdf
"Keywords:  Compartment Syndromes; Fibula; Knee; Amputation; Foot; Surgical FlapsJae Ha Hwang, Kwang Seog Kim,   and Sam Yong Lee  Department of Plastic and Reconstructive Surgery,  Chonnam National University Medical School,  Gwangju, Korea Received: 23 December 2013 Accepted: 3 January 2014 Address for Correspondence: Kwang Seog Kim, MD Department of Plastic and Reconstructive Surgery, Chonnam  National University Medical School, 42 Jebong-ro, Dong-gu,  Gwangju 501-757, Korea Tel: +82.62-220-6363, 6352, Fax: +82.62-227-1639 E-mail: pskim@chonnam.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.2.305  • J Korean Med Sci 2014; 29: 305-308 INTRODUCTION The fibular diaphysis can be excised along with the long pero - neal artery and vein for use as a fibular free flap (1).",Non-OADS,/arxiv_data1/oa_pdf/45/60/jkms-29-305.PMC3924016.pdf
• Nonisland Pedicled Foot Fillet Flap 306  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.305joint function.,Non-OADS,/arxiv_data1/oa_pdf/45/60/jkms-29-305.PMC3924016.pdf
• Nonisland Pedicled Foot Fillet Flap http://jkms.org   307 http://dx.doi.org/10.3346/jkms.2014.29.2.305can develop whenever the leg fascia is closed primarily.,Non-OADS,/arxiv_data1/oa_pdf/45/60/jkms-29-305.PMC3924016.pdf
ORCID Jae Ha Hwang http://orcid.org/0000-0001-6992-8067 Kwang Seog Kim http://orcid.org/0000-0002-6766-4640   Sam Yong Lee http://orcid.org/0000-0002-3185-2519 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/45/60/jkms-29-305.PMC3924016.pdf
• Nonisland Pedicled Foot Fillet Flap 308  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.2.30510.,Non-OADS,/arxiv_data1/oa_pdf/45/60/jkms-29-305.PMC3924016.pdf
http://dx.doi.org/10.1016/j.jhin.2013.11.007Journal of Hospital Infection 86 (2014) 83 e89 Open access under CC BY-NC-ND license.,OADS,/arxiv_data1/oa_pdf/be/09/main.PMC3924019.pdf
Supplementary data Supplementary data related to this article can be found online at http://dx.doi.org/10.1016/j.jhin.2013.11.007 .,OADS,/arxiv_data1/oa_pdf/be/09/main.PMC3924019.pdf
"In this review  Received: August 13, 2013 Accepted: September 13, 2013 Corresponding author: Dr. Toshimi Michigami, Depart- ment of Bone and Mineral Research Osaka Medical  Center and Research Institute for Maternal and Child  Health, 840 Murodo-cho, Izumi, Osaka 594-1101, Japan E-mail: michigami@mch.pref.osaka.jp This is an open-access article distributed under the terms  of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Clin Pediatr Endocrinol 2014; 23(1), 1–8 Copyright© 2014 by The Japanese Society for Pediatric Endocrinology",Non-OADS,/arxiv_data1/oa_pdf/d0/3f/cpe-23-001.PMC3924171.pdf
"Corresponding author: Yuki Naito, Clinical Research 1, Zeria Pharmaceutical Co., Ltd., 10-11 Nihonbashikobuna-cho,  Chuo-ku, Tokyo 103-8351, Japan E-mail: yuuki-naitou@zeria.co.jp This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives  (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Clin Pediatr Endocrinol 2014; 23(1), 9–15 Copyright© 2014 by The Japanese Society for Pediatric Endocrinology",Non-OADS,/arxiv_data1/oa_pdf/50/d4/cpe-23-009.PMC3924172.pdf
"The guideline for  treatment of childhood-onset Graves’ disease published in Japan in 2008 was mainly based  on clinical trials of adult-onset disease and the  therapeutic experience of pediatricians, and it was recommended that methimazole, an antithyroid drug, should be administered at 0.5–Received: August 26, 2013 Accepted: November 25, 2013 Corresponding author: Dr. Satoshi Takakuwa, Depart- ment of Pediatric Endocrinology and Metabolism, Oki- nawa Prefectural Nanbu Medical Center & Children’s  Medical Center, 118-1 Arakawa Haebaru-cho, Okinawa  901-1193, Japan E-mail: okinawa.endocrinology@gmail.com This is an open-access article distributed under the terms  of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Clin Pediatr Endocrinol 2014; 23(1), 17–25 Copyright© 2014 by The Japanese Society for Pediatric Endocrinology",Non-OADS,/arxiv_data1/oa_pdf/da/b8/cpe-23-017.PMC3924173.pdf
"This is an Open Access article distributed unde r the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/55/eht459.PMC3924183.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7d/b4/TOORTHJ-8-7.PMC3924209.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/a8/TOORTHJ-8-1.PMC3924210.pdf
"Profile of Orang Asli in Peninsular Malaysia, Kuala Lumpur (http://www.statistics.gov.my).",Non-OADS,/arxiv_data1/oa_pdf/7a/36/srep04101.PMC3924211.pdf
"Department of Orang Asli Development (JAKOA) Research and Development Division: Information Database, Jelebu District, Negeri Sembilan, Malaysia(http://www.jakoa.gov.my).",OADS,/arxiv_data1/oa_pdf/7a/36/srep04101.PMC3924211.pdf
"Ministry of Science, Technology and Innovation Database, Malaysia (http://www.met.gov.my).",OADS,/arxiv_data1/oa_pdf/7a/36/srep04101.PMC3924211.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4101 | DOI: 10.1038/srep04101 7",Non-OADS,/arxiv_data1/oa_pdf/7a/36/srep04101.PMC3924211.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/26/04/srep04099.PMC3924212.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4099 | DOI: 10.1038/srep04099 5",Non-OADS,/arxiv_data1/oa_pdf/26/04/srep04099.PMC3924212.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/32/78/srep04095.PMC3924213.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4095 | DOI: 10.1038/srep04095 7",Non-OADS,/arxiv_data1/oa_pdf/32/78/srep04095.PMC3924213.pdf
and T.L.R.helped to conduct lymphocyte transformation test.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/93/11/srep04097.PMC3924215.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4097 | DOI: 10.1038/srep04097 8",Non-OADS,/arxiv_data1/oa_pdf/93/11/srep04097.PMC3924215.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/96/6b/srep04063.PMC3924216.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4063 | DOI: 10.1038/srep04063 7",Non-OADS,/arxiv_data1/oa_pdf/96/6b/srep04063.PMC3924216.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4098 | DOI: 10.1038/srep04098 7",Non-OADS,/arxiv_data1/oa_pdf/b6/af/srep04098.PMC3924217.pdf
"We translated the mRNA sequences into the amino acid sequence, and wepredicted the protein domains by the similarity to domains in the PROSITE database (http://www.expasy.org/prosite/).",OADS,/arxiv_data1/oa_pdf/08/ef/srep04088.PMC3924218.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/08/ef/srep04088.PMC3924218.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4088 | DOI: 10.1038/srep04088 8",Non-OADS,/arxiv_data1/oa_pdf/08/ef/srep04088.PMC3924218.pdf
